Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3003181	u-na	mmol/l (mmol/l)	5186	7292	1.63%
3003181	u-na	— (—)	1758	2140	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Metabolic disorders

2571

2378

6.98

307.65

1.6

1.3

59.98

67.98

mmol/l

9.76

2013

1873

Other bacterial diseases

1784

4180

3.02

307.65

1.6

1.4

60.36

64.16

mmol/l

2.89

1373

3333

Mental and behavioural disorders due to alcohol, excluding acute intoxication

924

2305

4.13

307.65

1.5

1.3

53.36

65.61

mmol/l

13.18

646

1853

Mental and behavioural disorders due to alcohol

1005

2584

3.89

307.65

1.5

1.3

54.27

65.88

mmol/l

12.76

704

2090

1146

2835

3.81

307.65

1.5

1.3

54.82

65.89

mmol/l

13.00

800

2304

Convulsions, not elsewhere classified

579

897

6.64

307.65

1.6

1.5

67.28

67.11

mmol/l

0.03

454

713

Endocrine, nutritional and metabolic diseases

1197

1271

4.87

307.65

1.6

1.3

64.24

71.87

mmol/l

3.94

938

1013

Malaise and fatigue

1182

2075

4.92

307.65

1.6

1.3

59.62

64.69

mmol/l

3.38

961

1631

Anaemias

507

183

19.06

307.65

1.8

59.95

73.99

mmol/l

2.61

378

151

Hypokalaemia

467

387

13.27

307.65

1.8

1.2

63.08

65.58

mmol/l

0.39

375

298

Substance abuse, excluding more controls

1118

2227

4.52

307.65

1.5

1.3

54.54

66.44

mmol/l

13.28

785

1796

Condition for Implicit Sepsis (Organ dysfunction codes)

1633

3752

3.24

307.65

1.5

1.3

60.85

64.07

mmol/l

2.01

1267

2975

Substance abuse

1118

2918

3.76

307.65

1.5

1.3

54.54

65.75

mmol/l

12.99

785

2352

Mental and behavioural disorders due to psychoactive substance use

1144

2969

3.73

307.65

1.5

1.3

54.81

65.56

mmol/l

12.22

803

2389

Hypo-osmolality and hyponatraemia

2749

653

66.87

307.65

1.6

1.2

56.82

63.82

mmol/l

4.00

2160

498

Renal tubulo-interstitial diseases

1621

4221

3.01

307.65

1.5

1.4

56.81

65.45

mmol/l

12.76

1248

3380

Other disorders of fluid, electrolyte and acid-base balance

3079

1145

33.02

307.65

1.6

1.2

58.28

66.35

mmol/l

7.17

2432

884

Implicit Sepsis

1560

3573

3.49

307.65

1.5

1.3

59.08

64.40

mmol/l

4.63

1211

2833

1171

2886

3.73

307.65

1.5

1.3

54.66

65.85

mmol/l

13.55

815

2344

Alcohol use disorder, Swedish definition

1107

2731

3.87

307.65

1.5

1.3

54.05

66.03

mmol/l

14.79

769

2222

General symptoms and signs

1764

2867

3.13

307.65

1.5

1.4

62.33

65.21

mmol/l

1.51

1410

2244

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1811

4390

3.02

307.65

1.6

1.4

60.43

63.96

mmol/l

2.64

1404

3502

Benzodiazepine use

1729

4532

2.76

299.34

1.4

58.02

64.45

mmol/l

7.29

1289

3641

Alcohol use disorder, ICD-based

844

2145

4.06

292.78

1.5

1.3

53.37

65.84

mmol/l

12.27

589

1718

Bacterial infection, other or unspecified

1107

3101

3.32

276.63

1.6

1.3

60.15

64.18

mmol/l

2.36

853

2504

Exclusions for E4_PCOS_BROAD

504

891

5.99

273.23

2.0

1.4

76.03

65.17

mmol/l

4.39

439

721

Heart failure, not strict

1418

3394

2.95

271.91

1.4

58.81

64.68

mmol/l

5.26

1098

2713

Cerebrovascular diseases (FINNGEN)

609

819

5.47

269.71

1.4

1.3

70.98

66.35

mmol/l

1.09

491

627

Bacterial Sepsis

973

2523

3.54

268.01

1.6

1.3

57.61

64.45

mmol/l

5.25

753

2024

Implicit bacterial Sepsis

896

2289

3.72

266.66

1.6

1.3

57.36

64.20

mmol/l

4.90

695

1835

Pneumonia, organism unspecified

1543

4141

2.74

264.79

1.5

1.4

61.73

64.14

mmol/l

1.18

1179

3297

Pneumonias (Asthma/COPD co-morbidities)

1655

4394

2.65

263.58

1.6

1.4

61.68

64.36

mmol/l

1.47

1272

3501

1532

3480

2.81

263.38

1.6

1.4

62.23

63.95

mmol/l

0.69

1189

2756

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1532

3480

2.81

263.38

1.6

1.4

62.23

63.95

mmol/l

0.69

1189

2756

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1640

4410

2.66

262.98

1.5

1.4

61.57

64.21

mmol/l

1.44

1260

3514

All pneumoniae

1661

4404

2.65

262.98

1.6

1.4

61.70

64.36

mmol/l

1.45

1274

3512

Influenza and pneumonia

1695

4329

2.62

259.01

1.6

1.4

62.19

64.48

mmol/l

1.16

1306

3452

Heart failure and antihypertensive medication

506

575

6.01

236.36

1.5

1.3

58.30

68.97

mmol/l

4.00

391

447

Constipation

1512

4236

2.60

233.74

1.4

59.78

64.44

mmol/l

3.88

1176

3393

Fever of other and unknown origin

850

2378

3.38

223.00

1.7

1.4

62.37

64.93

mmol/l

0.88

698

1865

Explicit Sepsis

851

2485

3.38

222.95

1.8

1.3

59.63

65.45

mmol/l

3.35

661

1999

Nausea and vomiting

622

1522

4.16

221.70

1.9

1.5

63.18

65.13

mmol/l

0.46

504

1224

Persons encountering health services for specific procedures and health care

1671

4290

2.45

219.86

1.6

1.4

63.52

63.98

mmol/l

0.15

1365

3347

Hypertension, essential

1123

2152

3.02

213.82

1.4

60.70

66.01

mmol/l

3.04

883

1661

Disorders of lipoprotein metabolism and other lipidaemias

1046

2160

3.09

213.21

1.4

1.2

59.06

67.22

mmol/l

7.08

841

1692

Any mental disorder

1699

3521

2.45

210.26

1.5

1.4

61.55

65.38

mmol/l

2.53

1301

2858

Bleeding

1437

4231

2.52

208.18

1.6

1.3

67.03

61.26

mmol/l

4.37

1128

3353

Hypertensive diseases (excluding secondary)

729

1083

3.98

207.86

1.5

1.4

61.68

68.58

mmol/l

2.67

572

814

Septicaemia

836

2548

3.25

205.55

1.8

1.3

59.16

64.41

mmol/l

2.84

650

2067

Mood disorders, excluding more controls

1402

3364

2.57

203.39

1.5

1.4

58.66

65.32

mmol/l

6.13

1059

2727

Other antidepressants

1600

3433

2.47

203.38

1.5

1.3

61.36

64.67

mmol/l

1.99

1228

2773

Other septicaemia

775

2330

3.37

202.69

1.8

1.3

59.04

64.56

mmol/l

2.87

606

1890

Psychiatric diseases

1627

3372

2.45

201.36

1.5

1.4

62.13

65.23

mmol/l

1.71

1251

2738

Aplastic and other anaemias

933

3021

3.02

201.20

1.6

1.4

57.95

63.37

mmol/l

3.61

734

2428

Pure hypercholesterolaemia

939

2047

3.13

199.09

1.3

1.2

59.91

67.00

mmol/l

5.14

760

1604

Intracranial trauma

872

2074

3.19

197.59

1.5

65.96

61.98

mmol/l

1.51

693

1607

Epilepsy

649

1810

3.68

196.25

1.5

68.29

64.46

mmol/l

1.22

538

1434

Alcohol dependence

545

1367

4.12

192.96

1.5

1.3

52.86

65.85

mmol/l

8.94

376

1114

Hyperkalaemia

190

159

13.06

191.89

1.7

1.2

57.58

62.26

mmol/l

0.60

149

120

Other anaemias

869

2856

3.02

189.11

1.6

1.4

57.15

63.15

mmol/l

4.14

678

2302

Other and unspecified anaemias

863

2836

3.03

188.86

1.6

1.3

56.90

63.17

mmol/l

4.47

675

2284

Syncope and collapse

748

2040

3.32

188.28

1.5

1.3

61.02

64.23

mmol/l

1.24

605

1609

Renal failure

906

2892

2.95

186.15

1.5

1.3

52.90

64.07

mmol/l

14.93

705

2318

Hypertension

1092

2223

2.82

184.17

1.4

61.45

66.75

mmol/l

2.88

858

1716

Symptoms and signs involving cognition, perception, emotional state and behaviour

1467

4423

2.36

184.07

1.4

63.69

62.76

mmol/l

0.34

1187

3469

Hypertensive diseases

1092

2226

2.82

183.81

1.4

61.45

66.74

mmol/l

2.88

859

1719

Other heart diseases

639

1117

3.84

182.84

1.6

1.5

62.19

68.85

mmol/l

2.42

506

852

STROKE

984

2422

2.88

181.93

1.4

1.3

68.29

62.42

mmol/l

3.16

796

1870

Disorders of other endocrine glands

827

2772

3.01

180.29

1.8

1.5

69.37

62.42

mmol/l

4.00

694

2193

Acute tubulo-interstitial nephritis

1036

3508

2.67

177.43

1.6

1.4

58.06

65.71

mmol/l

7.41

814

2830

Volume depletion

239

303

8.34

177.37

2.3

1.3

60.18

66.73

mmol/l

1.12

192

223

Injuries to the head

1612

4782

2.22

173.78

1.5

1.4

62.88

63.93

mmol/l

0.39

1259

3801

Symptoms and signs involving the urinary system

1274

4143

2.42

172.47

1.4

60.55

63.35

mmol/l

1.48

1002

3290

Hypothyroidism (congenital or acquired)

282

178

9.23

172.25

1.9

1.6

71.62

76.34

mmol/l

0.41

227

145

Oxycodone

694

2143

3.22

168.87

1.4

1.3

59.13

63.93

mmol/l

2.21

528

1720

Cardiovascular diseases (excluding rheumatic etc)

739

1284

3.36

167.73

1.6

67.52

70.29

mmol/l

0.62

587

979

Hypothyroidism and >3 levothyroxin purchases

276

177

9.09

167.14

1.7

1.6

71.73

76.14

mmol/l

0.37

223

144

Hypothyroidism, levothyroxine purchases

276

177

9.09

167.14

1.7

1.6

71.73

76.14

mmol/l

0.37

223

144

Schizophrenia or delusion, excluding more controls

481

1218

4.01

165.33

1.4

1.3

54.85

65.34

mmol/l

5.33

351

968

First line medication for Crohn's disease

1581

3909

2.23

164.28

1.6

1.4

64.59

63.69

mmol/l

0.30

1235

3090

Acute renal failure

497

1326

3.92

162.31

1.5

1.3

51.68

63.40

mmol/l

8.13

366

1062

Asthma, unspecified (mode), excluding more controls

750

1950

3.07

161.62

1.4

1.3

62.77

65.33

mmol/l

0.78

589

1549

Tramadol

1156

3015

2.50

160.99

1.5

1.3

59.89

63.55

mmol/l

1.95

899

2401

Anxiety disorders, excluding more controls

1130

3033

2.50

159.29

1.5

1.4

59.46

65.43

mmol/l

4.05

880

2448

Use of hypnotics and sedatives

1536

4068

2.21

158.46

1.4

59.49

64.87

mmol/l

4.97

1193

3229

Depression medications

303

188

8.20

158.38

1.5

64.47

76.90

mmol/l

1.78

244

154

Fall on same level

1604

4173

2.17

157.27

1.5

62.39

64.67

mmol/l

1.12

1244

3330

Complications of surgical and medical care, not elsewhere classified

1445

4781

2.20

154.74

1.5

1.3

63.10

62.75

mmol/l

0.10

1151

3767

Headache

828

2507

2.80

154.24

1.6

1.4

61.88

65.02

mmol/l

1.17

692

1957

Any gastric operation

1077

2082

2.62

153.72

1.6

1.3

65.57

66.80

mmol/l

0.31

831

1693

GASTRO-related operations

1077

2082

2.62

153.72

1.6

1.3

65.57

66.80

mmol/l

0.31

831

1693

Oedema, not elsewhere classified

533

1529

3.56

153.64

1.4

1.3

58.31

64.32

mmol/l

2.48

404

1204

Heart failure,strict

931

2592

2.65

149.01

1.5

1.3

57.31

64.87

mmol/l

6.54

730

2092

Diseases of oesophagus, stomach and duodenum

1521

4369

2.14

147.02

1.5

1.4

61.07

63.70

mmol/l

1.44

1177

3459

Anxiety (asthma-related co-morbidities)

764

2134

2.86

146.23

1.5

56.91

68.16

mmol/l

8.59

584

1725

Dyspnoea

1322

4643

2.21

145.98

1.4

61.14

63.13

mmol/l

0.95

1057

3658

Focal epilepsy

448

1194

3.89

145.97

1.5

70.71

64.40

mmol/l

1.93

369

963

Asthma, unspecified (mode)

780

2222

2.83

145.83

1.4

1.3

62.66

63.94

mmol/l

0.33

617

1763

Other functional intestinal disorders

774

2734

2.75

142.86

1.7

1.4

60.91

64.99

mmol/l

1.82

619

2202

Any reimbursement code in KELA

634

928

3.46

142.26

1.6

1.4

64.51

69.88

mmol/l

1.43

496

716

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

373

885

4.30

141.72

1.6

1.3

56.08

66.72

mmol/l

3.53

263

709

Retention of urine

616

1691

3.16

140.88

1.4

1.3

57.52

65.05

mmol/l

4.58

481

1369

Diseases of arteries, arterioles and capillaries (FINNGEN)

403

651

4.43

140.60

1.4

1.3

56.59

67.80

mmol/l

4.24

312

504

Depression or dysthymia

976

2143

2.58

139.61

1.5

1.4

60.35

65.15

mmol/l

2.53

749

1762

Infections, IBD-co-morbidities

291

374

5.82

138.64

1.9

1.3

58.15

62.94

mmol/l

0.78

240

280

Mood [affective] disorders

1437

4530

2.11

136.90

1.5

1.4

58.86

64.71

mmol/l

5.21

1091

3604

Mood disorders

1441

4542

2.11

136.79

1.5

1.4

58.91

64.63

mmol/l

5.02

1093

3616

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1346

4307

2.15

135.28

1.7

1.4

63.17

63.70

mmol/l

0.15

1056

3405

Symptoms and signs concerning food and fluid intake

243

423

6.01

133.70

1.7

1.5

63.20

68.21

mmol/l

0.71

187

336

Osteopathies and chondropathies

918

3629

2.45

133.01

1.5

1.4

61.38

62.20

mmol/l

0.24

714

2887

Parasetamol

976

1989

2.53

130.76

1.4

1.3

63.09

64.82

mmol/l

0.49

771

1530

Other CVD (FINNGEN)

245

316

6.36

130.19

1.5

1.2

59.89

70.72

mmol/l

2.74

190

254

ILD medications: prednisolone, methylprednisolone, prednisone

1506

4172

2.06

130.10

1.5

1.4

62.55

63.96

mmol/l

0.58

1170

3301

Focal epilepsy, strict definition

412

1124

3.80

129.91

1.5

70.96

64.50

mmol/l

1.90

341

912

Hyperosmolality and hypernatraemia

28.72

129.85

2.2

1.4

66.80

62.41

mmol/l

0.26

Antihypertensive medication - note that there are other indications

620

1064

3.22

129.61

1.5

1.6

64.77

73.75

mmol/l

3.50

503

829

Concussion

663

2043

2.85

128.86

1.5

63.68

61.96

mmol/l

0.42

528

1582

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

334

793

4.41

128.22

1.5

1.3

51.02

63.92

mmol/l

6.02

213

641

Viral Sepsis

397

1067

3.85

127.99

1.8

1.3

64.45

64.28

mmol/l

0.03

321

864

Implicit viral Sepsis

396

1065

3.85

127.55

1.8

1.3

64.39

64.32

mmol/l

0.01

320

862

Diseases of liver

599

2077

2.96

127.33

1.5

1.4

55.14

64.13

mmol/l

5.81

435

1673

Depression

1295

4240

2.13

127.29

1.5

1.4

59.24

64.70

mmol/l

4.19

991

3368

Nutritional anaemias

830

3326

2.48

124.21

1.6

1.4

59.71

62.86

mmol/l

1.40

642

2682

Alcohol abuse, main dg, excluding more controls

260

516

5.20

123.61

1.4

1.3

57.93

66.47

mmol/l

1.85

191

423

Other disorders of urethra and urinary system

975

3155

2.35

123.53

1.5

1.3

63.09

63.90

mmol/l

0.23

782

2511

Transplanted organ and tissue status

242

458

5.57

122.17

1.6

1.5

58.45

67.04

mmol/l

1.89

208

366

Personality disorders, excluding more controls

326

788

4.21

120.95

1.5

1.3

55.23

67.39

mmol/l

4.88

240

631

Heart failure, strict

1009

3209

2.31

120.86

1.5

1.3

57.33

63.66

mmol/l

5.41

792

2581

Cardiovascular diseases

620

1115

3.06

119.45

1.6

1.7

67.30

71.02

mmol/l

0.83

510

856

Alcoholic liver disease

252

505

5.27

119.41

1.5

1.3

51.49

64.11

mmol/l

4.14

154

408

Focal epilepsy, mode (most common among epilepsy diagnosis)

381

1046

3.77

119.05

1.5

72.49

64.76

mmol/l

2.28

318

846

Cerebrovascular diseases

1173

3973

2.15

118.75

1.4

1.3

66.70

61.62

mmol/l

3.27

951

3145

Dental caries

441

1318

3.40

118.42

1.6

1.5

64.82

65.18

mmol/l

0.05

336

1040

Certain infectious and parasitic diseases

1294

3066

2.13

118.37

1.4

61.22

65.91

mmol/l

2.88

1002

2451

Abnormalities of breathing

1168

3219

2.18

117.78

1.5

64.27

64.78

mmol/l

0.13

911

2545

Persons encountering health services in other circumstances, wide

1638

4424

1.94

117.32

1.5

1.4

62.34

63.94

mmol/l

0.69

1280

3497

All-cause Heart Failure

990

3169

2.30

117.18

1.4

1.3

57.35

63.50

mmol/l

5.02

774

2549

Persons encountering health services in other circumstances

579

2058

2.86

117.00

1.4

61.67

64.64

mmol/l

0.82

445

1633

Intracranial injury

850

3506

2.38

116.93

1.5

1.4

65.64

63.96

mmol/l

0.47

672

2799

Atrial fibrillation and flutter

432

781

3.67

116.03

1.4

1.3

60.43

66.28

mmol/l

1.64

338

592

General examination and investigation of persons without complaint and reported diagnosis

941

2101

2.41

115.79

1.5

1.4

63.31

62.75

mmol/l

0.13

738

1640

Other diseases of intestines

1374

3965

2.03

115.66

1.6

1.4

62.07

65.12

mmol/l

1.55

1057

3141

ILD medications

1504

4213

1.98

115.64

1.5

1.4

62.44

64.41

mmol/l

0.90

1170

3341

Oral corticosteroids

1438

4423

1.99

114.64

1.5

1.4

62.44

63.27

mmol/l

0.29

1109

3503

Iron deficiency anaemia

710

2803

2.56

114.52

1.5

1.4

59.53

62.90

mmol/l

1.35

541

2254

Osteoporosis

569

1934

2.91

114.51

1.6

1.3

61.03

60.78

mmol/l

0.05

438

1548

Other diseases of urinary system

1352

3757

2.05

114.50

1.5

1.4

62.25

64.43

mmol/l

1.01

1069

2986

Dialysis, with operation codes

294

692

4.45

114.18

1.6

1.4

53.95

67.43

mmol/l

6.02

244

561

All anxiety disorders

767

2499

2.50

113.79

1.5

1.4

57.08

65.59

mmol/l

5.43

587

1970

Non-invasive ventilation

312

717

4.17

111.98

1.6

1.4

65.09

66.93

mmol/l

0.25

258

563

Other disorders of adrenal gland

160

220

7.93

111.67

1.8

1.4

72.24

63.97

mmol/l

1.20

143

183

Dizziness and giddiness

1049

3988

2.16

111.44

1.4

1.3

64.34

62.59

mmol/l

0.65

859

3136

Asthma, excluding more controls

917

2062

2.40

111.38

1.5

1.3

64.80

65.74

mmol/l

0.23

716

1636

COPD (mode)

525

1407

3.03

110.46

1.4

1.3

55.49

63.74

mmol/l

4.30

388

1116

Codeine

1188

3107

2.12

110.03

1.4

1.3

62.49

64.09

mmol/l

0.55

924

2474

Other heart diseases, wide

1168

3470

2.11

109.97

1.5

61.79

65.51

mmol/l

1.97

932

2712

Opioids

1240

3136

2.10

109.94

1.4

1.3

62.49

64.44

mmol/l

0.75

978

2497

Adrenocortical insufficiency

141

171

9.13

109.70

1.7

1.4

71.93

64.57

mmol/l

0.89

126

145

Cystitis

1136

3295

2.13

109.23

1.6

1.4

60.92

64.13

mmol/l

1.58

897

2628

Unspecified mental disorder

588

2203

2.71

107.50

1.4

54.06

64.87

mmol/l

7.92

426

1739

Acute alcohol intoxication

410

1259

3.33

107.35

1.5

1.3

55.97

65.48

mmol/l

3.91

289

1031

Other symptoms and signs involving cognitive functions and awareness

724

2812

2.46

106.41

1.5

1.3

61.96

62.31

mmol/l

0.08

576

2226

Dentinal caries

392

1175

3.40

105.79

1.5

1.4

64.49

64.93

mmol/l

0.06

295

928

Kela-code for severe mental illness

549

2005

2.79

105.63

1.4

53.88

64.63

mmol/l

7.36

398

1577

Other anxiety disorders

559

1801

2.79

105.40

1.6

1.4

53.60

65.12

mmol/l

8.13

439

1410

Diarrhoea and gastroenteritis of presumed infectious origin

971

4135

2.16

105.27

1.8

1.4

61.51

64.67

mmol/l

1.33

764

3266

Hypopituitarism

185

314

6.24

105.01

2.1

1.6

77.71

69.67

mmol/l

1.03

161

263

Complications of medical and surgical care

1037

4760

2.10

104.64

1.6

1.4

62.83

mmol/l

0.00

834

3763

Substance use, excluding alcohol

311

811

3.93

104.37

1.6

1.3

54.38

65.78

mmol/l

3.61

217

654

Neurotic, stress-related and somatoform disorders

1145

3998

2.06

104.26

1.5

1.4

59.44

64.79

mmol/l

3.52

890

3148

Schizophrenia, schizotypal and delusional disorders

484

1671

2.95

103.50

1.4

54.69

64.05

mmol/l

4.78

353

1320

Asthma (only as main-diagnosis), excluding more controls

821

2062

2.40

103.23

1.4

1.3

64.52

65.74

mmol/l

0.31

656

1636

Anxiety disorders

1158

4066

2.04

102.95

1.5

1.4

59.58

64.67

mmol/l

3.29

901

3209

Schizophrenia or delusion

481

1662

2.95

102.72

1.4

54.85

63.98

mmol/l

4.53

351

1311

Pain, not elsewhere classified

377

1129

3.41

102.59

1.6

1.4

60.85

65.50

mmol/l

1.17

297

883

Poisoning by drugs, medicaments and biological substances

367

1084

3.46

102.22

1.6

1.4

55.91

65.62

mmol/l

3.20

262

853

Symptoms and signs involving the digestive system and abdomen

1328

3367

1.99

102.08

1.5

1.4

62.70

64.74

mmol/l

0.81

1044

2679

Open wound of head

756

3215

2.35

101.85

1.5

1.4

62.19

63.92

mmol/l

0.48

577

2562

Inflammatory bowel disease treatment related agents

1490

4513

1.89

101.82

1.5

1.4

62.89

63.78

mmol/l

0.31

1142

3584

Asthma

968

2344

2.24

101.31

1.4

1.3

64.89

64.34

mmol/l

0.13

759

1858

Pain in throat and chest

1071

3128

2.11

101.08

1.4

63.25

64.17

mmol/l

0.27

849

2463

Used for control exclusion in common control thyroid runs

1335

3452

1.98

100.65

1.6

1.4

64.76

63.90

mmol/l

0.26

1077

2699

Complications of procedures, not elsewhere classified

1088

4662

2.04

100.62

1.5

1.3

62.64

62.81

mmol/l

0.04

861

3680

Type 2 diabetes, wide definition

1163

3771

2.04

100.59

1.4

57.86

63.22

mmol/l

4.38

904

3007

Atrial fibrillation and flutter with reimbursement

378

674

3.67

100.49

1.4

1.3

60.49

66.72

mmol/l

1.68

301

518

Autoimmune diseases excluding thyroid diseases

1333

3808

1.96

100.41

1.6

1.4

62.61

64.66

mmol/l

0.85

1063

3001

Poisoning by medicine

339

963

3.60

100.34

1.5

1.4

56.01

64.87

mmol/l

2.56

240

755

Cardiac arrhythmias

694

1845

2.51

99.24

1.4

62.15

64.63

mmol/l

0.68

557

1427

Nephropathy related operations

275

687

4.18

98.74

1.6

1.4

54.52

66.30

mmol/l

4.48

229

552

Early onset COPD, excluding more controls

330

933

3.62

98.33

1.5

1.3

53.14

65.40

mmol/l

5.34

230

749

COPD/asthma related infections

1348

3483

1.96

98.12

1.5

1.4

62.86

63.98

mmol/l

0.38

1070

2759

COPD/asthma/ILD related infections

1348

3483

1.96

98.12

1.5

1.4

62.86

63.98

mmol/l

0.38

1070

2759

Secondary hypertension

156

236

6.80

97.44

1.5

1.4

61.84

73.66

mmol/l

2.21

135

191

L04AD Calcineurin inhibitors

238

538

4.63

97.38

1.6

58.40

67.38

mmol/l

2.05

198

429

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

405

566

3.62

97.26

1.4

1.6

64.00

68.39

mmol/l

0.82

333

440

Intestinal infectious diseases

1231

4989

1.94

96.91

1.7

1.4

60.71

64.24

mmol/l

1.94

971

3941

Other medical care

652

2638

2.46

96.56

1.5

1.4

61.71

63.76

mmol/l

0.55

523

2091

Excluding asthma or asthma-COPD overlap

1012

2366

2.16

95.88

1.5

1.3

61.12

64.30

mmol/l

1.30

809

1878

Other disorders of electrolyte and fluid balance, not elsewhere classified

36.51

95.83

2.4

1.1

62.89

55.81

mmol/l

0.37

Alcohol withdrawal state with delirium

184

341

5.72

95.36

1.5

1.3

50.85

65.58

mmol/l

4.15

127

281

Stroke, including SAH

983

3511

2.11

95.21

1.4

68.71

61.35

mmol/l

5.22

791

2791

Acute alcohol intoxication, ICD10

326

946

3.54

93.57

1.4

57.57

65.04

mmol/l

1.91

226

763

Kidney transplant status

151

236

6.86

93.38

1.6

1.5

55.71

69.03

mmol/l

2.70

134

197

Other pulmonary diagnosis

1004

2366

2.15

93.31

1.5

1.3

60.84

64.30

mmol/l

1.50

802

1878

ILD medications: immunosuppressive drugs

808

3566

2.20

92.80

1.5

1.4

61.69

64.64

mmol/l

1.10

646

2822

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

467

995

3.01

92.27

1.4

1.3

63.19

67.62

mmol/l

1.07

354

756

Falls/tendency to fall

1356

3589

1.91

92.04

1.5

62.38

64.74

mmol/l

1.07

1051

2880

COPD differential diagnosis

999

2368

2.13

91.51

1.5

1.3

60.88

64.46

mmol/l

1.57

797

1874

ILD differential diagnosis

999

2368

2.13

91.50

1.5

1.3

60.88

64.46

mmol/l

1.57

797

1874

Autoimmune diseases excluding thyroid diseases, strict definition

1256

3655

1.93

90.87

1.6

1.4

62.08

64.14

mmol/l

0.84

1001

2871

Paralytic ileus and intestinal obstruction

448

1595

2.88

90.82

2.0

1.3

58.96

63.75

mmol/l

1.35

327

1291

Hyperfunction of pituitary gland

132

184

7.61

90.50

2.5

1.3

79.60

65.41

mmol/l

2.07

114

160

Asthma (only as main-diagnosis)

853

2344

2.22

90.40

1.4

1.3

64.24

64.34

mmol/l

0.02

685

1858

Disorders of mineral metabolism

153

250

6.38

89.94

2.3

1.3

61.32

65.42

mmol/l

0.45

130

196

Covid-19 confirmed case

461

1679

2.81

89.51

1.5

1.4

61.75

63.46

mmol/l

0.35

375

1339

Care involving dialysis

184

363

5.33

88.78

1.5

1.4

55.14

67.38

mmol/l

3.33

161

288

Asthma (mode)

920

2368

2.15

88.68

1.4

1.3

65.21

64.46

mmol/l

0.18

732

1874

Chronic kidney disease

521

2021

2.63

88.57

1.5

1.3

51.79

63.85

mmol/l

12.87

425

1611

Examination and observation for other reasons

774

2081

2.29

88.23

1.6

1.4

63.48

62.73

mmol/l

0.17

612

1624

Selective serotonin reuptake inhibitors

1254

3466

1.92

88.05

1.4

60.92

64.96

mmol/l

2.34

948

2804

Ascites

183

363

5.33

87.89

1.4

1.3

46.37

62.53

mmol/l

5.78

105

289

Hyperlipidaemia, other/unspecified

447

1526

2.82

86.98

1.4

1.2

56.62

66.34

mmol/l

5.95

368

1203

Diseases of the digestive system

712

3213

2.25

86.39

2.0

1.3

61.91

63.35

mmol/l

0.39

563

2562

Provisional assignment of new diseases of uncertain etiology

600

2537

2.40

85.13

1.5

1.4

62.36

64.21

mmol/l

0.46

483

2001

Medical observation and evaluation for suspected diseases and conditions

885

2110

2.17

85.12

1.4

62.36

62.70

mmol/l

0.07

676

1646

Codes for special purposes

600

2541

2.40

84.83

1.5

1.4

62.36

64.24

mmol/l

0.47

483

2004

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

927

4305

2.02

84.69

1.4

1.3

62.71

62.72

mmol/l

0.00

751

3414

Other and unspecified iron deficiency

531

2149

2.52

83.30

1.5

1.4

59.30

63.64

mmol/l

1.62

407

1726

Low back pain

937

3604

2.02

83.12

1.5

1.4

62.07

62.86

mmol/l

0.22

753

2818

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

373

1263

3.00

82.62

1.6

1.4

56.08

65.19

mmol/l

2.90

263

998

Asthma-related pneumonia

579

2455

2.40

81.71

1.5

1.4

62.92

63.32

mmol/l

0.08

459

1956

Exposure to unspecified factor

1222

5207

1.84

81.70

1.5

1.4

60.00

64.29

mmol/l

2.94

945

4139

Asthma, hospital admissions 3, pneumonia

579

2458

2.40

81.47

1.5

1.4

62.92

63.28

mmol/l

0.07

459

1959

Asthma-related pneumonia or sepsis

579

2458

2.40

81.47

1.5

1.4

62.92

63.28

mmol/l

0.07

459

1959

Autoimmune diseases

1360

3832

1.83

81.46

1.6

1.4

62.97

64.74

mmol/l

0.70

1075

3018

Other neurological diseases

1027

4311

1.94

81.18

1.5

1.4

67.41

61.33

mmol/l

4.14

835

3409

Diabetes, varying definitions

1295

4262

1.83

81.16

1.5

1.4

59.35

64.66

mmol/l

4.34

1009

3382

Abdominal and pelvic pain

1246

3362

1.88

80.99

1.4

62.18

64.70

mmol/l

1.10

990

2674

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1373

4380

1.80

80.83

1.6

1.4

62.11

63.99

mmol/l

0.82

1103

3468

Diabetes mellitus

1296

4266

1.83

80.83

1.5

1.4

59.41

64.67

mmol/l

4.25

1010

3384

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

251

675

3.81

80.73

1.5

1.4

54.80

63.82

mmol/l

1.88

169

534

Neurological diseases, wide definition

345

497

3.52

79.76

1.4

1.7

65.80

67.12

mmol/l

0.16

296

383

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1247

4181

1.84

79.44

1.5

1.4

58.11

64.48

mmol/l

6.22

966

3320

Suicide or other Intentional self-harm

348

1160

3.06

79.41

1.5

1.4

55.11

64.35

mmol/l

2.93

241

918

Other and unspecified nonorganic psychotic disorders

275

795

3.53

79.31

1.4

55.37

64.34

mmol/l

2.32

200

631

Asthma, hospital admission 2, infections

798

3842

2.07

78.58

1.5

63.33

63.40

mmol/l

0.02

638

3047

Asthma-related infections

798

3842

2.07

78.58

1.5

63.33

63.40

mmol/l

0.02

638

3047

Care involving use of rehabilitation procedures

830

3909

2.04

78.22

1.5

1.4

64.83

63.40

mmol/l

0.42

699

3067

COPD

699

2658

2.21

78.08

1.4

1.3

56.69

63.67

mmol/l

4.50

525

2116

Alcohol abuse, main dg

260

739

3.62

77.21

1.4

57.93

65.03

mmol/l

1.51

191

601

Haemorrhage from respiratory passages

523

2010

2.46

76.80

1.5

1.4

61.24

63.66

mmol/l

0.63

402

1617

Non-ischemic cardiomyopathy

513

1713

2.52

76.55

1.5

1.3

57.14

64.00

mmol/l

3.35

394

1378

Asthma (diagnoses ohter than nonallergic)

1094

5113

1.85

75.71

1.4

63.19

63.70

mmol/l

0.15

876

4048

Diabetes medication

1293

4426

1.79

75.71

1.4

58.79

64.58

mmol/l

5.11

1011

3502

Codeine or tramadol medication

1411

4489

1.76

75.59

1.4

1.3

62.86

62.92

mmol/l

0.02

1102

3541

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

827

4152

2.01

75.31

1.6

1.3

64.15

62.90

mmol/l

0.34

665

3283

Neurological diseases

1031

2686

1.95

74.68

1.5

65.80

62.74

mmol/l

1.14

839

2094

Insulin, fast-acting

535

2281

2.39

74.65

1.6

1.4

56.94

65.05

mmol/l

5.06

433

1803

Other chronic obstructive pulmonary disease

671

2581

2.20

74.48

1.4

1.3

56.75

63.58

mmol/l

4.16

504

2061

Injuries to the abdomen, lower back, lumbar spine and pelvis

589

2608

2.28

74.07

1.5

1.4

62.63

62.52

mmol/l

0.02

471

2072

Erysipelas

744

3295

2.09

74.01

1.4

1.3

58.20

63.66

mmol/l

3.10

589

2637

Traumatic subdural haemorrhage

238

644

3.75

73.96

1.5

1.3

70.48

62.66

mmol/l

1.43

189

516

Disorders of lens

907

2903

1.99

73.91

1.5

1.3

59.78

63.17

mmol/l

1.61

721

2305

Other diseases of pleura

690

2896

2.15

73.09

1.5

1.3

59.47

63.35

mmol/l

1.54

518

2342

Other chronic obstructive pulmonary disease, including avohilmo

792

3276

2.04

72.69

1.4

1.3

56.89

64.00

mmol/l

5.10

595

2629

Stroke, excluding SAH

885

3375

1.98

72.60

1.4

66.16

61.82

mmol/l

2.11

709

2691

Diabetes, insulin treatment (Kela reimbursement)

1295

4532

1.76

72.07

1.5

1.4

58.65

64.25

mmol/l

5.10

1005

3594

Hard cardiovascular diseases

1073

3747

1.86

71.39

1.4

66.04

61.26

mmol/l

2.74

858

2940

Insulin, fast-acting or short human

539

2351

2.33

71.37

1.6

1.4

56.84

64.80

mmol/l

4.95

437

1859

Polyuria

345

1229

2.87

70.08

1.4

1.3

62.80

64.61

mmol/l

0.32

280

996

Intestinal stricture

504

2159

2.39

69.97

2.3

1.3

60.14

62.98

mmol/l

0.69

366

1743

Dialysis

118

193

6.56

69.92

1.5

1.4

56.94

71.72

mmol/l

2.72

107

162

Episodal and paroxysmal disorders

1349

3989

1.75

69.82

1.5

65.01

62.55

mmol/l

1.12

1082

3121

Hypertensive heart and/or renal disease

369

1024

2.85

69.67

1.4

1.3

54.87

65.57

mmol/l

5.32

295

815

Gastrointestinal diseases

677

1533

2.23

69.44

1.4

64.69

68.06

mmol/l

0.92

535

1225

Non-selective monoamine reuptake inhibitors

547

2354

2.29

69.24

1.4

1.3

58.23

63.13

mmol/l

2.08

421

1906

Bipolar affective disorders

248

734

3.44

68.98

1.4

1.3

52.55

67.42

mmol/l

5.83

186

580

Pain in limb

992

3880

1.87

68.85

1.4

61.47

63.49

mmol/l

0.77

806

3033

Delirium, not induced by alcohol and other psychoactive substances

242

711

3.53

68.59

1.5

1.3

58.23

61.33

mmol/l

0.57

194

561

Status epilepticus

105

156

7.19

68.15

1.6

1.4

70.84

71.33

mmol/l

0.03

127

Disorders of adult personality and behaviour

342

1231

2.82

67.82

1.5

1.4

54.55

64.73

mmol/l

4.30

255

954

Other or unspecified ileus, impaction or obstruction

318

1104

2.95

67.77

2.2

1.3

61.03

63.37

mmol/l

0.36

227

896

Other diseases of the digestive system

506

2210

2.33

67.10

1.8

1.3

60.09

62.88

mmol/l

0.80

393

1755

Other reaction to severe stress, and adjustment disorders

408

1615

2.56

66.88

1.6

1.4

64.52

64.60

mmol/l

0.01

317

1259

External causes of morbidity and mortality

810

2012

2.03

66.05

1.4

1.5

64.56

65.60

mmol/l

0.23

652

1606

Fracture of lumbar spine and pelvis

387

1507

2.63

66.05

1.5

1.3

62.48

61.57

mmol/l

0.15

305

1196

Type 2 diabetes

1210

4127

1.76

66.02

1.4

58.62

63.96

mmol/l

4.20

934

3264

Insulin medication

810

3595

1.95

65.98

1.5

1.4

57.36

64.31

mmol/l

5.41

652

2861

COPD, early/later onset

677

2786

2.09

65.91

1.4

1.3

56.85

64.14

mmol/l

4.79

510

2244

Personality disorders

326

1165

2.84

65.56

1.5

1.4

55.23

64.55

mmol/l

3.46

240

916

Hypertensive Heart Disease

329

943

2.91

65.54

1.4

1.3

55.07

65.76

mmol/l

4.81

260

756

Gastro-oesophageal reflux disease

849

4004

1.90

64.39

1.5

1.4

63.98

63.52

mmol/l

0.11

674

3183

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

762

3943

1.96

64.34

1.5

1.4

64.43

62.80

mmol/l

0.45

607

3141

Injuries to the thorax

615

2951

2.11

64.31

1.5

1.3

61.00

62.83

mmol/l

0.47

465

2340

Lower back pain or/and sciatica

1236

5042

1.71

64.12

1.4

62.84

62.72

mmol/l

0.03

992

3956

GI-bleeding

503

2235

2.29

64.04

1.8

1.3

59.92

62.93

mmol/l

0.90

393

1774

Benign neoplasm: Pituitary gland, craniopharyngeal duct

119

213

5.88

64.03

1.7

1.4

83.02

64.07

mmol/l

2.86

107

176

COPD, hospital admissions

667

2773

2.07

63.66

1.4

1.3

56.52

64.03

mmol/l

5.07

502

2233

Type 1 diabetes

354

1340

2.68

63.59

1.7

1.5

56.71

66.93

mmol/l

5.01

295

1082

Use of disulfiram, acamprosate or naltrexone

165

391

4.37

63.57

1.4

1.3

52.72

63.96

mmol/l

2.09

110

319

COPD related to multimorbidity

596

2364

2.16

63.54

1.5

1.3

56.84

63.37

mmol/l

3.59

450

1913

Abnormal findings on diagnostic imaging of lung

682

3336

2.02

62.74

1.4

1.3

61.58

62.95

mmol/l

0.39

548

2654

Nonorganic sleeping disorders, excluding more controls

219

637

3.50

62.62

1.5

1.3

57.46

67.14

mmol/l

2.51

170

512

Recurrent or chronic depression

410

1171

2.55

62.48

1.5

1.3

59.53

66.58

mmol/l

2.39

309

953

Other disorders of skin and subcutaneous tissue

902

4540

1.84

62.41

1.5

1.3

59.21

63.04

mmol/l

2.08

727

3601

Other special examinations and investigations of persons without complaint or reported diagnosis

819

2110

1.98

62.38

1.4

66.85

62.70

mmol/l

1.53

651

1646

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

480

2115

2.31

62.33

1.7

1.4

71.25

62.72

mmol/l

3.27

398

1682

Dysphagia

355

1363

2.66

62.32

1.5

1.3

60.18

65.72

mmol/l

1.55

280

1091

Insulin, intermediate and long-acting

744

3787

1.95

62.21

1.5

1.4

57.15

64.08

mmol/l

5.17

597

3008

Symptoms and signs involving the circulatory and respiratory systems

1135

3225

1.78

62.12

1.4

1.5

64.75

64.85

mmol/l

0.02

892

2550

Chronic lower respiratory diseases

1427

4707

1.65

61.23

1.4

1.5

62.51

64.28

mmol/l

0.76

1108

3724

Senile cataract

827

2691

1.93

61.12

1.4

1.3

60.51

63.03

mmol/l

0.97

656

2132

Problems related to lifestyle

165

402

4.22

61.10

1.5

1.4

53.58

65.54

mmol/l

1.97

114

323

Hypothyroidism, drug reimbursement

115

128

6.49

61.02

1.3

1.2

63.28

74.40

mmol/l

1.25

104

Other dialysis

153

6.96

60.99

1.6

1.3

57.02

69.20

mmol/l

1.77

132

Fracture of rib(s), sternum and thoracic spine

442

1905

2.37

60.53

1.5

1.3

62.08

63.20

mmol/l

0.20

331

1514

Type 1 diabetes, wide definition, subgroup 1

289

1012

2.90

60.37

1.7

1.5

56.97

67.19

mmol/l

4.43

245

825

Other soft tissue disorders, not elsewhere classified

1111

3959

1.75

60.32

1.4

62.42

63.78

mmol/l

0.47

900

3090

Symptoms and signs involving the nervous and musculoskeletal systems

748

3936

1.92

60.10

1.5

1.4

63.87

62.99

mmol/l

0.23

612

3121

Alcohol-induced chronic pancreatitis

140

310

4.73

59.02

1.5

1.3

52.50

65.39

mmol/l

2.52

105

249

Chronic pancreatitis

223

688

3.35

58.54

1.6

1.3

57.92

63.07

mmol/l

0.87

171

553

Nontraumatic intracranial haemmorrhage

349

1373

2.60

58.49

1.6

1.3

83.10

61.47

mmol/l

10.96

287

1090

Insulin, combination of fast acting with intermediate-acting or long-acting

814

4086

1.86

58.08

1.5

1.4

57.39

64.09

mmol/l

5.23

654

3239

Accidents

977

2712

1.82

57.65

1.4

1.5

61.19

65.38

mmol/l

2.02

771

2170

Heart failure and bmi 25plus

498

1540

2.27

57.34

1.4

1.3

57.65

63.43

mmol/l

2.42

376

1211

COPD, hospital admission 2, with asthma infections

485

1875

2.25

57.19

1.5

1.3

56.68

63.69

mmol/l

3.43

369

1506

Hypotension

304

1132

2.77

57.10

1.5

1.3

60.78

61.78

mmol/l

0.17

236

897

Unspecified fall

655

3330

1.98

57.03

1.5

62.83

63.67

mmol/l

0.19

507

2656

Other external causes of accidental injury

974

2712

1.81

56.91

1.4

1.5

61.08

65.38

mmol/l

2.11

762

2170

Dorsalgia

1157

3686

1.71

56.87

1.4

64.65

63.28

mmol/l

0.45

939

2883

Osteoporosis with pathological fracture (FG)

182

506

3.80

56.73

1.6

1.3

64.75

57.01

mmol/l

1.42

138

386

Schizophrenia

237

774

3.13

56.31

1.4

53.78

64.38

mmol/l

3.21

164

613

Valvular heart disease excluding rheumatic fever

636

2332

2.02

55.52

1.4

61.13

65.29

mmol/l

1.77

519

1859

Other and unspecified myopathies

179

498

3.74

55.40

1.5

1.3

53.89

63.17

mmol/l

1.93

125

399

Non-rheumatic valve diseases

632

2312

2.02

55.36

1.4

61.03

65.07

mmol/l

1.71

515

1841

Other acute lower respiratory infections

683

3418

1.93

55.12

1.7

1.5

61.34

64.13

mmol/l

1.11

552

2707

Polyneuropathies and other disorders of the peripheral nervous system

343

1379

2.55

54.99

1.5

1.3

58.71

64.22

mmol/l

1.86

277

1110

Continuous positive airway pressure

235

653

3.16

54.94

1.6

69.70

67.06

mmol/l

0.30

179

525

Fracture of skull and facial bones

281

1022

2.80

54.88

1.5

1.3

61.61

65.00

mmol/l

0.57

213

803

Benign neoplasm of other and unspecified endocrine glands

208

642

3.34

54.52

1.6

1.3

73.10

63.78

mmol/l

1.85

183

521

Vocal cord dysfunction

149

335

4.20

54.26

1.4

1.3

65.26

72.18

mmol/l

0.88

120

268

Glomerular diseases

289

1076

2.75

54.17

1.6

1.4

51.59

65.44

mmol/l

8.16

245

865

Diseases of pulp and periapical tissues

434

1946

2.26

53.97

1.6

1.4

61.05

64.03

mmol/l

0.68

333

1515

Diverticular disease of intestine

891

3327

1.80

53.86

1.4

1.3

60.36

63.15

mmol/l

1.22

700

2649

Disorders of calcium metabolism

103

189

5.65

53.79

2.4

1.3

61.97

64.59

mmol/l

0.20

148

541

2630

2.06

53.41

1.5

63.57

65.02

mmol/l

0.34

436

2079

Dermatitis

744

4062

1.85

53.35

1.4

61.18

63.70

mmol/l

0.82

573

3233

Hypothyreosis and Thyroxine purchase for inclusion criteria

1097

4327

1.69

53.25

1.5

1.4

65.45

62.93

mmol/l

1.05

884

3430

Specific personality disorders

274

999

2.78

53.18

1.5

1.4

56.25

64.84

mmol/l

2.55

204

779

Hypothyroidism, other/unspecified

1059

4146

1.70

52.90

1.5

1.4

65.27

62.75

mmol/l

1.03

853

3283

Hypothyroidism, strict autoimmune

839

3083

1.82

52.77

1.5

1.3

62.23

63.34

mmol/l

0.32

675

2439

Spondylopathies

980

3442

1.74

52.72

1.4

60.44

62.26

mmol/l

0.71

786

2687

Diseases of the myoneural junction and muscle

222

728

3.15

52.72

1.5

1.4

56.94

64.39

mmol/l

1.65

163

585

Presence of other functional implants

793

3085

1.84

52.55

1.4

1.3

62.20

62.63

mmol/l

0.11

644

2459

Type 1 diabetes, wide definition

297

1137

2.65

52.31

1.7

1.5

57.03

66.70

mmol/l

4.25

250

922

Early onset COPD

330

1339

2.52

51.82

1.5

1.3

53.14

65.68

mmol/l

6.01

230

1067

Genitourinary diseases

665

1687

1.99

51.50

1.6

1.5

63.19

69.16

mmol/l

2.29

528

1338

Benign neoplasm of colon, rectum, anus and anal canal

702

2669

1.90

51.43

1.4

59.91

63.51

mmol/l

1.52

555

2121

Gastroduodenal ulcer

392

1721

2.31

51.16

1.6

1.3

58.99

61.86

mmol/l

0.72

289

1379

Benign neoplasm: Pituitary gland, craniopharyngeal duct

119

260

4.81

51.13

1.7

1.3

83.02

64.60

mmol/l

2.82

107

213

Other arrhythmias

718

2976

1.86

50.45

1.4

62.33

64.67

mmol/l

0.75

597

2341

Neuromuscular dysfunction of bladder

157

426

3.81

50.26

1.6

1.3

60.42

63.48

mmol/l

0.39

125

343

Other CVD

325

1330

2.50

50.26

1.5

1.3

61.19

62.27

mmol/l

0.18

253

1064

Other and unspecified polyneuropathies, also in other diseases

302

1197

2.58

49.98

1.5

1.3

56.28

63.55

mmol/l

3.08

241

965

Later onset COPD, excluding more controls

326

1021

2.54

49.60

1.4

1.3

60.12

62.34

mmol/l

0.45

264

825

Other disorders of teeth and supporting structures

303

1206

2.56

49.53

1.5

1.4

59.51

63.15

mmol/l

0.79

226

949

Diseases of the skin and subcutaneous tissue

1192

3663

1.64

49.45

1.4

60.00

65.09

mmol/l

3.60

919

2919

Aneurysms, operations, SAH

270

1020

2.71

49.27

1.6

1.3

82.86

62.57

mmol/l

7.34

223

809

Hernia of abdominal wall, postoperative

220

744

3.01

49.16

2.2

1.3

57.53

66.12

mmol/l

2.25

160

612

Diseases of arteries, arterioles and capillaries

898

3916

1.73

48.75

1.4

59.07

62.75

mmol/l

1.87

697

3132

Nerve, nerve root and plexus disorders

1238

4892

1.60

48.66

1.4

62.12

62.68

mmol/l

0.18

995

3834

Spinal stenosis

692

2945

1.86

48.60

1.4

1.3

59.08

61.70

mmol/l

1.05

554

2319

Generalized anxiety disorder

172

505

3.46

48.58

1.7

1.4

62.21

64.54

mmol/l

0.24

131

406

1323

4428

1.59

48.50

1.5

1.4

62.70

63.32

mmol/l

0.21

1076

3482

COPD, hospital admissions 3, with asthma pneumonia sepsis

406

1558

2.26

48.48

1.5

1.3

57.40

63.38

mmol/l

2.21

314

1251

Factors influencing health status and contact with health services

378

776

2.47

48.47

1.4

1.3

63.70

62.94

mmol/l

0.11

304

602

Disorders of gallbladder, biliary tract and pancreas

1174

4713

1.62

48.30

1.5

1.4

61.91

62.94

mmol/l

0.33

907

3738

Pleural effusion

254

941

2.77

48.22

1.5

1.3

58.18

62.75

mmol/l

1.04

189

762

Infections of the skin and subcutaneous tissue

644

3459

1.87

48.00

1.7

1.4

60.25

65.17

mmol/l

2.10

489

2727

Other and unspecified dermatitis

626

3350

1.89

47.98

1.4

61.10

63.94

mmol/l

0.88

492

2658

Any event in cancer register

1052

3781

1.66

47.45

1.4

62.77

63.54

mmol/l

0.21

832

2967

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

560

2530

1.97

47.44

1.3

1.4

61.32

63.88

mmol/l

0.67

418

2018

Exclusions for E4_PCOS_CONSORTIUM

851

3064

1.76

47.27

1.7

1.4

67.32

62.53

mmol/l

2.02

683

2408

Glomerular disorders in diseases classified elsewhere

195

632

3.18

47.24

1.5

1.3

49.49

66.05

mmol/l

8.16

166

505

Deposits [accretions] on teeth

133

322

4.13

47.18

2.9

1.9

77.58

67.81

mmol/l

1.16

110

259

Diseases of the respiratory system

762

2088

1.84

47.06

1.5

1.3

63.48

64.15

mmol/l

0.14

607

1653

Supplementary factors related to causes of morbidity and mortality classified elsewhere

393

1793

2.22

47.01

1.6

1.4

62.90

63.50

mmol/l

0.09

300

1419

Bronchitis

1221

5074

1.59

46.92

1.5

1.4

61.11

63.70

mmol/l

1.36

971

4004

Disorders of thyroid, IBD co-morbidities

179

379

3.48

46.88

1.4

1.3

67.24

64.31

mmol/l

0.33

147

288

Persons encountering health services for examination and investigation

767

2110

1.84

46.87

1.4

64.50

62.70

mmol/l

0.48

619

1646

Fungal Sepsis

182

5.48

46.66

2.2

1.3

59.90

60.87

mmol/l

0.07

152

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1020

3642

1.67

46.57

1.4

62.28

64.00

mmol/l

0.54

788

2880

Polyarthropathies

820

3131

1.76

46.56

1.4

62.03

62.93

mmol/l

0.23

648

2445

Superficial injury of head

316

1320

2.44

46.52

1.4

60.94

64.10

mmol/l

0.61

243

1034

Disorders of the thyroid gland

1087

4386

1.63

46.52

1.5

1.4

66.24

62.87

mmol/l

1.64

876

3473

Invasive ventilation

145

394

3.83

46.52

1.7

1.5

60.04

64.64

mmol/l

0.51

110

321

severe traumatic brain injury, does not include concussion

335

1442

2.37

46.22

1.5

1.3

71.10

61.92

mmol/l

2.69

266

1152

Ischaemic Stroke, excluding all haemorrhages

767

3295

1.78

46.14

1.3

1.4

63.20

62.14

mmol/l

0.28

605

2641

Other cataract

556

2214

1.97

45.97

1.5

1.3

59.95

62.98

mmol/l

1.00

461

1772

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1016

3639

1.66

45.84

1.4

62.29

64.02

mmol/l

0.54

785

2877

Organic, including symptomatic, mental disorders

713

2863

1.82

45.77

1.4

1.3

62.26

61.64

mmol/l

0.15

563

2302

Malignant neoplasm, wide definition for exclusion

1016

3641

1.66

45.75

1.4

62.29

64.00

mmol/l

0.54

785

2878

Other symptoms and signs involving the urinary system

171

522

3.37

45.74

1.3

60.35

66.29

mmol/l

1.12

139

423

Mental and behavioural disorders due to sedatives or hypnotics

120

289

4.29

45.37

1.8

1.3

48.15

62.06

mmol/l

2.58

237

L04AA Selective immunosuppressants

302

1253

2.46

45.23

1.6

1.4

58.64

64.93

mmol/l

1.73

251

1004

Sequelae of external causes of morbidity and mortality

358

1602

2.28

45.07

1.7

1.3

61.87

62.89

mmol/l

0.17

295

1276

Type 2 diabetes, definitions combined

1095

4057

1.62

45.00

1.4

60.16

63.72

mmol/l

1.92

832

3218

Unspecified haematuria

513

2230

2.00

44.96

1.5

1.3

56.84

64.57

mmol/l

4.25

403

1799

Benign neoplasms

770

2449

1.79

44.87

1.5

65.86

65.35

mmol/l

0.10

614

1909

Asthma/COPD (KELA code 203)

1068

4688

1.62

44.75

1.4

1.5

62.72

64.32

mmol/l

0.59

870

3709

Sequelae of cerebrovascular disease

504

2250

2.00

44.22

1.4

1.3

71.24

61.61

mmol/l

4.39

398

1806

Type 2 diabetes, strict (exclude DM1)

1098

4091

1.61

44.20

1.4

60.28

63.61

mmol/l

1.73

833

3246

Fibrosis and cirrhosis of liver

146

414

3.67

44.02

1.4

51.14

62.00

mmol/l

2.50

104

335

Total colectomy operation

188

5.19

43.85

3.3

1.3

60.47

63.90

mmol/l

0.16

162

Total colectomy

188

5.19

43.85

3.3

1.3

60.47

63.90

mmol/l

0.16

162

Type 2 diabetes, definitions combined, including avohilmo

1092

4035

1.61

43.85

1.4

60.19

63.66

mmol/l

1.85

828

3208

Chronic periapical parodontitis

278

1126

2.51

43.85

1.6

1.4

62.28

63.42

mmol/l

0.16

209

885

Acute bronchitis

536

2751

1.93

43.82

1.6

1.4

61.38

63.79

mmol/l

0.76

421

2177

Cirrhosis of liver, NAS

112

267

4.41

43.22

1.4

1.3

46.27

63.51

mmol/l

4.83

218

Cough

487

2378

1.99

43.15

1.4

1.5

61.82

63.81

mmol/l

0.49

382

1904

Neoplasms

764

2315

1.78

43.13

1.5

1.6

66.74

66.41

mmol/l

0.06

613

1814

Lung cancer and mesothelioma

264

889

2.59

42.76

1.3

64.53

62.89

mmol/l

0.24

202

720

Pain (limb, back, neck, head abdominally)

849

2475

1.73

42.76

1.4

1.5

63.43

65.43

mmol/l

0.58

684

1940

Implicit fungal Sepsis

163

5.53

42.67

1.8

1.3

58.27

61.90

mmol/l

0.30

134

Benign neoplasm: Colon

609

2538

1.86

42.47

1.4

60.85

63.46

mmol/l

0.83

482

2022

Other headache syndromes

475

2416

1.99

42.44

1.5

1.4

63.49

62.38

mmol/l

0.24

404

1881

Emotionally unstable personality disorder

135

370

3.71

42.40

1.7

1.3

56.74

65.90

mmol/l

1.38

305

All influenza

317

1384

2.32

42.22

1.9

1.4

63.99

64.24

mmol/l

0.04

253

1119

Injuries to the hip and thigh

625

3174

1.82

42.18

1.5

1.4

59.15

62.86

mmol/l

1.65

491

2535

Benign neoplasm of other and unspecified endocrine glands

208

748

2.86

41.90

1.6

1.3

73.10

62.33

mmol/l

2.38

183

603

Behavioural syndromes associated with physiological disturbances and physical factors

340

1532

2.24

41.83

1.6

1.5

60.81

65.57

mmol/l

1.07

251

1222

Malignant neoplasm

1028

3797

1.62

41.77

1.4

61.42

63.65

mmol/l

0.82

804

2999

Peripheral artery disease

621

2760

1.84

41.75

1.4

1.3

56.12

62.22

mmol/l

3.40

478

2224

Type of accident

363

1684

2.19

41.74

1.6

1.4

63.89

63.48

mmol/l

0.06

276

1340

Other dorsopathies, not elsewhere classified

1113

3704

1.59

41.70

1.4

64.61

63.53

mmol/l

0.33

903

2899

Abnormalities of heart beat

413

1997

2.07

41.44

1.4

1.3

62.63

63.86

mmol/l

0.23

335

1586

Transient ischemic attack

697

3312

1.76

41.44

1.3

1.4

62.26

61.90

mmol/l

0.09

566

2663

Diseases of the eye and adnexa

829

2421

1.72

41.42

1.5

64.99

65.00

mmol/l

0.00

673

1885

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

318

1405

2.31

41.35

1.3

60.95

65.45

mmol/l

1.06

238

1127

Dermatitis and eczema

1219

5217

1.54

41.21

1.4

61.80

63.96

mmol/l

0.94

943

4147

Disorders of choroid and retina

982

4468

1.61

41.04

1.4

1.3

60.07

62.73

mmol/l

1.29

809

3506

Gastric ulcer

274

1144

2.44

40.59

1.6

1.3

58.89

62.22

mmol/l

0.71

201

912

Subarachnoid haemorrhage

183

625

3.01

40.57

1.7

1.3

90.86

62.92

mmol/l

8.22

148

501

Iron deficiency anaemia secondary to blood loss (chronic)

252

1014

2.54

40.50

1.6

1.3

60.17

62.55

mmol/l

0.40

191

817

Mycoses

344

1584

2.21

40.37

1.7

1.4

62.18

63.89

mmol/l

0.29

274

1267

Postmenopausal osteoporosis with pathological fracture

151

469

3.40

39.84

1.6

1.3

62.72

58.87

mmol/l

0.52

115

373

Acute and transient psychotic disorders

169

560

3.09

39.37

1.4

56.97

65.64

mmol/l

1.51

116

440

Asthma, including avohilmo

1308

5065

1.51

39.23

1.4

1.5

63.77

63.67

mmol/l

0.03

1039

3997

Viral hepatitis, IBD co-morbidity

101

6.47

38.89

1.6

1.2

49.50

67.51

mmol/l

1.43

Fracture of femur

411

1866

2.05

38.86

1.5

1.3

57.70

61.58

mmol/l

1.37

322

1496

Other symptoms and signs involving the nervous and musculoskeletal systems

490

2599

1.91

38.74

1.4

64.51

63.57

mmol/l

0.18

400

2047

Ulcer of lower limb, not elsewhere classified

225

878

2.63

38.65

1.4

1.3

56.16

62.49

mmol/l

1.55

181

703

Autoimmune diseases related-to ILD

941

5235

1.59

38.51

1.6

1.4

60.95

63.34

mmol/l

0.97

713

4147

Other degenerative diseases of the nervous system

333

1144

2.24

38.40

1.5

1.3

60.23

61.52

mmol/l

0.23

260

912

Pneumonitis due to solids and liquids

146

452

3.33

38.33

1.8

1.3

65.64

63.60

mmol/l

0.18

115

359

Other (not insulin) diabetes medications

1090

4242

1.56

38.20

1.3

1.4

59.21

63.62

mmol/l

2.80

836

3357

Postprocedural disorders of digestive system, not elsewhere classified

172

5.12

38.19

6.0

1.4

77.59

63.21

mmol/l

1.57

145

Hypothyroidism, strict autoimmune, 3 medication purchases required

949

4069

1.60

38.18

1.4

61.61

62.67

mmol/l

0.33

762

3223

Sub-endpoint used in defining T1D endpoints

371

1765

2.09

38.13

1.7

1.4

56.71

64.86

mmol/l

3.83

311

1399

Benign neoplasms

1049

3738

1.58

37.94

1.4

65.40

63.93

mmol/l

0.46

828

2928

Follow-up examination after treatment for conditions other than malignant neoplasms

496

1699

1.93

37.67

1.4

1.3

59.39

62.27

mmol/l

0.86

408

1325

Ischemic heart diseases

953

3763

1.60

37.37

1.4

60.92

62.23

mmol/l

0.42

757

2940

Acute pancreatitis

271

1169

2.36

37.31

1.5

1.3

61.20

63.77

mmol/l

0.38

196

940

Paroxysmal tachycardia

215

691

2.66

37.17

1.5

1.4

57.89

69.74

mmol/l

3.48

173

541

Intracerebral haemorrhage

200

751

2.73

37.08

1.5

1.3

79.45

61.75

mmol/l

5.08

164

598

Bacterial pneumoniae

486

2296

1.89

36.99

1.5

1.3

59.97

63.86

mmol/l

1.30

383

1848

Extracorporeal dialysis

116

319

3.78

36.69

1.5

1.4

59.48

64.84

mmol/l

0.72

260

Noninfective enteritis and colitis

531

2936

1.82

36.64

2.0

1.4

63.08

64.03

mmol/l

0.18

392

2350

Other gastritis (incl. Duodenitis)

308

1412

2.22

36.63

1.5

1.3

55.55

63.58

mmol/l

2.81

228

1124

Preparatory care for dialysis

228

4.38

36.41

1.5

1.3

55.60

63.69

mmol/l

1.32

188

Diabetic nephropathy, excluding more controls

211

677

2.66

35.89

1.5

1.3

49.70

62.34

mmol/l

5.72

181

522

Other noninfective gastroenteritis and colitis

322

1514

2.16

35.82

2.1

1.4

62.20

64.78

mmol/l

0.48

255

1215

Panic disorder

148

480

3.13

35.67

1.6

1.3

59.80

63.89

mmol/l

0.43

109

386

Schizoaffective disorder

113

310

3.74

35.67

1.4

50.16

64.11

mmol/l

3.26

259

Sequelae with surgical and medical care as external cause

279

1250

2.27

35.21

1.6

1.3

61.62

62.90

mmol/l

0.19

231

998

Unspecified kidney failure

166

582

2.93

35.18

1.6

1.3

53.95

64.08

mmol/l

2.66

134

465

Acidosis

8.85

35.09

1.7

1.2

68.39

64.23

mmol/l

0.16

Injury, poisoning and certain other consequences of external causes

589

1636

1.82

35.06

1.4

1.5

63.78

66.32

mmol/l

0.63

479

1308

Chronic periodontitis

208

819

2.59

35.02

1.4

1.3

64.99

62.78

mmol/l

0.27

159

650

Persons encountering health services for specific procedures, not carried out

108

291

3.81

34.99

2.1

1.4

64.46

64.84

mmol/l

0.02

231

Diseases of oral cavity, salivary glands and jaws

1058

3531

1.55

34.65

1.5

1.4

63.64

63.24

mmol/l

0.10

859

2793

Leisure time condition

242

1027

2.40

34.63

1.6

1.4

65.04

64.21

mmol/l

0.10

183

834

Disorders of eyelid, lacrimal system and orbit

958

4877

1.55

34.50

1.4

61.89

63.11

mmol/l

0.41

785

3848

Ischaemic heart disease, wide definition

929

3716

1.58

34.44

1.4

1.3

60.20

62.33

mmol/l

0.82

746

2900

COPD-related respiratory insufficiency

185

695

2.73

34.37

1.5

1.3

54.57

63.20

mmol/l

1.90

140

559

Asthma, hospital admissions , main diagnosis only

902

5202

1.56

34.29

1.4

1.5

64.00

63.63

mmol/l

0.09

726

4109

Hepatic failure, not elsewhere classified

176

4.78

34.23

1.5

1.3

52.38

64.32

mmol/l

1.56

148

Other diseases of blood and blood-forming organs, wide

298

1387

2.19

34.20

1.6

1.4

64.23

63.82

mmol/l

0.06

234

1118

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

136

301

3.38

34.20

1.5

1.2

65.68

64.93

mmol/l

0.06

122

227

Bacterial pneumonia, not elsewhere classified

460

2192

1.88

34.11

1.5

1.3

59.81

63.78

mmol/l

1.28

362

1762

Acute pancreatitis (for exclusion)

271

1217

2.27

33.99

1.5

1.3

61.20

63.84

mmol/l

0.39

196

975

Disorder of lipoprotein metabolism, unspecified

143

470

3.10

33.78

1.5

1.2

55.97

65.51

mmol/l

2.28

119

364

Other retinal disorders

777

3885

1.62

33.76

1.4

60.39

63.00

mmol/l

1.06

645

3075

Other diseases of the respiratory system

290

1344

2.20

33.68

1.6

1.4

62.98

62.70

mmol/l

0.03

219

1080

Other respiratory disorders and diseases

290

1344

2.20

33.68

1.6

1.4

62.98

62.70

mmol/l

0.03

219

1080

Glucagon-like peptide-1 (GLP-1) analogues

704

3530

1.66

33.46

1.3

57.88

62.78

mmol/l

2.72

545

2826

Spondylosis

626

3181

1.70

33.31

1.4

1.3

62.03

61.82

mmol/l

0.05

516

2497

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

139

456

3.13

33.13

1.6

1.5

56.97

62.68

mmol/l

0.97

113

367

Mental and behavioural disorders due to tobacco

130

410

3.26

33.12

1.6

1.3

53.81

65.34

mmol/l

2.23

334

Nonorganic sleeping disorders

219

906

2.45

33.11

1.5

1.4

57.46

64.80

mmol/l

1.73

170

720

COPD, hospital admissions 1, only main diagnosis

457

2113

1.87

32.93

1.4

1.3

56.95

63.43

mmol/l

2.92

348

1702

Other bacterial intestinal infections

247

1089

2.31

32.40

2.0

1.3

58.33

63.56

mmol/l

1.16

201

853

Smoking dependency

130

416

3.21

32.34

1.6

1.3

53.81

65.55

mmol/l

2.30

340

Sleep disorders

244

1070

2.31

32.32

1.4

58.51

65.33

mmol/l

1.65

185

854

Manic episode

6.05

32.02

1.4

1.3

56.92

63.72

mmol/l

0.59

Other pleural conditions

165

611

2.77

31.59

1.5

1.4

55.31

62.67

mmol/l

1.59

126

490

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

240

1058

2.31

31.56

1.3

61.34

63.83

mmol/l

0.35

168

838

Other metabolic disorders

123

385

3.24

31.55

1.5

1.3

61.31

69.28

mmol/l

1.29

108

299

Undetermined asthma, excluding more controls

146

506

2.93

31.38

1.4

1.3

64.50

66.48

mmol/l

0.22

111

409

Inflammatory diseases of the central nervous system

132

435

3.12

31.25

1.4

1.3

70.37

62.80

mmol/l

0.92

102

345

Candidiasis

188

746

2.57

31.23

2.0

1.3

59.68

63.82

mmol/l

0.62

150

600

Drug-induced adrenocortical insufficiency

6.71

30.91

2.0

1.6

78.91

68.85

mmol/l

0.69

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

229

3.97

30.79

1.6

1.3

48.28

64.46

mmol/l

2.26

193

Other disorders of glucose regulation and pancreatic internal secretion

133

444

3.07

30.78

1.7

1.4

61.01

66.40

mmol/l

0.67

109

362

Biguanides

1064

4423

1.49

30.67

1.3

1.4

59.69

63.08

mmol/l

1.78

816

3511

Atherosclerosis, excluding cerebral and coronary sclerosis

558

2615

1.73

30.67

1.4

1.3

55.80

62.35

mmol/l

3.51

429

2105

Artificial opening status

100

283

3.67

30.39

3.5

1.4

68.38

62.94

mmol/l

0.42

233

KRA_PSY_EATING, excluding more controls

135

4.94

30.31

2.2

1.6

64.17

72.46

mmol/l

0.49

117

Symptoms and signs involving the skin and subcutaneous tissue

744

4719

1.58

30.21

1.4

60.80

63.45

mmol/l

1.03

598

3732

Mixed and other personality disorders

100

283

3.61

30.16

1.5

1.3

54.14

66.62

mmol/l

2.02

233

Persistent mood disorders

234

1042

2.28

29.95

1.5

1.3

54.77

64.12

mmol/l

3.02

178

829

Alcohol-induced acute pancreatitis

154

4.75

29.93

1.5

1.3

57.60

62.38

mmol/l

0.29

130

Other and unspecified drugs and medicaments

133

453

3.02

29.77

1.6

1.4

56.68

62.18

mmol/l

0.94

109

361

Chronic gastritis

368

1944

1.92

29.74

1.4

1.3

61.39

62.78

mmol/l

0.27

282

1548

Intestinal adhesions without obstruction

131

443

3.04

29.68

1.8

1.3

59.04

62.05

mmol/l

0.27

370

Other disorders of bladder

156

579

2.75

29.67

1.4

1.3

63.71

64.60

mmol/l

0.09

116

466

Benign neoplasm of colon, rectum, anus and anal canal

744

4292

1.58

29.53

1.4

1.3

60.26

62.22

mmol/l

0.69

591

3420

Fracture of shoulder and upper arm

449

2530

1.79

29.37

1.6

1.4

58.33

64.09

mmol/l

2.38

358

2013

Parodontitis or operation codes

985

4899

1.49

29.22

1.4

63.40

62.29

mmol/l

0.33

774

3865

Other intervertebral disc disorders

882

3537

1.54

29.20

1.4

1.3

64.34

62.62

mmol/l

0.53

694

2757

Bacterial pneumonia (organism specified)

525

2812

1.72

29.10

1.5

1.4

60.71

63.58

mmol/l

0.88

417

2232

Dorsopathies

1079

3735

1.48

29.10

1.4

63.71

63.80

mmol/l

0.02

858

2929

Vascular disorders of the intestines

112

351

3.29

28.92

1.5

1.3

63.37

61.36

mmol/l

0.19

286

Assault

138

486

2.88

28.89

1.6

1.4

62.49

66.03

mmol/l

0.28

396

Parodontitis

982

4901

1.49

28.76

1.4

63.46

62.28

mmol/l

0.35

772

3866

Other diseases of anus and rectum

351

1850

1.92

28.45

1.5

1.3

60.31

64.63

mmol/l

1.14

268

1491

Abnormal findings on examination of blood, without diagnosis

535

2982

1.70

28.44

1.4

60.14

64.00

mmol/l

1.39

439

2366

Coronary atherosclerosis

819

3439

1.55

28.29

1.4

1.3

59.38

62.25

mmol/l

1.26

661

2697

Insulin, fast-acting (human)

170

674

2.56

28.24

1.4

55.43

65.65

mmol/l

3.02

142

532

Phobic anxiety disorders

116

376

3.12

28.06

1.6

1.5

58.85

66.26

mmol/l

0.88

313

Colectomy operation

236

1086

2.21

28.05

2.2

1.3

55.94

63.38

mmol/l

1.57

146

882

Familial hypercholesterolemia

158

608

2.64

27.90

1.3

1.2

64.96

65.69

mmol/l

0.08

134

465

Sciatica+with lumbago

529

2998

1.69

27.89

1.4

1.3

63.41

62.35

mmol/l

0.23

425

2331

Unknown and unspecified causes of morbidity

260

3.61

27.83

1.6

1.3

58.26

62.44

mmol/l

0.48

198

Other symptoms and signs involving the digestive system and abdomen

203

879

2.35

27.82

1.7

1.4

59.19

65.73

mmol/l

1.22

156

696

Postprocedural endocrine and metabolic disorders, not elsewhere classified

111

353

3.19

27.79

1.5

1.3

60.84

68.30

mmol/l

1.09

273

Chronic periodontitis, including avohilmo

973

4905

1.48

27.66

1.4

63.28

62.34

mmol/l

0.26

766

3868

Lung diseases due to external agents

195

833

2.39

27.65

1.7

1.3

64.37

63.32

mmol/l

0.11

151

669

Mental and behavioural disorders due to opioids

5.76

27.51

2.1

1.3

69.71

69.99

mmol/l

0.01

Hypoglycaemia, other or unspecified

106

332

3.28

27.40

1.7

1.4

62.83

66.71

mmol/l

0.36

272

Respiratory insufficiency

115

378

3.11

27.26

1.8

1.4

66.48

62.00

mmol/l

0.42

308

Missing teeth due to accident, extraction or parodontitis

162

640

2.58

27.25

1.6

1.4

61.25

61.57

mmol/l

0.03

123

507

Gingivitis and periodontal diseases

992

3469

1.48

27.08

1.4

63.71

63.13

mmol/l

0.15

801

2747

Other diseases of liver

218

986

2.25

26.99

1.5

1.4

56.74

65.11

mmol/l

2.13

168

787

Cutaneous abscess, furuncle and carbuncle

276

1366

2.04

26.96

1.6

1.4

60.47

64.09

mmol/l

0.76

203

1078

Coagulation defects, purpura and other haemorrhagic conditions

235

1097

2.18

26.88

1.6

1.4

62.66

65.11

mmol/l

0.33

178

889

Bacterial intestinal infections, IBD co-morbidities

245

1164

2.14

26.81

2.0

1.4

57.72

63.41

mmol/l

1.35

199

921

Viral pneumonia

156

612

2.59

26.58

2.5

1.4

64.46

63.88

mmol/l

0.06

127

494

Undetermined asthma

146

555

2.67

26.42

1.4

1.3

64.50

64.88

mmol/l

0.04

111

454

Other problems related to primary support group, including family circumstances

128

442

2.87

26.41

2.8

1.8

74.80

66.22

mmol/l

1.04

112

374

Visual disturbances and blindness

570

3537

1.63

26.11

1.5

1.4

67.10

62.77

mmol/l

1.48

469

2814

Amputation

151

590

2.62

26.03

1.4

1.3

54.80

62.94

mmol/l

1.71

120

480

Presence of cardiac and vascular implants and grafts

554

2558

1.66

26.03

1.4

1.3

60.23

62.47

mmol/l

0.71

448

2050

Functional dyspepsia

297

1529

1.97

25.96

1.5

1.3

59.10

63.61

mmol/l

1.13

250

1205

Other diseases of hard tissues of teeth

647

3056

1.59

25.86

1.7

1.4

62.74

63.71

mmol/l

0.20

517

2418

Polycystic ovarian syndrome, consortium definition

730

2846

1.56

25.73

1.5

1.4

65.53

61.02

mmol/l

1.81

578

2245

Budesonide

160

646

2.52

25.66

1.7

1.3

66.79

64.13

mmol/l

0.26

112

523

Insomnia

178

755

2.39

25.61

1.4

57.04

64.30

mmol/l

1.45

139

600

Fall on and from stairs and steps

304

1587

1.94

25.55

1.5

1.4

57.48

63.58

mmol/l

1.70

221

1273

Injuries to the elbow and forearm

741

4416

1.53

25.55

1.6

1.4

61.51

63.38

mmol/l

0.59

583

3507

Attention to artificial openings

197

3.96

25.48

2.8

1.3

62.93

65.03

mmol/l

0.13

156

Parodontitis and operation codes

914

4870

1.47

25.46

1.4

63.26

62.34

mmol/l

0.25

718

3838

Migraine

419

2036

1.76

25.46

1.5

67.05

63.92

mmol/l

0.65

339

1586

Cardiomyopathy

211

966

2.22

25.36

1.5

1.3

59.72

64.99

mmol/l

1.00

163

777

Myalgia

248

1209

2.08

25.28

1.3

1.4

65.59

63.11

mmol/l

0.38

200

935

Other/unspecified dorsalgia

408

2326

1.76

25.25

1.5

1.4

61.28

61.94

mmol/l

0.11

340

1812

Peripheral arterial reconstruction

238

1148

2.11

25.12

1.4

1.3

53.33

62.33

mmol/l

2.95

178

927

Dental operations

768

2571

1.54

25.10

1.4

63.66

62.61

mmol/l

0.27

634

2029

149

591

2.56

24.81

1.8

1.4

68.88

67.02

mmol/l

0.15

124

464

Other complications of surgical and medical care, not elsewhere classified

132

495

2.72

24.71

2.4

1.4

65.53

63.12

mmol/l

0.24

107

399

Other specified and unspecified personality disorders

106

354

3.05

24.53

1.6

1.4

54.61

64.61

mmol/l

1.51

289

Obesity related asthma

352

1952

1.82

24.44

1.4

63.05

64.09

mmol/l

0.17

276

1555

Enterocolitis due to Clostridium difficile

163

681

2.45

24.42

1.9

1.3

57.98

61.78

mmol/l

0.57

129

542

Psychotic depression

216

3.69

24.38

1.4

1.3

52.36

63.18

mmol/l

1.66

177

Sequelae of injuries of head

226

3.64

24.37

1.7

1.2

73.62

64.85

mmol/l

0.73

189

Other mental disorders due to brain damage and dysfunction and to physical disease

173

745

2.38

24.25

1.5

1.3

60.89

61.10

mmol/l

0.02

133

593

Degeneration of nervous system due to alcohol

115

4.97

24.18

2.0

1.3

54.10

62.93

mmol/l

0.62

Visual disturbances

517

3194

1.63

24.17

1.5

1.4

67.25

63.17

mmol/l

1.24

426

2532

Somatoform disorder

182

800

2.31

24.15

1.5

1.3

58.28

63.55

mmol/l

0.95

149

637

L04AX Other immunosuppressants

570

3608

1.59

24.01

1.6

1.4

65.15

63.87

mmol/l

0.29

453

2855

Purpura and other haemorrhagic conditions

176

766

2.34

23.99

1.6

1.4

61.66

64.22

mmol/l

0.30

131

619

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

299

1318

1.93

23.93

1.3

63.22

63.91

mmol/l

0.10

233

1055

Other disorders of skin and subcutaneous tissue, not elsewhere classified

192

870

2.25

23.78

1.6

1.3

53.86

64.53

mmol/l

3.55

149

705

Malnutrition

109

5.07

23.76

1.6

1.7

64.76

65.95

mmol/l

0.06

Fracture of lower leg, including ankle

601

3847

1.57

23.71

1.4

59.80

63.42

mmol/l

1.37

464

3039

Second line medication for Crohn's disease

578

3684

1.58

23.64

1.6

1.4

65.31

63.97

mmol/l

0.31

459

2917

Pain associated with micturition

154

637

2.46

23.56

1.5

1.4

58.25

65.07

mmol/l

1.20

130

517

Noninfectious colitis NAS

176

772

2.32

23.55

2.2

1.4

57.17

64.31

mmol/l

1.20

145

628

Degeneration of the brain due to alcohol

118

4.84

23.46

2.0

1.3

54.10

62.82

mmol/l

0.62

Hernia

1006

4819

1.42

23.38

1.6

1.4

61.33

63.01

mmol/l

0.62

792

3798

Oesophageal varices

219

3.66

23.35

1.4

1.3

49.77

66.65

mmol/l

2.95

181

Explicit bacterial Sepsis

129

492

2.67

23.34

1.6

1.3

60.78

65.80

mmol/l

0.65

396

Acute upper respiratory infections of multiple and unspecified sites

739

3701

1.50

23.23

1.5

1.4

62.46

64.06

mmol/l

0.45

584

2895

Direct fill therapy

168

729

2.34

23.04

2.0

1.6

67.05

66.66

mmol/l

0.04

137

591

Cellulitis

245

1233

2.01

22.97

1.5

1.4

59.03

64.34

mmol/l

1.06

185

995

Other systemic involvement of connective tissue (FG)

317

1726

1.85

22.92

1.5

1.3

60.33

62.34

mmol/l

0.42

263

1356

Diagnoses used for exclusion with ILD

307

1668

1.86

22.87

1.5

1.3

64.04

62.99

mmol/l

0.15

245

1321

Soft tissue disorders

1084

4008

1.41

22.87

1.4

1.5

63.15

64.19

mmol/l

0.32

874

3130

Disorders of tooth development and eruption

178

3.86

22.85

3.1

2.4

78.09

75.69

mmol/l

0.14

153

Heartburn

124

469

2.69

22.82

1.5

1.3

71.60

64.90

mmol/l

0.77

372

Dental caries 1 and operation codes

973

3488

1.44

22.72

1.4

63.76

63.44

mmol/l

0.08

771

2768

Hypoparathyroidism

214

3.66

22.69

1.6

1.3

60.12

59.73

mmol/l

0.02

173

Paralytic ileus

177

3.92

22.58

2.3

1.3

62.49

64.62

mmol/l

0.12

146

Diseases of peritoneum

146

602

2.48

22.55

1.6

1.3

56.84

63.21

mmol/l

1.23

110

483

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

234

1151

2.03

22.53

2.3

1.6

69.48

66.95

mmol/l

0.32

191

911

Other general symptoms and signs

166

3.96

22.44

1.7

2.3

70.10

69.64

mmol/l

0.02

135

Other disorders of lacrimal gland

380

2211

1.74

22.43

1.4

63.76

62.89

mmol/l

0.16

310

1750

Weight loss

143

586

2.50

22.42

1.6

1.4

64.59

63.68

mmol/l

0.08

114

468

Acute peritonitis

101

347

2.99

22.41

1.7

1.3

54.51

63.61

mmol/l

1.44

276

Abnormal weight loss

134

533

2.58

22.40

1.6

1.4

62.68

63.24

mmol/l

0.05

107

428

Systemic connective tissue disorders

417

2493

1.69

22.28

1.5

1.3

58.57

62.96

mmol/l

1.60

348

1966

Suppurative and necrotic conditions of lower respiratory tract

281

3.23

22.18

1.7

1.3

54.66

64.55

mmol/l

1.48

231

Viral infections characterized by skin and mucous membrane lesions

440

2667

1.66

22.17

1.4

1.5

61.84

64.33

mmol/l

0.67

359

2106

Injuries to the shoulder and upper arm

879

5162

1.44

22.15

1.5

1.4

61.05

63.18

mmol/l

0.78

705

4063

Persons with potential health hazards related to communicable diseases

312

1703

1.83

22.15

1.6

68.10

66.94

mmol/l

0.16

240

1357

Other nutritional deficiencies

598

3808

1.54

22.12

1.4

62.83

64.26

mmol/l

0.33

446

3013

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

123

4.51

22.09

1.6

1.2

51.27

65.88

mmol/l

2.18

101

Peripheral artery operations in Hilmo

174

782

2.26

22.00

1.3

53.71

63.12

mmol/l

2.66

132

629

Cerebral palsy and other paralytic syndromes

148

621

2.43

21.96

2.5

1.5

66.92

64.85

mmol/l

0.19

119

500

Benign neoplasm: Colon

616

3969

1.53

21.93

1.4

1.3

60.71

62.49

mmol/l

0.52

489

3176

Other diseases of intestine

156

672

2.36

21.82

2.4

1.3

58.87

62.64

mmol/l

0.48

115

562

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1008

4694

1.41

21.69

1.4

63.71

62.48

mmol/l

0.39

794

3690

Stomatitis and related lesions

105

375

2.85

21.62

1.6

1.5

65.00

64.81

mmol/l

0.01

296

Volvulus

126

4.48

21.56

1.9

1.3

56.42

61.91

mmol/l

0.44

105

Intestinal malabsorption

216

3.53

21.53

3.8

1.3

57.78

64.69

mmol/l

0.74

175

Other diseases of pancreas

116

439

2.71

21.48

1.6

1.3

59.58

63.55

mmol/l

0.41

350

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

133

537

2.53

21.47

1.5

1.4

61.19

62.86

mmol/l

0.15

106

429

Conduction disorders

333

1559

1.79

21.39

1.4

1.3

57.44

65.05

mmol/l

2.75

260

1250

Traumatic subarachnoid haemorrhage

144

4.16

21.28

1.4

1.2

83.79

62.56

mmol/l

2.15

113

Heart failure and coronary heart disease

434

1957

1.67

21.23

1.4

1.3

58.49

61.06

mmol/l

0.73

346

1581

Agranulocytosis

151

650

2.37

21.21

1.8

1.5

67.95

63.82

mmol/l

0.56

110

526

Diabetic nephropathy

212

1033

2.06

21.11

1.5

1.3

49.70

61.16

mmol/l

5.39

181

797

Complications of internal orthopaedic prosthetic devices, implants and grafts

291

1597

1.85

21.11

1.4

59.90

62.14

mmol/l

0.47

234

1279

Amenorrhoea

180

3.72

21.10

2.5

1.4

69.98

64.49

mmol/l

0.29

142

Glomerulonephritis

137

566

2.47

21.09

1.7

1.4

55.45

64.85

mmol/l

1.97

116

456

Type 1 diabetes, definitions combined

102

362

2.85

21.07

2.3

1.7

64.49

74.79

mmol/l

1.47

307

Disorders resulting from impaired renal tubular function

191

3.71

21.06

1.5

1.3

56.56

66.66

mmol/l

1.30

155

Type 1 diabetes, strict (exclude DM2)

102

363

2.84

20.97

2.3

1.7

64.49

74.40

mmol/l

1.39

308

Statin medication

695

2601

1.51

20.93

1.3

1.4

61.24

64.50

mmol/l

1.11

558

1987

Zoster [herpes zoster]

228

1162

1.99

20.75

1.4

1.3

58.10

62.76

mmol/l

1.11

188

932

Erosion of teeth

6.79

20.66

3.4

2.0

67.50

65.22

mmol/l

0.07

Hydrocephalus

121

478

2.60

20.57

1.7

1.4

92.21

62.03

mmol/l

6.96

107

378

Open wound of lower leg

182

858

2.15

20.47

1.4

57.29

64.58

mmol/l

1.67

140

697

Finngen Rheumatological endpoints

951

3862

1.41

20.44

1.4

62.63

63.38

mmol/l

0.21

766

2989

Migraine with aura

198

962

2.08

20.43

1.5

1.4

58.69

64.80

mmol/l

1.34

161

751

Sleep disorders (combined)

1000

4732

1.39

20.41

1.4

62.95

62.98

mmol/l

0.01

785

3743

Dental caries 3 and operation codes

993

3646

1.40

20.37

1.4

64.18

63.66

mmol/l

0.13

781

2904

ILD medications: azathioprine

159

711

2.27

20.34

1.8

1.4

63.33

66.83

mmol/l

0.40

120

566

Drug-induced osteoporosis with pathological fracture

5.36

20.34

1.6

1.3

69.97

61.83

mmol/l

0.39

Other and unspecified injuries of head

317

2.98

20.33

1.3

1.4

61.46

63.27

mmol/l

0.13

252

Collagenous colitis

126

510

2.53

20.32

2.1

1.3

65.34

61.31

mmol/l

0.55

411

Focal brain injury

265

3.15

20.17

1.5

1.3

75.63

65.50

mmol/l

0.89

210

Benign neoplasm of other and ill-defined parts of digestive system

212

1066

2.02

20.06

1.3

1.4

58.17

63.63

mmol/l

1.36

167

852

Pain in joint

542

2309

1.56

19.96

1.5

1.4

64.16

64.80

mmol/l

0.12

427

1804

Endovascular or surgical operations to intracerebral aneurysms

348

2.86

19.93

1.6

1.4

89.37

61.30

mmol/l

5.55

280

Dental pulpitis 2

799

2827

1.45

19.90

1.4

64.26

63.06

mmol/l

0.32

655

2250

Other and unspecified mood [affective] disorders

197

3.50

19.90

1.2

48.98

65.95

mmol/l

2.90

172

Dental caries 1

873

3136

1.43

19.85

1.4

64.04

63.45

mmol/l

0.14

705

2493

Benign neoplasm: Colon, unspecified

276

1511

1.84

19.84

1.4

1.3

62.10

64.08

mmol/l

0.35

220

1204

Dental caries, including avohilmo

872

3134

1.43

19.79

1.4

64.06

63.48

mmol/l

0.14

705

2491

Enlarged lymph nodes

146

637

2.32

19.78

1.5

1.4

64.88

66.77

mmol/l

0.20

110

504

Obsessive-compulsive disorder

147

3.93

19.74

1.8

1.4

61.73

72.39

mmol/l

0.62

130

Injuries to the knee and lower leg

1205

5138

1.35

19.72

1.4

61.19

64.12

mmol/l

1.66

951

4065

Exposure to other specified factors

697

4497

1.46

19.71

1.5

1.4

60.23

64.97

mmol/l

2.26

536

3546

Non-allergic asthma (mode), excluding more controls

191

920

2.08

19.69

1.5

1.4

66.92

66.99

mmol/l

0.01

159

734

Disorders of lacrimal system

458

2896

1.60

19.59

1.4

62.87

62.57

mmol/l

0.05

373

2293

Congenital malformations, deformations and chromosomal abnormalities

515

3196

1.55

19.57

1.7

1.4

68.29

64.79

mmol/l

0.84

403

2522

Deforming dorsopathies

298

1689

1.78

19.36

1.3

1.4

61.94

63.70

mmol/l

0.31

236

1334

Sequelae of injuries, of poisoning and of other consequences of external causes

244

1301

1.90

19.36

1.5

1.4

63.78

63.12

mmol/l

0.08

192

1027

Osteonecrosis

299

2.99

19.36

1.4

1.3

60.51

59.65

mmol/l

0.06

239

Disorders of continuity of bone

111

433

2.61

19.30

1.5

1.4

60.94

63.37

mmol/l

0.22

354

Streptococcal septicaemia

109

422

2.64

19.27

1.7

1.3

61.79

64.88

mmol/l

0.29

342

Dental pulpitis 4

1135

4356

1.36

19.24

1.5

1.4

65.52

63.17

mmol/l

0.93

886

3482

Speech disturbances, not elsewhere classified

128

536

2.44

19.22

1.5

1.3

69.77

60.90

mmol/l

1.16

101

426

Dental pulpitis 1

1135

4358

1.36

19.21

1.5

1.4

65.50

63.16

mmol/l

0.93

886

3484

Diseases of pulp and periapical tissues, including avohilmo

1133

4354

1.36

19.06

1.5

1.4

65.34

63.16

mmol/l

0.84

885

3479

Somnolence, stupor and coma

214

3.37

18.98

1.5

1.3

58.81

66.54

mmol/l

0.78

168

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

255

1148

1.88

18.94

1.3

63.61

64.15

mmol/l

0.07

197

921

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

286

3.00

18.93

1.5

1.3

62.83

66.36

mmol/l

0.25

235

Gout

322

1707

1.74

18.90

1.4

1.3

54.02

61.79

mmol/l

3.61

250

1344

Major coronary heart disease event

823

3892

1.42

18.89

1.4

1.3

61.88

61.95

mmol/l

0.02

660

3088

Pruritus

135

583

2.36

18.85

1.4

60.19

64.66

mmol/l

0.68

110

473

Primary_lymphoid and hematopoietic malignant neoplasms

269

1494

1.82

18.76

1.4

60.08

64.01

mmol/l

0.83

227

1203

Angina pectoris

700

3260

1.46

18.72

1.4

1.3

61.51

62.35

mmol/l

0.22

562

2570

Azathioprine

159

737

2.18

18.67

1.8

1.4

63.33

66.38

mmol/l

0.34

120

589

Osteomyelitis

316

2.89

18.65

1.5

1.4

55.47

65.17

mmol/l

1.44

261

Amyloidosis, other/unspecified

6.68

18.54

1.5

1.1

48.18

65.68

mmol/l

1.86

Amyloidosis

6.02

18.52

1.5

1.2

51.20

65.52

mmol/l

1.40

Dental pulpitis 2, only avohilmo

806

2900

1.43

18.36

1.4

64.33

63.19

mmol/l

0.29

655

2310

Disturbances of skin sensation

255

1404

1.83

18.28

1.5

1.4

61.34

63.73

mmol/l

0.40

202

1112

Transport accidents

382

2075

1.64

18.22

1.4

1.5

63.06

66.24

mmol/l

0.69

311

1641

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

490

2476

1.56

18.19

1.4

1.3

58.42

63.71

mmol/l

1.99

355

1980

Dental caries 3

903

3323

1.40

17.97

1.4

64.18

63.66

mmol/l

0.13

727

2655

Decubitus ulcer and pressure area

340

2.78

17.94

1.6

1.3

50.11

62.15

mmol/l

2.35

271

Other systemic involvement of connective tissue

321

1901

1.71

17.92

1.5

1.4

60.64

62.73

mmol/l

0.44

267

1504

Lumbar disc prolapse

612

3317

1.47

17.77

1.4

1.3

62.64

62.61

mmol/l

0.01

481

2589

Chronic periodontitis, complicated

126

543

2.37

17.76

1.4

1.3

64.88

62.06

mmol/l

0.26

438

Pulmonary heart disease, diseases of pulmonary circulation

379

2349

1.63

17.71

1.4

62.94

62.36

mmol/l

0.10

287

1885

Abnormalities of gait and mobility

154

722

2.17

17.70

1.4

62.61

64.24

mmol/l

0.21

132

586

Anaemia in chronic diseases classified elsewhere

120

4.18

17.59

1.6

1.3

56.39

62.83

mmol/l

0.52

100

Visual field defects

115

478

2.46

17.58

1.7

1.3

75.11

62.18

mmol/l

1.92

100

379

Irritable bowel syndrome

261

1468

1.79

17.45

1.6

1.3

62.32

64.91

mmol/l

0.45

213

1182

AV-block

204

960

1.95

17.44

1.3

55.06

64.68

mmol/l

2.88

157

773

Diabetic retinopathy, excluding more controls

291

924

1.80

17.39

1.4

57.20

60.58

mmol/l

0.76

237

712

Migraine without aura

144

660

2.20

17.36

1.6

68.68

67.46

mmol/l

0.10

117

514

Diseases of the musculoskeletal system and connective tissue

524

1713

1.54

17.31

1.4

1.6

63.74

66.75

mmol/l

0.76

426

1337

Eating disorder

205

3.25

17.29

2.2

1.6

64.17

71.11

mmol/l

0.41

180

Allergic asthma (mode), excluding more controls

173

835

2.05

17.29

1.5

1.4

60.37

68.37

mmol/l

1.67

140

660

Later onset COPD

350

1669

1.67

17.16

1.4

1.3

59.84

62.59

mmol/l

0.68

283

1345

Gout, FINNGEN

322

1933

1.68

17.11

1.4

1.3

54.02

62.87

mmol/l

4.68

250

1549

Disorders of parathyroid gland

274

1555

1.76

17.09

1.5

1.3

55.82

60.38

mmol/l

1.32

221

1233

ILD, hospital admission 2, with pulmonary infections

111

461

2.45

16.98

1.3

66.47

61.69

mmol/l

0.59

100

364

Dentofacial anomalies [including malocclusion]

236

1286

1.83

16.87

2.4

1.5

68.06

65.19

mmol/l

0.43

203

1014

Diaphragmatic hernia

421

2708

1.57

16.84

1.5

1.4

59.02

62.90

mmol/l

1.38

346

2162

Cardiomyopathy, other and unspecified

380

2.60

16.80

1.5

1.4

59.74

64.34

mmol/l

0.45

305

Haemorrhage, not elsewhere classified

156

3.63

16.79

1.4

1.3

60.42

60.08

mmol/l

0.02

123

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

258

3.00

16.75

1.2

1.3

56.46

64.37

mmol/l

1.22

206

Calcific aortic valvular stenosis, operated

369

2257

1.62

16.70

1.3

59.90

61.86

mmol/l

0.45

293

1809

Calcific aortic valvular stenosis

369

2257

1.62

16.70

1.3

59.90

61.86

mmol/l

0.45

293

1809

Other symptoms and signs involving the circulatory and respiratory systems

302

2.80

16.62

1.3

1.4

55.71

64.00

mmol/l

0.92

241

Abnormal involuntary movements

153

734

2.12

16.56

1.7

1.4

60.96

63.97

mmol/l

0.50

124

589

Monoamine oxidase A inhibitors

129

578

2.26

16.55

1.4

1.3

58.31

65.33

mmol/l

1.09

472

Persistent delusional disorders

105

431

2.49

16.52

1.2

1.3

57.53

60.94

mmol/l

0.39

344

Other and unspecified effects of external causes

253

1440

1.77

16.29

1.7

1.5

61.02

64.64

mmol/l

0.63

196

1150

Non-allergic asthma (mode)

191

987

1.93

16.25

1.5

1.4

66.92

65.89

mmol/l

0.11

159

796

Calcific aortic valvular stenosis, including rheumatic fever

367

2256

1.61

16.22

1.3

59.28

61.63

mmol/l

0.59

291

1807

Unspecified acute lower respiratory infection

162

800

2.05

16.20

1.4

57.73

64.27

mmol/l

1.36

138

637

Fracture of forearm

574

3708

1.46

16.19

1.5

1.4

61.92

62.76

mmol/l

0.19

454

2944

Scoliosis

381

2.56

16.17

1.4

1.5

64.19

62.43

mmol/l

0.14

313

Viral pneumonia (known virus, not influenza)

110

4.17

16.13

3.1

1.5

72.63

60.84

mmol/l

0.94

Charcot foot

5.16

16.12

1.3

1.2

53.66

67.68

mmol/l

1.17

Operations 2 for CAVS

365

2250

1.60

16.01

1.3

59.20

61.59

mmol/l

0.60

289

1802

Calcific aortic valvular stenosis, diagnosis (helper)

365

2250

1.60

16.01

1.3

59.20

61.59

mmol/l

0.60

289

1802

Abnormal findings on examination of urine, without diagnosis

222

3.10

15.97

1.5

1.4

61.80

64.17

mmol/l

0.19

188

Hypertensive Renal Disease

147

3.63

15.95

1.5

1.3

56.96

63.62

mmol/l

0.66

119

Other abnormal uterine and vaginal bleeding

276

1138

1.75

15.95

1.4

1.3

68.86

59.93

mmol/l

2.54

212

871

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

112

482

2.37

15.91

1.3

1.4

56.28

63.17

mmol/l

1.38

381

Other disorders of ear

951

4733

1.34

15.87

1.4

65.18

62.65

mmol/l

1.00

773

3734

Acute sinusitis

458

2827

1.52

15.82

1.5

1.4

65.92

63.67

mmol/l

0.50

370

2181

Benign neoplasm of other and ill-defined parts of digestive system

212

1157

1.86

15.82

1.3

1.4

58.17

61.94

mmol/l

0.80

167

930

Cerebral aneurysm, nonruptured

111

477

2.37

15.79

1.4

71.17

63.28

mmol/l

0.92

384

Alzheimer disease, excluding more controls

195

674

1.95

15.79

1.3

62.97

60.56

mmol/l

0.38

153

546

Post-traumatic stress disorder

172

3.35

15.71

3.2

1.3

53.57

66.21

mmol/l

1.01

150

Fracture of neck

312

2.73

15.70

1.8

1.3

60.04

63.48

mmol/l

0.36

253

Chronic ulcer of skin, not elsewhere classified

400

2.51

15.66

1.7

1.3

47.92

62.34

mmol/l

4.52

318

Venous thromboembolism

592

4018

1.44

15.65

1.4

63.18

62.14

mmol/l

0.25

458

3204

Other inflammatory liver diseases

341

2.64

15.64

1.7

1.3

57.38

64.78

mmol/l

1.01

274

Elevated blood glucose level

106

449

2.41

15.59

1.4

60.11

65.35

mmol/l

0.58

367

Degeneration of macula and posterior pole

553

3141

1.46

15.53

1.4

1.3

61.12

62.10

mmol/l

0.24

460

2501

Disorders of oesophagus in diseases classified elsewhere

4.36

15.49

1.5

1.3

48.03

61.37

mmol/l

1.66

Other eating disorders

117

3.90

15.49

2.0

1.7

66.23

76.75

mmol/l

0.44

110

Other viral diseases

254

1465

1.74

15.47

1.9

1.6

70.28

65.79

mmol/l

0.67

216

1161

Encephalitis

132

3.76

15.38

1.3

1.4

64.38

65.10

mmol/l

0.03

112

Myocardial infarction, without ST-elevation

462

2851

1.51

15.30

1.4

1.3

58.41

62.16

mmol/l

1.49

374

2289

Benign neoplasm: Stomach

121

547

2.25

15.30

1.3

57.67

62.79

mmol/l

0.92

104

437

Cervical disc disorders

368

2350

1.58

15.22

1.5

1.3

64.46

62.75

mmol/l

0.32

299

1836

Disorders of skin appendages

417

2735

1.53

15.21

1.4

61.52

64.91

mmol/l

0.90

323

2166

Malignant neoplasm of head and neck

108

467

2.36

15.18

1.5

1.3

60.37

61.76

mmol/l

0.10

374

Duodenal ulcer

133

626

2.16

15.17

1.6

1.3

58.85

63.48

mmol/l

0.57

495

Myocardial infarction

578

2885

1.45

15.10

1.4

1.3

60.62

62.19

mmol/l

0.41

462

2279

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

102

4.16

15.10

1.4

1.3

82.44

63.18

mmol/l

2.17

Thrombocytopenia, unspecified

395

2.48

15.09

1.9

1.4

65.58

61.27

mmol/l

0.33

320

Major coronary heart disease event excluding revascularizations

745

3736

1.38

15.04

1.4

1.3

60.82

61.85

mmol/l

0.29

597

2964

Parkinson's disease, excluding more controls

136

630

2.13

15.02

1.3

1.2

72.60

61.49

mmol/l

2.47

105

515

Speech and linguistic disorders, excluding more controls

220

2.95

14.92

2.9

2.4

72.40

72.97

mmol/l

0.03

194

Cardiomyopathy (excluding other)

141

683

2.09

14.92

1.6

1.3

56.40

65.33

mmol/l

1.98

111

543

Pyothorax

221

3.03

14.86

1.5

1.3

55.21

62.58

mmol/l

0.74

180

Pacemaker

398

2530

1.54

14.81

1.3

59.50

62.26

mmol/l

0.71

314

2045

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

232

2.97

14.80

1.5

1.3

65.36

61.29

mmol/l

0.26

184

Dental operations, only avohilmo

770

2861

1.39

14.80

1.4

62.94

63.30

mmol/l

0.08

627

2258

Unspecified urinary incontinence

118

536

2.24

14.78

1.3

62.19

61.61

mmol/l

0.05

429

Erosion of teeth, including avohilmo

173

871

1.94

14.74

1.8

1.5

64.43

63.86

mmol/l

0.05

137

692

Other diseases of oesophagus

118

536

2.24

14.74

1.6

1.3

53.88

62.09

mmol/l

1.46

430

Obesity and other hyperalimentation

538

3700

1.45

14.73

1.3

1.4

62.68

64.33

mmol/l

0.36

391

2935

Dependent personality disorder

4.50

14.65

2.0

1.3

51.77

61.85

mmol/l

1.03

Other encephalitis

118

3.85

14.63

1.3

1.4

65.47

64.67

mmol/l

0.04

102

Amputation of ankle bones

105

4.07

14.58

1.3

51.35

60.13

mmol/l

0.68

Molar incisor enamel hypoplasia

120

3.78

14.56

2.4

3.6

79.14

83.25

mmol/l

0.19

113

Allergic asthma (mode)

173

890

1.92

14.51

1.5

1.4

60.37

66.97

mmol/l

1.26

140

708

Need for other prophylactic measures

303

2.67

14.40

1.6

1.5

63.95

62.57

mmol/l

0.10

249

Other disorders involving the immune mechanism, not elsewhere classified

129

3.67

14.33

2.3

1.6

60.95

61.05

mmol/l

0.01

111

Temporomandibular joint disorders

140

686

2.06

14.32

1.6

1.4

66.41

65.74

mmol/l

0.06

123

527

Infection of intervertebral disc (pyogenic)

5.95

14.31

2.2

1.4

58.95

52.00

mmol/l

0.36

Drug-induced neutropenia

393

2.44

14.30

1.3

66.62

62.70

mmol/l

0.40

322

Paraplegia, diplegia of upper limbs

102

4.07

14.30

1.6

1.2

57.58

64.41

mmol/l

0.49

Fentanyl

124

582

2.16

14.26

1.8

1.3

57.23

62.57

mmol/l

0.70

454

Any dementia, excluding more controls

396

1791

1.55

14.22

1.4

1.3

63.53

61.95

mmol/l

0.35

321

1474

Dental caries 3, only avohilmo

902

3453

1.34

14.20

1.4

63.59

mmol/l

0.00

721

2757

Obesity

531

3672

1.44

14.19

1.3

1.4

62.43

64.34

mmol/l

0.43

390

2912

Viral and other specified intestinal infections

168

860

1.92

14.10

2.5

1.6

67.33

67.82

mmol/l

0.04

137

692

Reimbursement for rheumatic diseases

581

4123

1.41

14.04

1.5

1.4

62.52

62.86

mmol/l

0.07

475

3253

Pulmonary embolism

332

2113

1.59

14.02

1.4

1.3

63.09

62.26

mmol/l

0.14

251

1694

Other diseases of lip and oral mucosa

175

935

1.89

14.00

1.4

59.27

62.69

mmol/l

0.55

143

730

Other diseases of spinal cord

136

3.56

13.99

1.7

1.5

56.11

62.73

mmol/l

0.54

116

Pulmonary heart disease

332

2114

1.58

13.99

1.4

1.3

63.09

62.31

mmol/l

0.13

251

1697

Misadventures to patients during surgical and medical care

151

769

1.99

13.95

1.5

1.4

57.04

64.39

mmol/l

1.25

122

625

Meningitis

229

2.90

13.92

1.3

76.36

66.08

mmol/l

0.81

192

Recurring oral aphthae

246

2.84

13.90

1.8

1.5

66.90

64.38

mmol/l

0.19

201

Dental caries 1, only avohilmo

861

3285

1.35

13.88

1.4

63.80

63.42

mmol/l

0.09

694

2611

Glaucoma

623

3936

1.40

13.87

1.4

1.3

59.58

62.43

mmol/l

1.13

506

3131

Other and unspecified local infections of skin and subcutaneous tissue

111

505

2.23

13.85

2.4

1.4

59.56

63.70

mmol/l

0.41

414

Vitamin deficiency, wide

241

2.85

13.83

1.6

1.3

69.02

62.20

mmol/l

0.51

200

Vitamin deficiency

241

2.85

13.83

1.6

1.3

69.02

62.20

mmol/l

0.51

200

Oesophagitis

275

2.71

13.79

1.5

1.3

55.71

62.42

mmol/l

0.77

215

Cardiomyopathies, Primary/intrinsic

133

650

2.07

13.78

1.6

1.4

56.38

64.39

mmol/l

1.60

106

521

Primary_lymphoid and hematopoietic malignant neoplasms

269

1636

1.66

13.73

1.4

60.08

62.80

mmol/l

0.50

227

1310

Type 1 diabetes, strict definition

246

2.79

13.71

2.8

1.9

65.82

80.48

mmol/l

1.78

206

5-aminosalicylic acid

186

1021

1.84

13.61

2.1

1.4

63.08

65.13

mmol/l

0.24

126

824

Arthropathies in other diseases classified elsewhere

179

3.16

13.58

1.4

1.3

57.45

61.99

mmol/l

0.35

145

Acute upper respiratory infections

1037

5018

1.30

13.57

1.5

1.4

63.77

63.09

mmol/l

0.20

844

3955

Superficial injury of hip and thigh

168

895

1.90

13.57

1.6

1.3

59.94

62.83

mmol/l

0.46

140

720

Other arthritis (FG)

302

1894

1.61

13.56

1.5

1.4

63.73

63.78

mmol/l

0.01

245

1480

Recurring oral aphthae, including avohilmo

151

777

1.97

13.56

1.4

65.35

63.93

mmol/l

0.17

124

636

Special screening examination for other diseases and disorders

335

2.51

13.54

1.4

1.3

61.62

65.82

mmol/l

0.42

257

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

112

517

2.21

13.54

1.5

1.3

57.52

63.14

mmol/l

0.99

415

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

120

3.69

13.51

2.2

1.7

62.18

61.50

mmol/l

0.03

103

Alcohol abuse counselling and surveillance

5.19

13.48

1.2

1.3

63.87

60.57

mmol/l

0.12

Hydronephrosis

122

583

2.12

13.44

1.5

1.3

59.92

67.95

mmol/l

1.22

477

Disorders of psychological development

400

2.32

13.41

2.5

81.64

73.51

mmol/l

0.69

342

Unspecified jaundice

240

2.81

13.35

1.5

1.3

60.98

63.51

mmol/l

0.15

185

Other diseases of upper respiratory tract

1157

4718

1.28

13.33

1.5

1.4

63.30

63.23

mmol/l

0.02

928

3709

Other local infections of skin and subcutaneous tissue

116

546

2.16

13.31

2.3

1.3

60.89

63.47

mmol/l

0.22

444

Small cell lung cancer, helper endpoint

112

3.78

13.31

1.4

1.3

82.44

62.05

mmol/l

2.47

Small cell lung cancer

112

3.78

13.31

1.4

1.3

82.44

62.05

mmol/l

2.47

Type 1 diabetes, strict definition, subgroup 1

228

2.83

13.30

2.8

1.9

65.41

81.02

mmol/l

1.86

192

Fissure and fistula of anal and rectal regions

229

1346

1.72

13.27

1.4

1.3

58.99

65.57

mmol/l

1.59

159

1089

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

165

852

1.89

13.19

1.7

1.8

68.18

67.15

mmol/l

0.10

138

691

Assault by bodily force

276

2.64

13.09

1.5

1.4

73.06

66.81

mmol/l

0.32

229

Acute alcohol intoxication ICD-9

147

3.35

13.08

1.7

1.3

51.03

66.78

mmol/l

2.00

127

Inflammatory bowel disease

287

1795

1.61

13.05

1.8

1.4

64.00

64.36

mmol/l

0.04

191

1436

Other viral diseases, not elsewhere classified

175

954

1.85

13.03

2.1

1.6

71.05

65.63

mmol/l

0.70

150

762

Alzheimer’s disease (Late onset), excluding more controls

163

567

1.94

13.02

1.3

65.46

60.76

mmol/l

0.78

127

457

362

2112

1.53

12.97

1.4

1.3

61.01

60.96

mmol/l

0.01

298

1700

Diabetic neuropathy

142

724

1.99

12.95

1.4

1.3

58.24

60.50

mmol/l

0.30

114

561

Nephrotic syndrome

164

3.21

12.89

1.5

1.6

52.98

67.99

mmol/l

1.73

135

Isolated proteinuria

129

3.52

12.87

1.4

1.3

61.79

62.90

mmol/l

0.06

112

Ulcerative colitis

226

1337

1.70

12.81

1.8

1.4

61.06

64.10

mmol/l

0.39

143

1072

In situ neoplasms

350

2192

1.53

12.80

1.3

1.4

59.62

64.07

mmol/l

1.19

290

1758

Dental pulpitis 4, only avohilmo

1109

4528

1.28

12.80

1.5

1.4

65.34

63.04

mmol/l

0.90

860

3607

Pure hyperglyceridaemia

4.61

12.68

1.3

1.2

58.82

69.28

mmol/l

0.59

Benign neoplasm: Colon, unspecified

276

1725

1.62

12.68

1.4

1.3

62.10

62.21

mmol/l

0.01

220

1390

Other abnormalities of plasma proteins

4.43

12.63

1.3

57.37

63.04

mmol/l

0.28

Secondary parkinsonism, excluding more controls

3.98

12.62

1.3

1.2

62.92

62.75

mmol/l

0.01

Small fibre neuropathy

141

3.38

12.60

1.4

1.3

51.92

66.56

mmol/l

1.80

120

Vitamin B12 deficiency anaemia

135

687

1.99

12.58

1.8

1.3

60.29

62.04

mmol/l

0.21

115

553

Sensorineural hearing loss

803

4253

1.33

12.53

1.5

1.4

64.78

62.21

mmol/l

0.92

650

3356

Symptoms and signs involving speech and voice

331

2162

1.54

12.51

1.4

66.43

63.28

mmol/l

0.62

268

1724

Superficial injury of abdomen, lower back and pelvis

147

771

1.93

12.49

1.7

1.4

59.91

64.33

mmol/l

0.57

116

623

Dermatitis due to substances taken internally

266

2.65

12.48

1.3

1.4

65.73

68.12

mmol/l

0.19

220

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

169

873

1.85

12.42

1.3

58.77

63.79

mmol/l

0.87

132

694

Use of biperiden

261

2.66

12.42

1.6

1.3

52.61

60.84

mmol/l

1.03

210

ILD, hospital admissions 3, with pneumonia sepsis

425

2.27

12.41

1.3

68.34

61.77

mmol/l

0.79

346

Vascular diseases of the intestine

211

2.87

12.37

1.4

1.3

62.84

62.90

mmol/l

0.00

175

Obesity due to excess calories

386

2608

1.49

12.37

1.3

1.4

62.39

64.40

mmol/l

0.37

279

2083

Migraine without aura and triptan purchases

112

535

2.11

12.32

1.7

1.5

70.45

66.20

mmol/l

0.34

427

Rheumatism, unspecified

158

853

1.87

12.31

1.4

61.70

62.88

mmol/l

0.14

132

673

Conductive and sensorineural hearing loss

829

4375

1.32

12.29

1.5

1.4

64.85

62.27

mmol/l

0.93

664

3453

Pneumonia due to other infectious organisms, not elsewhere classified

133

3.40

12.27

1.5

1.3

72.13

58.75

mmol/l

1.14

113

Certain disorders involving the immune mechanism

200

1160

1.74

12.25

1.6

1.4

65.50

63.83

mmol/l

0.22

168

931

Benign neoplasm: Adrenal gland

378

2.35

12.19

1.5

1.3

60.64

61.38

mmol/l

0.06

309

Complications of other internal prosthetic devices, implants and grafts

213

2.85

12.17

1.7

1.4

74.34

64.28

mmol/l

0.69

176

Mental and behavioural disorders due to cannabinoids

4.82

12.16

1.3

1.4

64.64

71.61

mmol/l

0.19

Eating disorders

335

2.41

12.06

2.1

1.5

60.43

65.77

mmol/l

0.36

287

Other and unspecified hydrocephalus

111

3.67

12.02

1.8

1.5

93.68

63.66

mmol/l

2.67

Cholelithiasis, broad definition with cholecystitis

848

4457

1.31

11.98

1.5

1.3

62.30

62.65

mmol/l

0.09

665

3553

Chronic viral hepatitis

176

3.00

11.98

1.6

1.4

42.94

67.87

mmol/l

3.23

145

DVT of lower extremities and pulmonary embolism

450

3143

1.44

11.97

1.4

62.69

62.26

mmol/l

0.08

337

2510

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

118

526

2.05

11.94

2.1

2.4

67.68

76.31

mmol/l

0.98

446

Soft tissue disorders related to use, overuse and pressure

267

1680

1.60

11.92

1.4

61.31

63.34

mmol/l

0.34

225

1318

Mental retardation, excluding more controls

148

3.19

11.86

4.0

2.7

71.88

67.70

mmol/l

0.23

135

Blood alcohol or alcohol intoxication level

4.33

11.80

1.3

49.30

55.58

mmol/l

0.26

Dental pulpitis 1, only avohilmo

1101

4544

1.27

11.71

1.4

65.39

63.03

mmol/l

0.93

854

3621

Gout, idiopatic and unspecified

257

1611

1.61

11.70

1.5

1.3

53.61

63.59

mmol/l

4.69

197

1292

Other specified/unspecified arthritis

264

1664

1.60

11.70

1.5

1.4

64.30

63.31

mmol/l

0.14

216

1315

Parodontitis or/and operation codes

626

2736

1.37

11.57

1.4

64.17

62.60

mmol/l

0.35

488

2154

Fitting and adjustment of other devices

369

2328

1.48

11.57

1.4

1.3

60.72

62.98

mmol/l

0.54

289

1844

Other disorders of eye and adnexa

141

750

1.90

11.53

1.6

1.4

61.09

63.89

mmol/l

0.33

113

606

Viral encephalitis, not elsewhere classified/unspecified

3.82

11.52

1.4

82.57

62.87

mmol/l

1.44

Injuries to the neck

196

1150

1.72

11.51

1.6

1.4

62.12

65.51

mmol/l

0.55

156

917

Other congenital malformations of the digestive system

224

2.72

11.45

5.2

1.9

70.39

72.43

mmol/l

0.12

190

Disorders of ocular muscles, binocular movement, accommodation and refraction

395

2701

1.46

11.43

1.8

1.5

71.86

64.18

mmol/l

2.45

324

2140

Asthma and allergy, excluding more controls

402

2.23

11.37

1.6

1.5

61.38

70.83

mmol/l

1.19

319

Emotional disorders starting during childhood or adolecense, excluding more controls

4.18

11.36

2.3

3.5

63.68

81.75

mmol/l

1.06

Benign neoplasm of meninges

118

595

2.01

11.35

1.2

1.3

74.29

62.68

mmol/l

1.88

474

Polyarthrosis

240

1429

1.63

11.32

1.4

1.3

66.02

60.24

mmol/l

1.30

188

1106

Polyglandular dysfunction

12.47

11.31

1.3

1.2

84.58

62.55

mmol/l

0.53

Faecal incontinence

108

529

2.07

11.25

1.6

1.3

61.80

62.38

mmol/l

0.05

422

Adjustment and management of implanted device

205

1227

1.69

11.25

1.8

1.3

57.70

63.58

mmol/l

1.31

164

962

Other disorders of eyelid

479

3319

1.40

11.16

1.3

1.4

61.39

62.51

mmol/l

0.26

396

2627

Hyperkinetic disorders, excluding more controls

167

2.93

11.13

1.8

2.3

66.92

78.91

mmol/l

0.98

142

All influenza (not pneumonia)

133

703

1.91

11.08

1.7

1.3

63.63

66.18

mmol/l

0.28

104

568

Other diseases of biliary tract

112

560

2.03

11.06

1.6

1.3

58.58

63.38

mmol/l

0.56

449

Sequelae of other external causes

265

2.54

11.04

1.9

1.3

64.89

62.00

mmol/l

0.17

209

Barrett oesophagus

236

2.64

11.03

1.5

1.3

60.20

60.63

mmol/l

0.03

193

Intentional self-harm by sharp object

4.45

11.03

2.3

1.4

62.30

69.75

mmol/l

0.27

Coxarthrosis [arthrosis of hip](FG)

569

3021

1.37

11.02

1.4

1.3

61.66

61.87

mmol/l

0.04

468

2360

Cerebral cysts

230

2.65

11.01

2.5

1.4

76.53

67.90

mmol/l

0.53

187

Diffuse brain injury

117

3.39

10.99

1.4

1.2

76.40

67.29

mmol/l

0.35

Rheumatoid arthritis

336

2054

1.50

10.97

1.5

1.3

62.04

61.74

mmol/l

0.05

270

1604

Alzheimer’s disease, wide definition, excluding more controls

164

619

1.82

10.94

1.3

66.44

60.89

mmol/l

0.99

128

502

Other diseases of stomach and duodenum

340

2.34

10.90

1.7

1.3

59.06

61.93

mmol/l

0.26

270

Asthma and allergy

410

2.18

10.86

1.6

1.5

61.38

70.38

mmol/l

1.11

326

Amputation of foot

139

3.21

10.86

1.4

1.3

57.41

61.50

mmol/l

0.23

115

Amputation of toe

411

2.21

10.85

1.4

1.3

52.93

62.55

mmol/l

1.60

330

Crohn's disease NAS

285

2.46

10.85

2.3

1.4

70.31

65.36

mmol/l

0.30

233

Superficial injury of lower leg

228

1416

1.62

10.80

1.4

59.24

64.38

mmol/l

1.20

184

1130

Abnormal results of function studies

431

2.17

10.78

1.5

1.4

55.51

64.96

mmol/l

1.18

350

Abnormal findings on diagnostic imaging of central nervous system

210

2.72

10.76

1.7

1.3

80.68

65.40

mmol/l

1.01

171

Valvular operations

149

826

1.82

10.73

1.6

1.4

63.26

64.78

mmol/l

0.17

129

659

Malignant neoplasm of oral cavity

194

2.81

10.72

1.5

1.3

63.83

61.96

mmol/l

0.09

162

Hypoplasia of dental enamel , including avohilmo

113

3.41

10.67

2.2

3.2

82.29

85.49

mmol/l

0.13

105

Drug-induced cataract

115

3.42

10.65

2.0

1.2

59.65

63.45

mmol/l

0.20

102

Other meningitis

4.37

10.65

1.3

68.59

59.73

mmol/l

0.36

Pneumonia due to Streptococcus pneumoniae

183

2.84

10.65

1.5

1.3

60.49

61.14

mmol/l

0.04

152

Viral hepatitis

306

2.39

10.63

1.6

1.3

50.14

66.52

mmol/l

1.97

253

Benign neoplasm: Stomach

121

631

1.95

10.61

1.3

57.67

61.35

mmol/l

0.59

104

510

Other symptoms and signs involving general sensations and perceptions

207

2.72

10.53

1.3

1.4

49.33

63.07

mmol/l

2.09

167

Benign neoplasm: Cerebral meninges

108

543

2.02

10.52

1.3

72.50

61.55

mmol/l

1.64

434

Migraine with aura and triptan purchases

109

549

2.00

10.47

1.5

61.83

65.11

mmol/l

0.34

430

Injuries to the ankle and foot

558

3770

1.35

10.44

1.4

1.5

61.89

65.48

mmol/l

1.11

434

2968

Lichen simplex chronicus and prurigo

328

2.33

10.42

1.3

61.60

61.84

mmol/l

0.02

260

465

3163

1.39

10.35

1.3

61.94

61.70

mmol/l

0.05

379

2544

L01XE Protein kinase inhibitors

355

2.28

10.34

1.3

1.4

58.84

59.71

mmol/l

0.06

284

Other shoulder lesions

445

2.12

10.32

1.4

1.3

64.06

64.44

mmol/l

0.03

350

Excessive, frequent and irregular menstruation

357

1346

1.48

10.32

1.8

1.4

63.95

61.71

mmol/l

0.41

288

1031

Acute posthaemorrhagic anaemia

181

2.83

10.31

1.7

1.3

64.81

60.10

mmol/l

0.30

148

Chronic rhinitis, nasopharyngitis and pharyngitis

281

1852

1.53

10.27

1.6

1.4

58.77

63.78

mmol/l

1.31

225

1474

Generalized epilepsy

170

2.87

10.27

1.5

1.7

70.54

72.45

mmol/l

0.08

145

Chronic hepatitis, not elsewhere classified

165

2.92

10.26

1.2

1.3

54.62

62.01

mmol/l

0.73

145

263

1618

1.55

10.25

1.3

60.85

60.87

mmol/l

0.00

217

1289

Fracture of foot, except ankle

208

1281

1.64

10.22

1.4

64.48

64.55

mmol/l

0.01

166

1023

Crohn disease

118

617

1.93

10.21

2.1

1.4

67.73

65.81

mmol/l

0.15

493

Other endocrine disorders

264

2.45

10.20

4.2

2.4

73.54

72.18

mmol/l

0.08

227

Actinic keratosis

437

2979

1.40

10.18

1.3

61.55

61.58

mmol/l

0.00

357

2397

Chronic sinusitis

383

2689

1.43

10.12

1.4

62.67

63.15

mmol/l

0.08

311

2093

Event of undetermined intent

252

2.50

10.11

1.5

1.4

70.16

66.93

mmol/l

0.16

214

Gout, unspecified

209

1294

1.63

10.10

1.5

1.3

52.60

63.07

mmol/l

4.32

161

1037

Trochanteric bursitis

148

836

1.79

10.06

1.4

59.22

62.73

mmol/l

0.66

130

654

Malignant neoplasm of respiratory system and intrathoracic organs

229

1334

1.59

9.97

1.4

1.3

67.19

62.40

mmol/l

0.92

182

1080

Other sleep disorders

102

512

2.01

9.95

1.3

58.89

65.91

mmol/l

0.99

404

Skin changes due to chronic exposure to nonionizing radiation

444

3036

1.39

9.95

1.3

61.74

61.47

mmol/l

0.05

362

2439

Other viral hepatitis

242

2.51

9.95

1.7

1.3

49.87

67.52

mmol/l

1.66

202

Parkinson's disease, strict definition, excluding more controls

115

590

1.93

9.92

1.3

1.2

74.12

61.61

mmol/l

2.84

481

Extrapyramidal and movement disorders

379

2670

1.43

9.91

1.4

64.54

62.78

mmol/l

0.37

300

2125

Other and unspecified nerve root and plexus disorders, also in other diseases

171

1010

1.71

9.90

1.4

1.3

62.16

63.48

mmol/l

0.16

145

810

Endocarditis

152

2.96

9.88

1.8

1.3

52.17

68.17

mmol/l

2.03

127

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

458

3262

1.38

9.84

1.4

63.64

62.92

mmol/l

0.14

374

2532

Other postsurgical states

330

2.28

9.84

1.8

1.6

73.54

65.33

mmol/l

0.60

270

Gout, strict definition

187

1135

1.67

9.81

1.4

1.3

53.25

63.51

mmol/l

3.60

144

914

Other arthrosis

528

2795

1.36

9.76

1.4

1.3

62.22

61.59

mmol/l

0.12

419

2171

Cardiac arrest

187

2.61

9.75

2.7

1.2

63.04

73.19

mmol/l

0.71

151

Acute gastritis

416

2.12

9.72

1.6

1.3

61.07

61.85

mmol/l

0.06

334

Hepatomegaly and splenomegaly, not elsewhere classified

6.11

9.68

1.2

1.5

49.67

69.18

mmol/l

—

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

133

3.10

9.64

1.5

1.4

59.23

64.70

mmol/l

0.27

106

Dissociative [conversion] disorders

117

3.21

9.62

1.2

1.3

63.45

67.93

mmol/l

0.21

101

Salpingitis and oophoritis

174

1042

1.69

9.60

1.5

1.4

64.01

62.00

mmol/l

0.23

134

819

Oesophageal obstruction

183

2.74

9.56

1.8

1.3

52.31

62.47

mmol/l

0.84

151

Cervicalgia

196

1211

1.63

9.55

1.4

1.3

62.96

62.36

mmol/l

0.08

166

958

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

329

2.26

9.49

1.3

1.4

60.53

63.49

mmol/l

0.24

261

Tubulo-interstitial nephritis, not specified as acute or chronic

374

2.17

9.48

1.4

1.3

58.25

65.62

mmol/l

1.02

306

Extreme obesity with alveolar hypoventilation

213

2.59

9.45

1.4

1.3

66.47

61.03

mmol/l

0.26

180

Pneumonia derived septicemia

156

2.89

9.45

1.5

1.6

59.16

67.74

mmol/l

0.64

133

Social phobias

218

2.54

9.44

1.9

1.4

56.88

67.34

mmol/l

0.90

188

Trigeminal neuralgia

317

2.28

9.44

1.2

1.3

68.39

60.55

mmol/l

0.94

256

Irregular menses

343

1931

1.45

9.42

1.7

1.4

67.57

62.38

mmol/l

1.14

276

1525

Fibromyalgia

368

2.17

9.42

1.4

1.3

64.43

66.09

mmol/l

0.13

283

Other condition

131

728

1.82

9.42

1.6

1.4

65.79

63.83

mmol/l

0.18

580

Mental and behavioural disorders due to use of other stimulants, including caffeine

4.28

9.41

1.8

1.4

58.56

70.79

mmol/l

0.32

Crohn's disease of small intestine

292

2.33

9.40

2.3

1.4

70.70

64.72

mmol/l

0.34

244

Assault by unspecified means

4.44

9.38

1.5

1.4

49.81

65.43

mmol/l

0.68

Cholelithiasis

797

4402

1.27

9.34

1.4

1.3

62.23

62.57

mmol/l

0.08

622

3513

Emphysema

370

2.17

9.33

1.4

1.3

63.30

63.99

mmol/l

0.05

296

Urethral stricture

244

2.46

9.31

1.2

61.27

66.75

mmol/l

0.53

197

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

146

842

1.75

9.27

1.3

1.4

63.18

64.60

mmol/l

0.15

119

679

Fall on same level involving ice and snow

527

3959

1.34

9.27

1.4

61.83

62.93

mmol/l

0.23

416

3132

Other and unspecified intracranial injuries

136

3.01

9.26

1.3

61.35

65.28

mmol/l

0.24

114

Sleep disorders, other/unspecified

110

3.24

9.22

1.7

1.4

55.35

71.66

mmol/l

1.50

Hallux valgus (acquired)

359

1822

1.43

9.22

1.3

64.77

61.54

mmol/l

0.74

276

1421

Other disorders of kidney and ureter

140

800

1.77

9.21

1.6

1.4

56.53

63.78

mmol/l

1.65

123

642

Tobacco use

228

2.50

9.16

1.5

1.3

47.90

66.04

mmol/l

2.04

190

Benign neoplasm of mouth and pharynx

108

571

1.91

9.12

1.5

1.3

58.08

62.73

mmol/l

0.56

462

Pain and other conditions associated with female genital organs and menstrual cycle

137

745

1.77

9.11

1.6

1.4

64.50

63.98

mmol/l

0.05

109

557

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

322

2.24

9.11

1.4

1.3

54.65

65.83

mmol/l

1.20

248

Inflammatory diseases of female pelvic organs

529

2988

1.34

9.09

1.5

1.4

63.21

61.93

mmol/l

0.28

418

2367

Sequelae of injuries of neck and trunk

127

3.06

9.07

1.8

1.3

58.11

62.81

mmol/l

0.22

112

Non-small cell lung cancer

169

1021

1.67

9.06

1.3

58.77

63.09

mmol/l

0.71

132

824

Superficial injury of thorax

142

820

1.75

8.98

1.5

1.3

58.22

62.92

mmol/l

0.72

108

654

Other infectious diseases

457

2.02

8.96

1.6

1.4

62.07

63.65

mmol/l

0.14

373

Immunodeficiencies

243

2.43

8.94

1.6

1.5

69.04

64.82

mmol/l

0.32

202

Myeloproliferative diseases

100

520

1.95

8.92

1.2

1.4

57.14

60.71

mmol/l

0.47

412

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

108

3.24

8.86

1.8

1.3

58.50

65.69

mmol/l

0.35

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

504

2578

1.35

8.86

1.3

59.79

63.59

mmol/l

1.37

409

2051

Other congenital malformations

404

2.08

8.85

2.3

2.0

84.54

67.75

mmol/l

1.70

350

Lesion of ulnar nerve

131

743

1.78

8.83

1.4

1.3

61.44

64.08

mmol/l

0.28

105

591

Diseases of male genital organs

450

1655

1.38

8.75

1.5

64.31

66.45

mmol/l

0.42

358

1290

Primary biliary cholangitis (PBC)

104

3.27

8.72

1.3

1.4

58.52

55.24

mmol/l

0.17

Abscess of lung

3.85

8.72

2.0

1.3

49.62

64.40

mmol/l

1.19

Retinal vascular occlusion

138

799

1.75

8.70

1.5

1.3

62.52

62.75

mmol/l

0.02

109

625

Other specific joint derangements/joint disorders

621

3204

1.30

8.69

1.5

1.4

63.72

63.64

mmol/l

0.02

489

2504

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

537

2769

1.33

8.69

1.3

1.4

60.48

63.78

mmol/l

1.12

434

2200

Nonalcoholic fatty liver disease

455

2.00

8.69

1.5

1.3

59.54

64.14

mmol/l

0.41

364

Diseases of the ear and mastoid process

1091

4514

1.23

8.68

1.4

64.84

63.31

mmol/l

0.52

863

3548

Dissocial personality disorder

4.49

8.67

1.4

1.3

67.25

58.30

mmol/l

0.18

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

122

682

1.81

8.67

1.4

1.3

53.33

63.38

mmol/l

2.79

100

539

Benign neoplasm: Adrenal gland

436

2.03

8.65

1.5

1.3

60.64

60.55

mmol/l

0.01

350

Diseases of salivary glands

176

1087

1.63

8.64

1.4

65.06

62.86

mmol/l

0.29

145

857

Syphilis

115

3.12

8.62

1.2

1.3

61.33

62.56

mmol/l

0.07

Psoriasis

255

1714

1.50

8.60

1.5

1.4

62.13

63.66

mmol/l

0.22

190

1359

Viral infections of the central nervous system

357

2.13

8.53

1.3

72.83

61.48

mmol/l

1.36

286

Hernia of abdominal wall

420

3091

1.37

8.53

1.8

1.3

56.59

63.63

mmol/l

3.26

311

2448

Unspecified privation

111

606

1.85

8.52

1.6

1.4

62.28

61.91

mmol/l

0.03

494

Other specified/unspecified systemic involvement of connective tissue

312

2.22

8.51

1.4

1.3

57.19

61.51

mmol/l

0.40

257

Mucosal proctocolitis

106

570

1.88

8.50

1.9

1.4

62.80

66.60

mmol/l

0.30

456

Fall involving bed

195

2.59

8.50

1.6

1.4

61.68

65.64

mmol/l

0.25

159

Other diseases of blood and blood-forming organs

378

2.10

8.49

1.3

1.4

55.88

62.18

mmol/l

0.81

302

Maltreatment syndromes

154

2.76

8.46

1.7

1.5

62.45

71.56

mmol/l

0.58

137

Contact with and exposure to communicable diseases

199

1266

1.57

8.45

1.6

1.7

68.69

67.77

mmol/l

0.09

151

1006

Sicca syndrome [Sjögren]

101

537

1.91

8.45

1.5

1.3

60.47

59.93

mmol/l

0.05

439

Exclusion endpoint for clefts

3.39

8.41

4.1

3.1

83.12

75.07

mmol/l

0.28

Bronchiectasis

489

1.95

8.40

1.4

60.71

62.19

mmol/l

0.13

399

Pericarditis

161

2.72

8.37

1.3

1.4

64.97

67.30

mmol/l

0.12

127

Cardiodefibrillation

379

2750

1.39

8.36

1.3

61.39

62.55

mmol/l

0.23

309

2209

Retinal vascular disorders

139

816

1.72

8.36

1.5

1.3

62.56

62.93

mmol/l

0.04

110

641

Cramp and spasm

208

2.50

8.35

1.6

1.4

59.51

65.73

mmol/l

0.64

173

Corns and callosities

394

2.06

8.35

1.5

1.4

61.59

62.63

mmol/l

0.08

311

Diplopia

132

764

1.75

8.34

1.6

1.3

70.94

62.91

mmol/l

1.14

112

613

Speech and linguistic disorders

332

2.13

8.32

3.0

2.2

75.77

77.36

mmol/l

0.09

282

Myocardial infarction, strict

498

2738

1.33

8.30

1.4

1.3

60.12

61.94

mmol/l

0.48

403

2174

Ulcerative colitis, NAS

125

713

1.77

8.29

1.7

1.4

64.65

65.63

mmol/l

0.06

570

Other skin changes

170

1054

1.63

8.27

1.4

60.17

63.89

mmol/l

0.60

138

855

Other diseases of pericardium

203

2.51

8.27

1.4

71.00

64.81

mmol/l

0.52

161

Malignant neoplasm of bronchus and lung

195

1166

1.58

8.26

1.4

1.3

66.68

62.10

mmol/l

0.84

154

937

Ovarian dysfunction

179

2.59

8.25

2.5

1.3

74.51

64.79

mmol/l

0.51

156

Ventral hernia

240

1609

1.50

8.24

1.7

1.3

57.69

63.18

mmol/l

1.33

174

1276

Colonic or urogenital fistula

249

1682

1.49

8.22

1.4

60.07

64.12

mmol/l

0.83

172

1346

Papulosquamous disorders

359

2595

1.39

8.18

1.5

1.4

62.23

63.37

mmol/l

0.19

271

2064

Bell's palsy

116

651

1.80

8.15

1.4

62.33

65.04

mmol/l

0.25

522

Anorexia (incl.atypical)

204

2.48

8.14

2.2

1.5

58.48

66.35

mmol/l

0.37

178

Myeloproliferative diseases (CML excluded)

481

1.94

8.13

1.2

1.3

57.65

61.81

mmol/l

0.52

382

Open wound of forearm

467

1.95

8.09

1.5

1.4

65.03

64.14

mmol/l

0.06

383

Morphin

3.62

8.05

1.1

1.2

61.89

57.16

mmol/l

0.23

Asthma and opportunity respiratory infection

294

2.22

8.04

1.5

1.3

57.58

62.03

mmol/l

0.37

238

Vasculitis limited to skin, not elsewhere classified

137

2.85

7.99

1.4

1.3

58.94

60.25

mmol/l

0.07

110

Dislocation of lens

3.82

7.98

1.2

1.3

65.12

65.09

mmol/l

0.00

Other Crohn's disease

288

2.21

7.95

2.3

1.4

64.56

66.51

mmol/l

0.09

236

Type1 diabetes, definitions combined, early onset

218

2.40

7.92

3.3

2.0

65.82

84.42

mmol/l

2.23

186

Obstructive hydrocephalus

3.59

7.91

2.0

1.8

99.08

69.44

mmol/l

1.72

Nummular dermatitis

430

1.98

7.88

1.4

1.3

54.02

63.38

mmol/l

1.54

353

Anterior Iridocyclitis

189

1216

1.57

7.87

1.3

1.4

62.04

62.96

mmol/l

0.11

156

968

Localized swelling, mass and lump of skin and subcutaneous tissue

284

1985

1.44

7.87

1.5

1.4

60.61

64.82

mmol/l

1.01

231

1580

Burns and corrosions

121

695

1.76

7.86

1.4

60.15

67.32

mmol/l

0.85

556

Speech therapy

268

1855

1.45

7.85

1.6

1.4

60.01

63.14

mmol/l

0.70

235

1468

Mixed hyperlipidaemia

116

2.97

7.84

1.4

1.2

54.96

68.67

mmol/l

1.58

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

107

594

1.82

7.83

1.4

1.3

53.20

63.41

mmol/l

2.62

472

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

106

3.11

7.82

1.5

1.3

57.75

64.30

mmol/l

0.31

Chronic laryngitis and laryngotracheitis

137

816

1.69

7.82

1.3

55.66

63.35

mmol/l

1.60

107

652

Vitamin D deficiency

3.74

7.80

1.3

1.4

68.11

59.77

mmol/l

0.26

Thyrotoxicosis, other and/or unspecified

180

1148

1.58

7.79

1.4

64.70

62.53

mmol/l

0.28

144

914

Other disorders of white blood cells

298

2.18

7.76

1.5

1.3

63.00

62.07

mmol/l

0.07

240

Amputation of thigh

168

2.62

7.75

1.5

1.3

61.15

61.04

mmol/l

0.01

136

Diabetic retinopathy

359

1637

1.39

7.74

1.3

1.4

56.75

59.74

mmol/l

0.79

290

1269

Thyroiditis, ILD-related definition

108

603

1.81

7.74

1.4

60.56

65.23

mmol/l

0.61

491

Right hemicolectomy

365

2.06

7.74

1.7

1.3

51.72

60.41

mmol/l

1.28

297

Carcinoma in situ of skin of other and unspecified parts of face

518

1.88

7.74

1.2

1.3

58.19

63.51

mmol/l

0.72

407

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

481

2512

1.33

7.73

1.3

59.46

63.52

mmol/l

1.52

393

2005

Acquired absence of limb

4.93

7.73

1.6

1.3

44.36

61.52

mmol/l

1.80

IBD patients in KELA-register

178

1134

1.58

7.72

1.8

1.4

65.81

65.41

mmol/l

0.04

114

911

Psoriasis vulgaris

168

1057

1.60

7.71

1.6

1.4

61.16

64.04

mmol/l

0.40

123

849

Cholecystitis

145

880

1.66

7.71

1.8

1.3

59.28

63.17

mmol/l

0.59

117

704

Burns and corrosions of external body surface, specified by site

532

1.86

7.69

1.4

1.5

61.86

67.03

mmol/l

0.45

429

Dementia, including avohilmo

494

2593

1.32

7.68

1.4

1.3

65.04

61.17

mmol/l

1.43

397

2092

Menorrhagia

329

1290

1.42

7.66

1.4

1.3

64.38

60.74

mmol/l

0.79

258

985

Schizotypal disorder

3.78

7.66

1.1

1.3

64.93

66.29

mmol/l

0.04

Benign neoplasm: Rectum, anus and anal canal

187

1209

1.56

7.65

1.4

1.3

57.97

64.59

mmol/l

1.61

146

972

Malignant neoplasm of tongue

3.19

7.65

1.7

1.3

64.45

62.10

mmol/l

0.08

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

100

548

1.85

7.65

2.2

1.4

58.87

63.99

mmol/l

0.62

444

Ulcer of oesophagus

380

2.03

7.64

1.5

1.3

59.19

63.73

mmol/l

0.46

306

Other salmonella infections

169

2.59

7.63

1.7

1.3

50.76

62.60

mmol/l

1.36

141

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

131

777

1.70

7.61

1.3

60.24

62.86

mmol/l

0.35

104

617

Benign neoplasm of meninges

118

681

1.76

7.60

1.2

1.4

74.29

61.32

mmol/l

2.26

551

Cluster headache, wide

135

2.78

7.57

1.4

1.3

66.41

67.98

mmol/l

0.07

115

Congenital malformations of the urinary system

301

2.16

7.57

1.5

59.58

69.04

mmol/l

1.07

250

Diabetic retinopathy, strict definition

186

1054

1.57

7.56

1.4

54.48

59.87

mmol/l

1.45

157

804

L01XX Other antineoplastic agents

355

2.07

7.56

1.3

53.61

62.14

mmol/l

1.59

286

Other and unspecified psoriasis

348

2.07

7.54

1.5

1.3

60.85

61.11

mmol/l

0.02

285

Abnormal blood-pressure reading, without diagnosis

200

2.44

7.54

1.7

1.4

65.64

62.03

mmol/l

0.21

161

Pemphigoid

159

2.65

7.53

1.4

1.3

57.49

61.40

mmol/l

0.26

129

Disorders of sclera, cornea, iris and ciliary body

474

3621

1.31

7.52

1.4

63.54

63.60

mmol/l

0.01

387

2846

Excessive attrition of teeth

330

1275

1.41

7.48

1.5

1.4

61.28

64.07

mmol/l

0.51

265

1017

Endocrine disorders, other/unspecified

3.20

7.48

1.4

1.3

62.10

64.92

mmol/l

0.13

Agoraphobia

3.70

7.48

1.5

1.3

48.23

67.09

mmol/l

1.21

Other disorders of the musculoskeletal system and connective tissue

147

904

1.64

7.45

1.3

61.83

61.88

mmol/l

0.00

120

720

Benign neoplasm: Cerebral meninges

108

613

1.79

7.39

1.3

72.50

60.94

mmol/l

1.80

496

Chronic nephritic syndrome

191

2.45

7.30

1.6

1.3

55.38

63.43

mmol/l

0.85

157

Benign neoplasm: Sigmoid colon

171

1096

1.57

7.30

1.5

1.3

61.81

63.82

mmol/l

0.23

129

881

Bacterial meningitis

150

2.65

7.25

1.4

1.3

77.20

62.43

mmol/l

1.12

132

Abscess of anal and rectal regions

353

2.03

7.24

1.5

1.3

64.09

68.52

mmol/l

0.30

292

Injury of other and unspecified intrathoracic organs

300

2.13

7.23

1.6

1.3

57.33

62.24

mmol/l

0.43

243

Other noninfective disorders of lymphatic vessels and lymph nodes

186

2.47

7.23

1.2

1.3

59.35

63.10

mmol/l

0.21

154

Paracetamol of NSAID medication

162

501

1.64

7.22

1.9

1.7

66.04

70.40

mmol/l

0.55

142

393

Benign neoplasm: Transverse colon

552

1.82

7.19

1.4

1.3

56.15

64.26

mmol/l

1.34

442

ILD, hospital admissions

152

952

1.61

7.18

1.4

1.3

66.34

62.55

mmol/l

0.56

137

764

Obesity, other/unspecified

254

1771

1.44

7.16

1.2

1.4

64.33

63.94

mmol/l

0.05

193

1416

Abnormal findings on diagnostic imaging of other body structures

127

761

1.69

7.14

1.5

1.3

63.67

62.83

mmol/l

0.07

109

618

Mental retardation

199

2.40

7.14

4.0

2.5

71.88

72.60

mmol/l

0.03

177

Other diseases of jaws

315

2.09

7.12

1.5

1.4

63.73

62.24

mmol/l

0.09

250

Hyperparathyroidism

207

1376

1.50

7.08

1.4

1.3

54.14

59.42

mmol/l

1.60

168

1088

Pneumococcal septicemia

164

2.55

7.06

1.4

1.6

56.59

69.42

mmol/l

1.14

142

Alcoholic gastritis

3.49

7.05

1.8

1.3

52.40

65.00

mmol/l

0.66

Toxic effects of substances chiefly nonmedicinal as to source

555

1.80

7.04

1.9

1.4

62.07

63.59

mmol/l

0.10

452

Methotrexate

137

840

1.64

7.04

1.7

1.4

62.82

63.10

mmol/l

0.03

120

678

Lymphoid leukaemia

297

2.12

7.03

1.3

1.7

67.89

65.76

mmol/l

0.12

238

In situ neoplasms

350

2588

1.36

7.01

1.3

1.4

59.62

63.05

mmol/l

0.83

290

2060

Other and unspecified disorders of skin and subcutaneous tissue

365

2.00

7.01

1.5

1.3

59.85

62.68

mmol/l

0.22

290

Other surgical follow-up care

124

2.79

7.00

2.7

1.3

60.89

66.54

mmol/l

0.32

100

Visual impairment including blindness (binocular or monocular)

407

1.94

6.99

1.9

1.4

67.48

62.37

mmol/l

0.43

330

Other interstitial pulmonary diseases

153

967

1.60

6.97

1.4

1.3

66.01

62.60

mmol/l

0.49

138

775

Covid-19 suspected case

152

958

1.60

6.96

1.6

1.4

64.78

65.01

mmol/l

0.02

119

757

Iridocyclitis

205

1382

1.49

6.93

1.3

1.4

62.47

63.17

mmol/l

0.09

166

1100

Problems related to social environment

131

2.72

6.87

1.4

1.3

55.46

65.44

mmol/l

0.70

110

Dermatophytosis

128

777

1.66

6.87

1.3

62.85

63.57

mmol/l

0.06

100

628

Interstitial lung disease

153

972

1.59

6.83

1.4

1.3

66.01

62.52

mmol/l

0.51

138

780

Interstitial lung disease endpoints

153

972

1.59

6.83

1.4

1.3

66.01

62.52

mmol/l

0.51

138

780

SLE (Finngen)

143

2.63

6.82

1.4

1.3

49.55

60.23

mmol/l

0.81

111

Congenital malformations of the circulatory system

129

760

1.66

6.82

1.8

78.17

67.69

mmol/l

1.38

104

623

Bullous disorders

335

2.03

6.80

1.3

64.05

60.34

mmol/l

0.32

271

Coxarthrosis

503

2647

1.29

6.79

1.4

1.3

61.98

61.65

mmol/l

0.06

411

2077

Atopic dermatitis, strict definition with reimbursement

197

1281

1.50

6.77

1.6

1.7

61.62

68.85

mmol/l

1.39

144

1020

Glaucoma suspect

368

2758

1.34

6.77

1.4

59.71

62.34

mmol/l

0.69

307

2193

Other respiratory diseases principally affecting the interstitium

179

1180

1.53

6.77

1.5

1.3

65.03

62.69

mmol/l

0.32

164

943

Viral warts

475

1.85

6.77

1.4

64.54

65.03

mmol/l

0.03

389

Strabismus

224

1541

1.46

6.76

1.4

1.5

77.49

64.07

mmol/l

3.42

180

1249

Other disorders of gingiva or/and edentulous alveolar ridge

249

2.20

6.76

2.9

1.5

73.71

63.41

mmol/l

0.67

199

Personal history of other diseases and conditions

416

1.90

6.75

2.9

1.8

70.86

70.17

mmol/l

0.04

347

Other neurotic disorders

269

2.15

6.73

1.8

1.3

61.40

59.58

mmol/l

0.11

211

ILD, hospital admissions 1, main diag only

137

851

1.63

6.73

1.4

1.3

66.13

62.68

mmol/l

0.47

124

681

Vitreous haemorrhage

102

586

1.76

6.72

1.4

57.18

62.40

mmol/l

0.66

465

Other benign neoplasms of skin

328

2371

1.36

6.71

1.3

1.4

60.74

64.10

mmol/l

0.90

262

1885

Autoimmune polyglandular failure

17.24

6.71

1.3

82.60

67.29

mmol/l

—

Other bursopathies

125

759

1.66

6.70

1.4

1.3

62.84

62.83

mmol/l

0.00

100

599

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

477

2535

1.30

6.70

1.3

59.41

63.48

mmol/l

1.51

392

2018

Acute and subacute iridocyclitis

175

1153

1.53

6.63

1.3

1.4

62.22

63.28

mmol/l

0.12

145

913

Hyperplasia of prostate

317

1310

1.39

6.62

1.3

64.72

63.31

mmol/l

0.21

259

1042

Injury of eye and orbit

106

618

1.73

6.60

1.7

1.4

61.01

65.38

mmol/l

0.40

489

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

140

2.63

6.60

1.3

1.4

58.75

65.50

mmol/l

0.36

111

Varicose veins

621

3757

1.25

6.59

1.3

65.11

62.16

mmol/l

1.04

503

2976

Ulcerative enterocolitis

134

2.66

6.59

2.1

1.3

39.50

66.25

mmol/l

4.74

114

Spondylolisthesis/Spondylolysis

166

1083

1.54

6.58

1.3

60.39

63.44

mmol/l

0.48

130

861

Other aneurysm

285

2.10

6.57

1.4

1.3

66.34

64.21

mmol/l

0.13

236

Lupus erythematosus

123

2.75

6.57

1.4

1.2

54.67

60.51

mmol/l

0.46

102

Crohn's disease of large intestine

226

2.24

6.56

2.2

1.4

66.87

65.32

mmol/l

0.07

189

Inflammatory bowel disease, strict (require KELA)

178

1179

1.52

6.56

1.8

1.4

65.81

65.26

mmol/l

0.05

114

944

Arthropathies

804

3346

1.23

6.55

1.5

63.92

64.23

mmol/l

0.07

644

2618

Seropositive rheumatoid arthritis

250

1766

1.42

6.54

1.5

1.3

64.08

62.39

mmol/l

0.26

202

1381

Open wound of abdomen, lower back and pelvis

107

2.85

6.45

1.5

1.3

67.44

64.53

mmol/l

0.12

Ovarian cyst

309

1296

1.38

6.45

1.4

1.3

62.42

61.00

mmol/l

0.23

257

988

Presence of other devices

223

1551

1.45

6.44

1.5

1.3

60.68

62.48

mmol/l

0.33

180

1247

Shoulder lesions

725

3612

1.23

6.43

1.4

64.32

62.44

mmol/l

0.54

603

2805

Radiculopathy

157

1019

1.55

6.39

1.3

62.71

61.95

mmol/l

0.08

127

803

Non-small cell lung cancer, adenocarcinoma

385

1.93

6.38

1.3

60.53

61.06

mmol/l

0.04

307

Non-small cell lung cancer, adenocarcinoma, helper endpoint

385

1.93

6.38

1.3

60.53

61.06

mmol/l

0.04

307

Other specified and unspecified disorders of eye and adnexa

210

2.28

6.38

1.3

1.4

58.03

62.85

mmol/l

0.32

170

Infections with a predominantly sexual mode of transmission

190

1282

1.49

6.37

1.4

59.34

64.62

mmol/l

0.97

154

994

Malignant neoplasm of digestive organs

380

2842

1.32

6.37

1.4

1.3

59.90

62.92

mmol/l

0.70

269

2289

Injuries to unspecified part of trunk, limb or body region

551

1.76

6.36

1.5

1.4

54.67

63.98

mmol/l

1.56

448

Secondary right heart disease

250

2.16

6.32

1.5

1.4

63.31

62.15

mmol/l

0.06

205

Opening and dilatation of root channel of tooth

263

2.12

6.29

3.0

1.3

72.02

64.24

mmol/l

0.53

223

Noninflammatory disorders of female genital tract

363

1359

1.35

6.28

1.8

1.4

62.43

61.70

mmol/l

0.11

298

1043

Other disorders starting during childhood or adolecense, excluding more controls

115

2.71

6.28

3.4

3.6

76.85

77.58

mmol/l

0.03

107

Left bundle-branch block

373

1.93

6.26

1.3

57.62

62.94

mmol/l

0.57

297

Urticaria and erythema

292

2138

1.37

6.26

1.7

1.5

64.39

64.45

mmol/l

0.01

227

1706

Atopic dermatitis

388

2520

1.32

6.26

1.6

1.5

58.31

66.82

mmol/l

3.68

292

2011

Disorders of conjunctiva

703

4811

1.23

6.26

1.4

60.38

64.38

mmol/l

1.75

563

3798

Blepharochalasis

302

2226

1.37

6.25

1.3

1.4

58.97

62.08

mmol/l

0.82

252

1773

Adverse effects, not elsewhere classified

158

1032

1.54

6.25

1.8

1.5

58.04

63.80

mmol/l

1.04

128

827

Brain meningioma, excluding all cancers (controls excluding all cancers)

291

2.06

6.25

1.2

1.4

77.82

62.33

mmol/l

1.98

239

Retinal detachments and breaks

337

2525

1.34

6.25

1.4

58.53

63.28

mmol/l

1.67

273

1986

Cervicobrachial syndrome

181

1217

1.50

6.24

1.5

1.3

65.09

63.19

mmol/l

0.26

160

953

Other embolism and thrombosis

127

790

1.62

6.23

1.4

1.3

58.07

63.57

mmol/l

0.84

641

D07AA Corticosteroids, weak (group I)

122

750

1.64

6.22

1.4

1.7

60.59

66.12

mmol/l

0.64

100

605

Hypermobility syndrome

168

2.41

6.21

2.2

1.5

65.11

71.11

mmol/l

0.44

147

Use of pramipexole

219

1532

1.44

6.18

1.4

1.3

61.13

62.90

mmol/l

0.32

180

1219

Dementia

449

2404

1.30

6.18

1.4

1.3

65.13

61.20

mmol/l

1.37

362

1944

139

2.58

6.18

1.4

1.3

59.61

61.02

mmol/l

0.07

119

Pre-eclampsia or poor fetal growth

180

1208

1.49

6.16

1.4

63.51

64.71

mmol/l

0.14

146

933

Emotional disorders and disorders of social functioning with onset specific to childhood

131

2.58

6.13

2.2

3.9

63.59

82.55

mmol/l

1.45

119

Benign neoplasm of mouth and pharynx

108

648

1.68

6.12

1.5

1.3

58.08

62.10

mmol/l

0.46

525

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

227

2.20

6.11

1.5

1.3

52.00

63.74

mmol/l

1.54

186

Coxarthrosis, primary

603

4226

1.24

6.10

1.4

1.3

60.43

62.06

mmol/l

0.50

493

3355

Cholangitis (primary sclerosing, PSC), with reimbursement 202

3.15

6.10

1.5

48.63

70.03

mmol/l

1.40

Secondary parkinsonism+Parkinsonism in other disease

146

2.52

6.08

1.3

62.92

61.26

mmol/l

0.07

117

Ulcerative ileocolitis

170

2.39

6.08

1.6

1.3

63.84

63.93

mmol/l

0.00

148

Neuralgia and neuritis, unspecified

234

2.17

6.06

1.3

61.47

61.91

mmol/l

0.02

184

Mental retardation, wide definition

221

2.21

6.06

4.0

2.3

71.71

71.20

mmol/l

0.02

195

Hypertrophic cardiomyopathy

228

2.19

6.06

1.8

1.3

61.81

64.48

mmol/l

0.21

189

Exposure to smoke, fire and flames

100

2.86

6.04

1.2

1.3

62.85

61.89

mmol/l

0.04

Other and unspecified visual disturbances

501

1.77

6.02

1.6

1.4

64.75

61.97

mmol/l

0.27

403

Disorders of vestibular function (Vertigo)

454

3536

1.28

6.02

1.4

63.44

61.87

mmol/l

0.38

362

2808

Disorders of optic nerve and visual pathways

472

1.80

6.00

2.0

1.4

71.74

64.52

mmol/l

0.69

391

Secondary parkinsonism

147

2.50

6.00

1.3

62.92

61.71

mmol/l

0.05

121

Other pulmonary heart/vessel disease

289

2.04

6.00

1.4

62.23

63.46

mmol/l

0.08

238

Other extrapyramidal and movement disorders in other diseases

212

1485

1.44

5.96

1.3

1.4

64.47

63.12

mmol/l

0.19

172

1181

Other and unspecified disorders of white blood cells

210

2.23

5.95

1.6

1.3

60.33

61.57

mmol/l

0.07

176

Drug-induced osteoporosis

3.51

5.94

1.5

1.3

68.79

63.52

mmol/l

0.19

Other fall from one level to another

180

1222

1.48

5.93

1.5

68.67

66.43

mmol/l

0.24

137

985

Sleep apnoea

825

4660

1.20

5.92

1.4

64.81

62.49

mmol/l

0.86

650

3672

Other epidermal thickening

230

2.17

5.92

1.7

1.4

63.97

66.56

mmol/l

0.17

190

Cervicocranial syndrome

563

1.72

5.92

1.3

1.4

59.05

61.73

mmol/l

0.33

435

Flat foot [pes planus] (acquired)

541

1.74

5.91

1.2

1.4

69.42

62.81

mmol/l

0.87

435

Cholangitis (primary sclerosing, PSC)

353

1.92

5.90

1.9

1.4

54.90

64.52

mmol/l

1.05

280

Myocarditis

118

2.65

5.89

1.2

69.28

76.77

mmol/l

0.47

Portal vein thrombosis

3.09

5.87

1.4

1.3

56.00

66.81

mmol/l

0.83

Bullous pemphigoid

125

2.63

5.87

1.4

1.3

59.22

59.53

mmol/l

0.01

103

Drug-induced hypoglycaemia without coma

3.08

5.86

2.0

1.2

49.26

61.24

mmol/l

1.28

Other maltreatment syndromes

2.85

5.86

1.8

1.3

54.12

67.92

mmol/l

0.62

Gingival hyperplasia

161

2.40

5.85

1.7

1.6

76.35

63.09

mmol/l

0.66

129

Vasomotor and allergic rhinitis

283

2062

1.36

5.73

1.5

1.6

67.69

66.17

mmol/l

0.21

216

1629

Other abnormal findings of blood chemistry

207

2.21

5.72

1.4

58.15

63.43

mmol/l

0.38

174

Atypical facial pain

260

2.07

5.72

1.3

58.75

60.38

mmol/l

0.13

211

Pain in thoracic spine

122

769

1.60

5.69

1.7

1.3

60.50

63.89

mmol/l

0.39

103

592

Other ulcerative colitis

247

2.09

5.68

2.0

1.4

68.71

66.06

mmol/l

0.11

207

Sleep apnoea, including avohilmo

865

4712

1.19

5.67

1.4

64.24

62.60

mmol/l

0.54

682

3717

Familial hypercholesterolemia, with ischemic heart disease

103

624

1.67

5.67

1.3

65.32

62.94

mmol/l

0.26

501

Other or ill-defined heart diseases

214

2.17

5.67

1.2

1.3

54.27

64.79

mmol/l

1.09

173

Other strabismus

174

1182

1.48

5.66

1.5

1.6

77.52

64.89

mmol/l

2.42

140

944

Fibroblastic disorders

211

1491

1.42

5.66

1.4

1.3

60.77

63.13

mmol/l

0.41

172

1161

Thyrotoxicosis

227

1626

1.40

5.64

1.4

63.05

62.86

mmol/l

0.02

184

1294

Other joint disorders

756

3330

1.21

5.63

1.5

65.41

64.02

mmol/l

0.37

586

2604

Cerebral palsy

3.35

5.62

8.3

2.9

87.15

69.39

mmol/l

0.56

Primary ovarian failure

3.46

5.62

4.3

1.3

75.64

60.09

mmol/l

0.69

Convalescence

255

2.07

5.62

1.7

1.3

58.33

62.45

mmol/l

0.31

197

Other and unspecified vascular occlusions

103

626

1.66

5.61

1.6

1.3

59.90

63.19

mmol/l

0.42

487

Postmenopausal bleeding

292

1181

1.37

5.60

1.4

1.3

61.64

59.75

mmol/l

0.32

218

897

Benign neoplasm: Rectum

156

1043

1.51

5.60

1.4

1.3

56.44

63.60

mmol/l

1.61

121

836

Mental disorders, not otherwise specified

303

1.96

5.59

1.8

1.4

52.24

66.09

mmol/l

1.55

255

Carcinoma in situ of skin of other and unspecified parts of face

574

1.70

5.58

1.2

1.3

58.19

61.80

mmol/l

0.43

458

Disorders of speech understanding and production

205

2.19

5.58

3.7

1.9

78.43

71.79

mmol/l

0.33

174

Squamous cell neoplasms and carcinomas of the skin

131

845

1.57

5.57

1.3

60.24

62.83

mmol/l

0.35

104

675

Multiple myeloma, excluding all cancers (controls excluding all cancers)

257

2.06

5.53

1.3

1.4

54.19

65.42

mmol/l

1.70

203

Benign neoplasm: Pancreas

141

2.47

5.52

1.3

1.4

54.70

63.45

mmol/l

0.73

117

Any dementia

410

2252

1.29

5.51

1.4

1.3

62.74

61.17

mmol/l

0.36

332

1818

Diseases of inner ear

515

4057

1.25

5.51

1.4

1.3

64.06

61.91

mmol/l

0.60

408

3224

Conjunctivitis

619

4417

1.22

5.51

1.4

1.5

59.98

64.39

mmol/l

1.84

500

3504

Other noninflammatory disorders of uterus, except cervix

234

1146

1.40

5.46

1.4

1.3

63.55

59.87

mmol/l

0.72

195

876

Malignant neoplasm of kidney, except renal pelvis

562

1.69

5.46

1.5

1.3

53.17

63.05

mmol/l

2.16

447

Correction of physiology of bite - demanding therapy visit

292

1.97

5.46

1.4

62.70

64.47

mmol/l

0.10

241

Benign neoplasm: Rectosigmoid junction

205

2.18

5.45

1.6

1.3

56.61

62.43

mmol/l

0.51

165

Colorectal cancer, excluding all cancers (controls excluding all cancers)

256

1820

1.37

5.43

1.4

57.80

63.99

mmol/l

1.58

179

1469

Idiopathic pulmonary fibrosis

466

1.76

5.41

1.3

69.89

61.60

mmol/l

0.97

370

Postprocedural musculoskeletal disorders, not elsewhere classified

444

1.78

5.41

1.5

1.4

63.17

60.72

mmol/l

0.25

359

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

122

780

1.58

5.40

1.4

1.3

58.83

63.65

mmol/l

0.70

100

629

Malignant neoplasm of urinary organs

102

626

1.65

5.36

1.5

1.3

52.81

62.30

mmol/l

2.19

499

Assault by sharp object

3.61

5.35

1.2

1.3

68.64

66.33

mmol/l

0.04

Complications of genitourinary prosthetic devices, implants and grafts

107

2.67

5.35

1.3

59.95

66.46

mmol/l

0.42

Multiple myeloma and malignant plasma cell neoplasms

254

2.04

5.32

1.3

1.4

52.83

65.59

mmol/l

2.14

201

Infective dermatitis

101

619

1.65

5.32

1.4

61.85

64.12

mmol/l

0.20

498

Haemorrhoids and perianal venous thrombosis

258

1905

1.36

5.32

1.4

1.3

60.85

64.53

mmol/l

0.83

203

1529

Benign neoplasm: Pancreas

144

2.42

5.29

1.3

54.70

63.07

mmol/l

0.68

121

Other malignant neoplasms of skin (=non-melanoma skin cancer)

565

3633

1.23

5.28

1.3

1.4

58.93

62.78

mmol/l

1.70

463

2907

Unstable angina pectoris

394

2555

1.28

5.28

1.4

1.3

60.62

61.77

mmol/l

0.27

318

2057

Generalized skin eruption due to drugs and medicaments

208

2.15

5.27

1.3

1.5

73.03

65.31

mmol/l

0.53

170

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

178

1238

1.45

5.26

1.5

1.3

54.50

62.92

mmol/l

2.16

125

995

Crohn disease (strict definition, require KELA)

255

2.02

5.24

2.3

1.5

69.78

67.00

mmol/l

0.13

214

Palmar fascial fibromatosis [Dupuytren]

144

962

1.51

5.22

1.4

1.3

59.89

63.63

mmol/l

0.61

115

755

Other necrotizing vasculopathies (FG)

354

1.86

5.22

1.7

1.3

52.80

60.71

mmol/l

1.39

279

Arthrosis

664

3008

1.22

5.21

1.3

62.89

61.99

mmol/l

0.21

538

2336

Other disorders of nervous system

347

1.87

5.21

1.4

59.69

60.19

mmol/l

0.03

276

Simple and mucopurulent chronic bronchitis

230

2.07

5.14

1.6

1.5

58.91

62.20

mmol/l

0.19

186

Nail disorders

421

1.77

5.14

1.4

60.60

63.46

mmol/l

0.25

343

Certain conditions originating in the perinatal period

275

1.91

5.14

3.2

2.5

87.56

78.17

mmol/l

0.58

237

Subjective visual disturbances

207

1486

1.40

5.12

1.4

62.15

62.96

mmol/l

0.10

169

1184

Pyogenic arthritis

356

1.85

5.12

1.4

61.11

66.59

mmol/l

0.42

283

Other (seronegative) rheumatoid arthritis, wide

188

1328

1.43

5.12

1.5

1.3

57.06

62.73

mmol/l

1.39

145

1069

Chronic tubulo-interstitial nephritis

204

2.14

5.10

1.4

1.3

51.35

59.70

mmol/l

0.86

164

Other and unspecified diseases of blood and blood-forming organs

116

2.55

5.08

1.3

50.46

62.81

mmol/l

0.83

102

Malignant neoplasm of skin

629

3913

1.21

5.08

1.3

59.07

62.65

mmol/l

1.60

514

3120

Benign neoplasm of other and unspecified female genital organs

225

2.08

5.05

1.3

1.4

68.03

62.87

mmol/l

0.34

183

Olecranon bursitis

301

1.92

5.03

1.4

1.3

62.37

63.48

mmol/l

0.05

237

Other hearing loss

279

2069

1.33

5.03

1.6

1.3

62.30

61.95

mmol/l

0.05

226

1656

Single delivery by forceps and vacuum extractor

337

0.38

5.00

1.2

1.5

73.13

67.12

mmol/l

0.17

259

Mixed connective tissue disease

359

1.83

5.00

1.4

1.3

58.79

62.03

mmol/l

0.27

291

Left ventricular outflow tract obstruction (LVOTO), broad definition

522

1.68

5.00

1.6

1.5

64.15

65.93

mmol/l

0.12

422

Crohn disease (strict definition, require KELA, min 2 HDR)

246

2.01

4.99

2.3

1.4

69.71

66.70

mmol/l

0.13

210

Specific development disorders of speech and language

250

1.98

4.97

3.3

2.2

72.37

72.97

mmol/l

0.03

212

Open wound of ankle and foot

517

1.68

4.91

1.5

1.3

57.38

66.69

mmol/l

0.93

415

Melanocytic naevi

201

1447

1.39

4.90

1.3

1.4

62.52

65.33

mmol/l

0.49

152

1149

Redundant prepuce, phimosis and paraphimosis

140

938

1.49

4.90

1.8

1.4

63.81

67.99

mmol/l

0.56

109

727

Injury of unspecified body region

413

1.76

4.89

1.5

1.4

51.76

64.46

mmol/l

2.78

332

Complications of labour and delivery

312

2262

0.77

4.89

1.4

61.75

63.64

mmol/l

0.33

247

1787

Polymyalgia rheumatica

142

961

1.49

4.89

1.4

1.3

60.38

61.02

mmol/l

0.07

117

761

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

419

3287

1.26

4.87

1.4

57.69

64.46

mmol/l

2.92

340

2596

Lymphoid leukaemia

341

1.84

4.86

1.3

1.6

67.89

63.04

mmol/l

0.31

278

Any event in hilmo or specialist outpatient

+∞

4.85

1.0

0.0

69.50

—

mmol/l

—

Aortic valve malfunction, age under 60 years

474

1.70

4.84

1.6

1.4

61.66

65.81

mmol/l

0.34

381

Carpal tunnel syndrome

530

3916

1.23

4.84

1.4

1.3

62.39

62.02

mmol/l

0.07

418

3081

Brain meningioma

313

1.88

4.83

1.2

1.3

78.74

59.62

mmol/l

2.73

249

Acute bronchiolitis

229

1.98

4.82

3.3

3.0

69.39

78.42

mmol/l

0.74

205

3.36

4.79

1.9

1.3

51.58

58.89

mmol/l

0.51

Burn and corrosion of shoulder and upper limb, except wrist and hand

2.72

4.78

1.4

1.6

72.44

63.56

mmol/l

0.29

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

278

1.92

4.78

2.2

1.5

68.03

67.44

mmol/l

0.03

234

Ocular pain

401

1.76

4.78

1.7

1.4

59.82

64.01

mmol/l

0.43

322

Acute generalized exanthematous pustulosis

237

2.01

4.77

1.3

1.4

70.11

66.18

mmol/l

0.24

196

Diseases of spleen

2.85

4.76

1.7

1.4

62.19

61.57

mmol/l

0.02

Benign neoplasm: Caecum

584

1.63

4.75

1.3

1.4

56.39

62.56

mmol/l

1.16

462

Essential (haemorrhagic) thrombocythaemia

197

2.12

4.74

1.1

1.4

55.84

62.34

mmol/l

0.52

158

Symptoms and signs involving emotional state

120

2.45

4.74

1.4

64.77

70.06

mmol/l

0.25

Coronary revascularization (ANGIO or CABG)

463

2604

1.25

4.74

1.4

1.3

62.00

62.02

mmol/l

0.00

371

2075

!Aliquae complicationes praecoces traumatis

197

2.11

4.73

1.2

1.3

62.67

63.17

mmol/l

0.02

163

Early complications of trauma

197

2.11

4.73

1.2

1.3

62.67

63.17

mmol/l

0.02

163

Allergic conjunctivitis

438

3470

1.25

4.73

1.4

58.08

64.54

mmol/l

2.71

355

2744

Non-follicular lymphoma, hilmo, excluding all cancers

516

1.66

4.71

1.5

1.4

57.28

63.96

mmol/l

0.88

412

Open wound of shoulder and upper arm

2.89

4.69

1.9

1.4

61.87

64.31

mmol/l

0.10

Benign neoplasm: Rectum, anus and anal canal

187

1343

1.40

4.67

1.4

1.3

57.97

62.48

mmol/l

0.93

146

1087

Basal cell carcinoma

567

3733

1.21

4.67

1.3

1.4

58.58

62.57

mmol/l

1.84

465

2984

Infection due to other mycobacteria

2.82

4.66

1.5

1.3

60.88

60.12

mmol/l

0.03

Dementia in other diseases classified elsewhere

261

1.94

4.62

1.6

1.3

62.95

61.42

mmol/l

0.08

212

Rash and other nonspecific skin eruption

565

1.62

4.62

1.4

58.84

64.94

mmol/l

0.86

457

Abrasion of teeth

218

1175

1.37

4.59

1.4

58.10

62.25

mmol/l

0.70

172

929

Malignant neoplasm of other and unspecified parts of tongue

2.94

4.55

1.6

1.4

71.33

63.69

mmol/l

0.26

Benign neoplasm: Sigmoid colon

171

1216

1.42

4.54

1.5

1.3

61.81

62.20

mmol/l

0.04

129

987

Disorders of refraction and accommodation

190

1369

1.39

4.54

2.2

1.6

68.23

64.55

mmol/l

0.54

157

1096

Degenerative diseases of the nervous system

354

2098

1.28

4.53

1.4

1.3

60.19

60.65

mmol/l

0.08

284

1677

TMD related pain

129

2.36

4.52

1.3

79.62

68.12

mmol/l

0.54

109

Rheumatoid arthritis, including avohilmo

357

2826

1.27

4.52

1.5

1.4

61.67

62.82

mmol/l

0.21

287

2244

Moderate visual impairment, binocular

181

2.14

4.52

1.5

68.77

60.78

mmol/l

0.54

147

Disorders of synovium and tendon

438

3190

1.24

4.52

1.4

62.77

62.80

mmol/l

0.00

341

2476

Lesion of radial nerve

201

2.07

4.51

1.3

46.33

61.84

mmol/l

2.45

159

Unspecified misadventure during surgical and medical care

299

1.86

4.50

1.6

1.4

60.39

63.33

mmol/l

0.16

242

Nonischemic cardiomyopathy

285

1.88

4.48

1.5

1.3

57.15

64.07

mmol/l

0.56

234

Pneumothorax

350

1.79

4.48

1.5

1.3

55.10

64.61

mmol/l

1.04

284

Degenerative macular diseases

128

865

1.49

4.48

1.4

1.3

59.17

62.18

mmol/l

0.42

109

679

Basal cell carcinoma, including avohilmo

576

3770

1.21

4.47

1.3

1.4

58.73

62.50

mmol/l

1.71

474

3011

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

2.74

4.46

1.9

1.6

53.88

66.16

mmol/l

0.66

Temporomandibular joint disorders, including avohilmo

278

2132

1.31

4.45

1.4

64.75

64.27

mmol/l

0.06

236

1671

Malignant neoplasm of small intestine

118

2.43

4.45

1.8

1.2

64.77

62.41

mmol/l

0.11

Benign neoplasm: Vagina

3.08

4.44

1.2

1.4

69.54

63.25

mmol/l

0.26

Hypothermia

2.61

4.43

1.5

1.3

73.63

63.07

mmol/l

0.33

Other specified/unspecified dorsopathies

156

2.21

4.42

1.3

60.41

57.18

mmol/l

0.14

124

Lesion of lateral popliteal nerve

244

1.95

4.41

1.7

1.3

52.56

60.54

mmol/l

0.87

196

Inguinal hernia

514

2848

1.22

4.38

1.4

1.3

65.52

63.32

mmol/l

0.52

409

2234

Diffuse large B-cell lymphoma, helper endpoint

238

1.96

4.38

1.7

1.3

64.90

65.03

mmol/l

0.01

191

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

238

1.96

4.38

1.7

1.3

64.90

65.03

mmol/l

0.01

191

Hemiplegia

273

1.89

4.37

1.7

1.3

67.98

63.47

mmol/l

0.27

217

Contact with heat and hot substances

231

1.97

4.36

1.4

1.5

62.94

68.10

mmol/l

0.26

194

Seronegative rheumatoid arthritis

112

740

1.52

4.36

1.4

1.3

57.98

61.54

mmol/l

0.47

581

Other congenital malformations of circulatory system

119

2.40

4.36

1.8

1.3

89.74

60.90

mmol/l

1.58

102

Anankastic personality disorder

125

2.35

4.35

1.4

1.3

66.67

68.29

mmol/l

0.06

108

Emotional disorders starting during childhood or adolescence

130

2.31

4.35

2.3

2.5

63.68

82.55

mmol/l

1.27

116

Unspecified event, undetermined intent

2.57

4.32

1.2

1.4

60.75

66.67

mmol/l

0.24

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

178

2.11

4.30

1.2

1.3

56.17

63.65

mmol/l

0.60

145

Seborrhoeic dermatitis

491

1.64

4.28

1.3

1.4

61.46

64.70

mmol/l

0.32

404

Chondrocostal junction syndrome [Tietze]

192

2.06

4.26

1.3

69.56

59.56

mmol/l

0.68

154

Other noninflammatory disorders of vagina

394

1.71

4.21

1.5

1.4

61.33

61.95

mmol/l

0.04

299

Other and unspecified mononeuropathies of upper limb

140

2.25

4.21

1.9

1.3

80.15

63.46

mmol/l

0.82

116

Dislocation, sprain and strain of joints and ligaments of thorax

147

2.21

4.17

1.4

1.3

55.81

64.60

mmol/l

0.48

126

Follicular cysts of skin and subcutaneous tissue

149

1051

1.43

4.17

1.4

1.3

58.77

64.45

mmol/l

1.01

114

836

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

441

1.67

4.17

1.4

62.55

64.12

mmol/l

0.11

360

Benign neoplasm: Descending colon

351

1.76

4.16

1.5

1.4

72.04

62.58

mmol/l

0.94

277

Benign neoplasm: Transverse colon

645

1.55

4.15

1.4

1.3

56.15

62.55

mmol/l

0.96

522

HSIL lesion of the cervix uteri, vagina or vulva

106

700

1.52

4.13

1.6

1.4

54.95

66.01

mmol/l

1.97

552

Thoracic aortic aneurysm

116

782

1.49

4.13

1.4

1.3

66.00

63.81

mmol/l

0.23

637

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

250

1.90

4.12

1.2

1.3

55.08

63.52

mmol/l

0.75

194

Lichen simplex chronicus

161

2.14

4.12

1.4

1.2

56.44

65.96

mmol/l

0.88

135

Oligomenorrhoea

122

2.32

4.12

1.6

1.4

62.43

64.20

mmol/l

0.08

Progressive vascular leukoencephalopathy

237

1.94

4.11

1.3

59.24

59.69

mmol/l

0.03

196

Single spontaneous delivery

263

1815

0.77

4.11

1.3

1.4

63.37

60.79

mmol/l

0.47

213

1445

Parodontitis, operation under 40 years and operation codes

174

2.08

4.10

1.4

1.6

85.76

75.76

mmol/l

0.36

136

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

451

1.66

4.10

1.5

1.4

54.37

63.48

mmol/l

1.28

364

Gonarthrosis [arthrosis of knee](FG)

687

3430

1.18

4.09

1.3

62.78

61.87

mmol/l

0.23

555

2657

Coxibs

270

1100

1.31

4.08

1.4

64.97

61.55

mmol/l

0.60

217

863

Inflammatory diseases of prostate (prostatitis)

100

655

1.54

4.07

1.4

1.3

65.74

65.28

mmol/l

0.03

522

Coxarthrosis, primary, with hip surgery

465

3635

1.22

4.07

1.4

1.3

60.69

62.25

mmol/l

0.41

387

2893

Polycythaemia vera

196

2.02

4.06

1.3

61.06

64.41

mmol/l

0.21

157

Acetic acid derivatives and related substances

274

1095

1.31

4.05

1.4

63.61

61.45

mmol/l

0.36

218

858

Childhood asthma (age<16), excluding more controls

219

1.85

4.05

1.7

1.8

77.38

79.30

mmol/l

0.09

171

Coeliac disease

633

1.54

4.02

1.5

1.4

66.54

65.61

mmol/l

0.07

515

Congenital malformations of cardiac septa

328

1.76

4.02

2.0

2.1

75.90

70.02

mmol/l

0.38

282

Acute pharyngitis

581

1.56

4.01

2.5

1.5

75.62

66.87

mmol/l

1.02

464

Disturbance of activity and attention

270

1.84

4.00

1.8

2.7

67.28

80.37

mmol/l

1.24

229

Seropositive rheumatoid arthritis, strict definition

136

952

1.44

4.00

1.4

69.18

61.97

mmol/l

1.19

108

768

Benign neoplasm: Tongue

124

2.29

3.99

1.7

1.3

56.95

62.00

mmol/l

0.22

102

Pedestrian injured in transport accident

363

1.72

3.99

1.4

1.3

62.75

61.48

mmol/l

0.07

291

Pre-eclampsia or eclampsia

140

985

1.43

3.98

1.3

1.4

62.85

63.74

mmol/l

0.09

110

769

Cholecystectomy

632

4742

1.18

3.98

1.6

1.3

62.57

62.26

mmol/l

0.06

504

3773

Overexertion and strenuous or repetitive movements

501

1.61

3.97

1.8

1.4

62.18

62.89

mmol/l

0.05

407

Systemic lupus erythematosus

184

2.04

3.96

1.4

49.55

63.59

mmol/l

1.24

150

Erythema intertrigo

125

2.28

3.94

1.5

1.3

55.94

65.16

mmol/l

0.52

102

Delivery

268

1822

0.78

3.93

1.3

1.4

63.40

60.84

mmol/l

0.48

220

1450

Diseases of external ear

278

2176

1.28

3.92

1.4

63.51

64.42

mmol/l

0.13

211

1743

Other demyelinating diseases of the central nervous system

125

2.26

3.91

1.3

1.5

47.90

71.96

mmol/l

2.88

110

Acne vulgaris

205

1.96

3.91

1.5

1.9

76.97

76.46

mmol/l

0.02

181

Benign neoplasm: Vagina

2.84

3.90

1.2

1.4

69.54

64.00

mmol/l

0.23

Alzheimer’s disease (Atypical or mixed), excluding more controls

347

1.68

3.88

1.3

55.60

60.82

mmol/l

0.63

273

Hypersomnia

3.03

3.88

1.1

1.5

68.73

62.73

mmol/l

0.16

Other necrotizing vasculopathies

451

1.64

3.86

1.7

1.4

50.48

60.83

mmol/l

2.50

364

Clear cell adenocarcinoma of kidney

271

1.83

3.86

1.5

1.3

52.00

61.02

mmol/l

1.08

217

Fistulae involving female genital tract

2.73

3.86

1.7

1.3

62.30

56.25

mmol/l

—

Other inflammation of eyelid

110

746

1.48

3.83

1.3

1.4

65.84

63.51

mmol/l

0.21

591

Need for immunization against other single viral diseases

2.52

3.83

1.6

1.3

59.31

64.20

mmol/l

0.18

Arterial embolism and thrombosis

330

1.74

3.83

1.5

1.3

55.18

63.37

mmol/l

0.74

275

Congenital malformations of heart and great arteries

104

675

1.50

3.81

1.8

1.9

73.70

67.71

mmol/l

0.58

557

Other and unspecified abdominal hernia

229

1.90

3.80

3.4

1.3

60.23

63.62

mmol/l

0.23

190

Childhood asthma (age<16)

224

1.81

3.80

1.7

1.8

77.38

79.10

mmol/l

0.08

176

Atopic dermatitis, strict definition

180

1305

1.36

3.80

1.6

1.8

60.95

68.90

mmol/l

1.51

135

1044

Parodontitis, under 40 years and operation codes

173

2.03

3.78

1.4

1.6

86.54

75.61

mmol/l

0.39

135

Inguinal hernia, bilateral

555

1.56

3.78

1.4

68.25

65.44

mmol/l

0.24

449

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

391

1.67

3.78

1.3

71.83

63.12

mmol/l

0.69

313

Aortic aneurysm

192

1412

1.34

3.78

1.3

62.74

63.82

mmol/l

0.14

155

1138

Dipeptidyl peptidase 4 (DPP-4) inhibitors

110

749

1.48

3.77

1.4

59.15

62.89

mmol/l

0.43

616

Secondary uncertain malignant neoplasm

116

798

1.46

3.77

1.3

61.90

62.69

mmol/l

0.07

642

Superficial injury of forearm

438

1.63

3.76

2.0

1.4

58.56

66.15

mmol/l

0.76

360

Labour and delivery complicated by fetal stress [distress]

450

0.52

3.75

1.2

1.5

59.37

69.78

mmol/l

0.61

352

Disorders of muscles

525

1.57

3.73

1.3

57.09

65.53

mmol/l

0.94

414

Respiratory conditions due to other external agents

109

2.34

3.73

1.5

1.3

57.47

65.64

mmol/l

0.49

Ingrowing nail

245

1.85

3.71

1.4

1.3

64.66

65.29

mmol/l

0.04

202

Benign neoplasm: Ascending colon

112

768

1.47

3.71

1.3

65.59

62.93

mmol/l

0.30

617

Superficial injuries involving multiple body regions

109

2.33

3.71

1.5

1.3

47.11

64.90

mmol/l

1.76

Benign paroxysmal vertigo

264

2071

1.28

3.70

1.4

61.13

62.20

mmol/l

0.17

216

1652

Special screening examination for infectious and parasitic diseases

117

599

1.46

3.70

1.4

1.3

65.80

65.19

mmol/l

0.04

458

Other peripheral vascular diseases

433

1.63

3.69

1.5

1.3

59.94

62.29

mmol/l

0.17

355

Rotator cuff syndrome

545

3411

1.19

3.69

1.3

64.94

62.15

mmol/l

0.77

450

2652

Benign neoplasm of middle ear and respiratory system

395

1.66

3.67

1.5

1.4

53.67

64.23

mmol/l

1.45

320

Parodontitis, under 40 years, or operation codes

189

1.97

3.67

1.4

1.6

85.76

74.33

mmol/l

0.43

149

Inguinal or femoral hernia, bilateral

568

1.54

3.65

1.4

68.40

65.65

mmol/l

0.24

459

Outcome of delivery

348

0.48

3.64

1.1

1.4

69.41

64.65

mmol/l

0.16

261

Thyrotoxicosis with diffuse goitre

108

738

1.47

3.63

1.3

68.34

62.08

mmol/l

0.75

582

Urticaria

217

1663

1.31

3.63

1.4

1.5

65.80

64.69

mmol/l

0.14

174

1325

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

397

1.65

3.62

1.3

59.45

61.31

mmol/l

0.15

321

Herpesviral [herpes simplex] infections

601

1.52

3.62

1.3

1.4

66.25

64.98

mmol/l

0.12

485

Dystonia

299

1.76

3.61

1.3

1.4

57.68

61.16

mmol/l

0.22

241

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

184

1356

1.34

3.61

1.3

1.4

59.30

61.91

mmol/l

0.41

141

1093

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

230

1775

1.30

3.60

1.4

1.5

64.80

66.54

mmol/l

0.22

171

1412

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

150

2.10

3.60

1.8

1.4

62.54

64.76

mmol/l

0.11

119

Seropositive rheumatoid arthritis, wide

250

1956

1.28

3.59

1.5

1.4

64.08

62.54

mmol/l

0.23

202

1563

Psoriasis (vulgaris), strict definition

137

2.14

3.57

1.5

1.4

58.80

63.41

mmol/l

0.25

118

Multiple myeloma and malignant plasma cell neoplasms

293

1.76

3.57

1.3

1.4

52.83

63.54

mmol/l

1.70

240

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

382

2037

1.23

3.56

1.4

60.28

62.18

mmol/l

0.37

290

1618

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

382

2037

1.23

3.56

1.4

60.28

62.18

mmol/l

0.37

290

1618

All dysplastic lesions of the cervix uteri, vagina or vulva

155

1126

1.37

3.56

1.5

1.4

55.08

66.57

mmol/l

3.28

134

881

Other diseases of peritoneum

249

1.83

3.55

1.2

1.3

62.03

61.45

mmol/l

0.04

197

Other disorders of optic [2nd] nerve and visual pathways

338

1.70

3.55

2.1

1.5

75.91

65.75

mmol/l

0.80

276

Parkinson's disease, including avohilmo

148

1077

1.38

3.54

1.3

72.23

62.21

mmol/l

2.24

115

874

Other female pelvic inflammatory diseases

135

967

1.40

3.53

1.5

1.4

65.49

62.13

mmol/l

0.43

105

775

Atypical mycobacterium lung infection

2.77

3.53

1.6

1.3

50.17

58.38

mmol/l

0.38

Vascular dementia

592

1.51

3.53

1.4

1.3

57.04

59.59

mmol/l

0.30

471

Viral pneumonia (unknown virus, not influenza)

301

1.74

3.52

2.2

1.4

73.05

67.49

mmol/l

0.33

247

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

145

2.10

3.49

1.6

2.0

79.00

68.94

mmol/l

0.33

123

Acute suppurative otitis media

145

981

1.38

3.49

2.2

1.8

74.78

68.96

mmol/l

0.60

111

788

Generalized epilepsy, mode (most common among epilepsy diagnosis)

125

2.18

3.49

1.8

1.6

63.81

71.44

mmol/l

0.34

108

Complications of cardiac and vascular prosthetic devices, implants and grafts

106

2.31

3.49

2.1

1.3

66.16

63.73

mmol/l

0.10

Benign neoplasm: Other and unspecified parts of mouth

159

2.04

3.47

1.4

1.3

60.57

61.59

mmol/l

0.04

125

Malignant neoplasm of liver and intrahepatic bile ducts

194

1.94

3.46

1.3

62.40

63.38

mmol/l

0.04

160

Other maternal disorders predominantly related to pregnancy

258

2053

0.79

3.44

1.4

64.30

63.40

mmol/l

0.11

205

1611

Chronic mastoiditis

153

2.06

3.44

1.4

1.3

72.29

64.30

mmol/l

0.48

129

Oter anti-inflammatory and antirheumatic agents, non-steroids

233

997

1.30

3.44

1.4

1.3

61.53

60.93

mmol/l

0.08

187

788

Other follicular disorders

281

1.76

3.43

1.4

1.3

66.50

66.72

mmol/l

0.01

236

Benign neoplasm: Rectosigmoid junction

245

1.82

3.43

1.6

1.3

56.61

59.00

mmol/l

0.17

202

HSIL lesion of the cervix uteri

584

1.51

3.43

1.7

1.4

55.76

67.00

mmol/l

1.69

457

ILD-related respiratory insufficiency

188

1.95

3.42

1.3

69.00

62.34

mmol/l

0.43

154

Other benign neoplasms of skin

328

2666

1.23

3.40

1.3

1.4

60.74

63.07

mmol/l

0.55

262

2120

Idiopathic gout

538

1.54

3.40

1.4

1.3

52.77

64.06

mmol/l

1.98

427

Cluster headache, strict, including avohilmo

202

1.90

3.40

1.3

67.73

67.60

mmol/l

0.01

176

Benign neoplasm of major salivary glands

514

1.55

3.39

1.3

1.4

54.90

64.11

mmol/l

1.48

416

Septal defects

320

1.70

3.39

2.1

2.2

72.90

72.38

mmol/l

0.03

274

Other disorders of veins

332

2702

1.23

3.38

1.4

63.67

62.58

mmol/l

0.19

271

2146

Benign lipomatous neoplasm of other sites/unspecified

507

1.55

3.37

1.4

1.3

57.15

62.84

mmol/l

0.79

406

Other hammer toe(s) (acquired)

181

1283

1.33

3.37

1.2

1.3

63.78

59.95

mmol/l

0.66

144

1006

Gestational diabetes (for exclusion)

830

0.65

3.37

1.3

1.5

64.26

69.31

mmol/l

0.36

655

Other intracranial haemorrhages

175

1.97

3.36

1.6

1.3

66.10

65.05

mmol/l

0.05

145

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

114

800

1.43

3.36

1.8

1.4

64.47

65.58

mmol/l

0.09

630

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

200

1.89

3.35

3.1

3.0

71.88

82.50

mmol/l

0.73

184

Parodontitis, under 40 years

189

1.91

3.33

1.4

1.6

86.54

74.33

mmol/l

0.45

149

Vascular dementia (subcortical)

190

1.93

3.32

1.3

66.04

60.19

mmol/l

0.47

150

Schizoid personality disorder

2.66

3.32

1.8

1.3

36.80

57.95

mmol/l

—

399

1.62

3.31

1.4

1.3

58.20

66.12

mmol/l

0.74

317

Optic neuritis

155

2.02

3.31

2.2

1.3

62.85

64.59

mmol/l

0.08

133

Melanocytic naevi, other sites/unspecified

330

1.68

3.29

1.4

54.40

66.39

mmol/l

1.91

272

Benign neoplasm of other and unspecified female genital organs

263

1.77

3.29

1.3

1.4

68.03

60.08

mmol/l

0.60

206

Other/unspecified rheumatoid arthritis

121

864

1.41

3.27

1.5

1.3

58.43

61.13

mmol/l

0.35

692

Benign neoplasm: Small intestine

227

1.83

3.27

1.5

1.3

61.41

64.46

mmol/l

0.19

180

Additional codes for the location of defect, injury or illness

301

1.71

3.26

1.2

1.4

69.23

62.80

mmol/l

0.41

244

Benign neoplasm: Rectum

156

1162

1.35

3.25

1.4

1.3

56.44

62.83

mmol/l

1.37

121

943

Ulcerative proctitis

249

1.78

3.24

1.9

1.4

63.44

67.71

mmol/l

0.23

211

Prolonged pregnancy

375

0.44

3.24

1.3

1.5

66.08

67.83

mmol/l

0.04

293

Striking against or struck by other objects

224

1752

1.28

3.24

1.6

1.5

61.09

66.35

mmol/l

0.93

176

1394

Malignant neoplasm of nasal cavity and sinuses

3.45

3.23

1.0

1.4

62.91

63.48

mmol/l

0.02

Other/unspecified seropositive rheumatoid arthritis

245

1941

1.27

3.23

1.5

1.4

64.44

62.50

mmol/l

0.30

197

1551

Arterial embolism and thrombosis of lower extremity artery

192

1.90

3.21

1.5

1.3

55.48

62.74

mmol/l

0.55

162

Other/unspecified synovitis and tenosynovitis

626

1.48

3.21

1.3

63.33

65.32

mmol/l

0.16

490

Persons encountering health services in circumstances related to reproduction

291

2439

0.81

3.21

1.5

1.6

70.93

63.99

mmol/l

1.61

235

1871

Rosacea

602

1.49

3.21

1.3

1.4

60.94

63.59

mmol/l

0.24

487

Unspecified/other endometriosis

287

1.72

3.20

1.3

1.4

62.57

64.15

mmol/l

0.10

217

Other noninflammatory disorders of vulva and perineum

426

1.58

3.20

1.9

1.4

51.07

61.49

mmol/l

1.65

330

Spondyloarthritis

137

1002

1.37

3.19

1.6

1.3

60.25

63.70

mmol/l

0.48

110

808

Autonomic disorders

104

2.25

3.18

1.2

1.3

82.28

65.57

mmol/l

0.70

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

240

1901

1.27

3.17

1.5

1.4

65.34

62.48

mmol/l

0.48

192

1517

Postprocedural disorders of nervous system

236

1.79

3.17

1.2

1.5

85.49

66.38

mmol/l

1.45

201

Mesothelioma, excluding all cancers (controls excluding all cancers)

2.68

3.17

1.6

1.3

87.44

62.80

mmol/l

—

Cardiac murmurs and other cardiac sounds

422

1.58

3.16

1.7

61.42

65.67

mmol/l

0.32

345

Benign neoplasm of brain and other parts of central nervous system

319

1.68

3.16

1.8

1.5

73.87

61.83

mmol/l

0.97

260

Oxicams

234

1041

1.28

3.15

1.3

60.35

61.08

mmol/l

0.10

184

819

Delayed milestone in childhood

118

2.11

3.15

5.3

4.0

92.00

83.60

mmol/l

0.32

109

Female genital prolapse

268

1231

1.26

3.15

1.4

1.3

64.21

60.47

mmol/l

0.76

219

937

Oral leukoplakia and related diseases, including avohilmo

524

1.52

3.14

1.4

1.3

59.18

61.05

mmol/l

0.17

422

Benign neoplasm: Skin of other and unspecified parts of face

613

1.48

3.14

1.3

59.44

64.17

mmol/l

0.64

488

Acne

281

1.71

3.14

1.6

1.8

77.51

72.33

mmol/l

0.26

243

Filling of root of tooth

145

2.03

3.12

1.5

1.3

64.04

61.52

mmol/l

0.12

128

Allergic contact dermatitis

663

1.46

3.12

1.5

1.4

63.59

65.33

mmol/l

0.13

528

7.82

3.09

1.2

1.0

98.00

70.13

mmol/l

—

Deviated nasal septum

251

2004

1.26

3.08

1.3

66.20

62.34

mmol/l

0.75

209

1549

Cluster headache, wide,, including avohilmo

224

1.80

3.07

1.3

66.56

66.49

mmol/l

0.00

191

Drug-induced myopathy

6.17

3.07

1.3

1.6

44.57

51.75

mmol/l

—

Embolic stroke

276

1.72

3.07

1.4

1.3

60.00

63.20

mmol/l

0.25

221

Pedestrian injured in collision with pedal cycle

146

2.01

3.07

1.4

1.3

54.71

60.18

mmol/l

0.27

120

SLE, ICD10

174

1.92

3.06

1.3

1.4

50.96

64.97

mmol/l

1.09

143

SLE, strict definition

174

1.92

3.06

1.3

1.4

50.96

64.97

mmol/l

1.09

143

Maternal care related to the fetus and amniotic cavity and possible delivery problems

161

1253

0.75

3.05

1.4

1.5

66.36

65.73

mmol/l

0.06

134

967

Bulimia nervosa (incl. atypical)

2.60

3.05

2.1

1.8

65.40

82.93

mmol/l

—

Use of antiglaucoma preparations and miotics

577

1.49

3.04

1.3

59.61

61.24

mmol/l

0.16

454

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

665

1.45

3.04

1.3

54.15

64.81

mmol/l

2.32

527

Retinal detachment with retinal break

113

809

1.41

3.03

1.3

51.31

64.05

mmol/l

4.65

635

therapeutic use

175

1.91

3.03

1.6

1.3

64.70

63.11

mmol/l

0.09

140

Biological medication for rheuma

102

717

1.43

3.02

2.0

1.4

70.69

64.52

mmol/l

0.60

570

Benign neoplasm: Parotid gland

401

1.58

3.02

1.3

1.4

54.84

63.66

mmol/l

1.05

326

Wet age-related macular degeneration

181

1368

1.31

3.02

1.4

1.3

60.64

60.15

mmol/l

0.06

142

1095

Keratitis

271

2190

1.24

3.02

1.5

1.4

63.97

63.68

mmol/l

0.04

224

1730

Vertigo of central origin

2.39

3.02

1.5

1.3

57.23

58.36

mmol/l

0.06

6-mercaptopurine

2.32

3.01

1.2

1.7

78.40

65.28

mmol/l

0.53

Hyperkinetic disorders

311

1.66

3.01

1.8

2.7

65.50

80.67

mmol/l

1.61

263

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

2.69

2.99

1.9

1.4

43.70

68.55

mmol/l

—

Disease of hard tissues of teeth, NOS

3.06

2.99

1.4

1.2

47.75

62.71

mmol/l

0.95

Other/unspecified enthesopathies of lower limb, excluding foot

301

1.67

2.99

1.4

60.48

63.73

mmol/l

0.23

244

Retinal haemorrhage

134

2.05

2.99

1.3

83.62

62.00

mmol/l

0.94

107

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

126

921

1.37

2.98

1.7

1.4

65.63

64.63

mmol/l

0.08

732

Carcinoma in situ of skin of trunk

162

1.94

2.97

1.2

1.4

58.71

62.42

mmol/l

0.24

126

Anuria and oliguria

3.25

2.97

1.3

1.5

63.33

55.86

mmol/l

—

Carcinoma in situ of skin

483

1.52

2.97

1.2

1.4

62.72

63.03

mmol/l

0.02

381

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

272

1.71

2.96

1.4

1.3

58.38

63.08

mmol/l

0.26

222

Melanocytic naevi of trunk

531

1.50

2.96

1.2

1.4

74.48

64.84

mmol/l

1.27

429

Hepatocellular carcinoma

101

2.22

2.96

1.3

74.85

63.69

mmol/l

0.45

Fenamates

148

744

1.35

2.93

1.4

1.3

63.66

62.29

mmol/l

0.13

120

587

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

213

1.79

2.91

1.7

1.5

74.27

67.34

mmol/l

0.33

177

Other and unspecified coagulation defects

206

1.81

2.91

1.6

1.5

78.04

64.88

mmol/l

0.70

177

Pleural plaque

558

1.48

2.91

1.5

1.3

60.35

64.18

mmol/l

0.38

450

Congenital malformations of aortic and mitral valves

199

1.83

2.91

1.2

1.5

79.90

69.30

mmol/l

0.51

168

Carcinoma in situ of skin, other sites/unspecified

2.65

2.91

1.2

1.4

52.89

61.29

mmol/l

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

192

1.85

2.90

1.3

1.5

59.70

63.67

mmol/l

0.19

157

Acanthosis nigricans

6.94

2.90

1.2

1.6

51.83

61.78

mmol/l

—

Other disorders starting during childhood or adolescence

183

1.86

2.89

3.4

3.2

76.29

81.74

mmol/l

0.28

166

Burns and corrosions of multiple and unspecified body regions

2.28

2.88

2.1

1.3

60.69

60.35

mmol/l

0.01

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

470

1.52

2.88

1.4

1.3

67.52

62.31

mmol/l

0.43

372

Ulcerative colitis (strict definition, require KELA)

116

842

1.38

2.88

1.7

1.4

64.47

64.84

mmol/l

0.03

668

Dronedarone medication

164

1.92

2.88

1.5

1.3

67.79

64.40

mmol/l

0.18

132

Car occupant injured in other and unspecified transport accidents

127

936

1.36

2.87

1.5

1.4

57.76

64.06

mmol/l

0.91

734

Delivery, wide proxy

236

1569

0.80

2.85

1.3

1.4

64.42

60.77

mmol/l

0.66

187

1257

Entropion and trichiasis of eyelid

536

1.49

2.85

1.4

1.3

62.43

60.39

mmol/l

0.17

434

Coronary artery bypass grafting

262

1612

1.24

2.84

1.4

1.3

63.23

62.31

mmol/l

0.16

214

1292

Other deformities of toe(s)

201

1.81

2.83

1.3

73.93

61.15

mmol/l

0.99

159

Other specified/unspecified inflammatory spondylopathies

158

1.91

2.80

1.7

1.4

66.56

65.19

mmol/l

0.05

133

Haemolytic anaemias

173

1.87

2.78

1.5

1.3

65.91

65.79

mmol/l

0.01

141

Xerosis cutis

2.36

2.77

2.1

1.2

46.58

64.24

mmol/l

1.47

Diseases of tongue

347

1.60

2.77

1.4

51.60

60.95

mmol/l

1.53

281

Right bundle-branch block

159

1.91

2.77

1.4

1.3

52.75

63.81

mmol/l

1.04

129

Special screening examination for neoplasms

195

1.81

2.77

1.5

1.3

57.86

61.15

mmol/l

0.19

147

Diffuse large B-cell lymphoma

278

1.67

2.76

1.7

1.3

64.90

61.21

mmol/l

0.23

223

Conjunctivitis (acute, non atopic)

200

1574

1.27

2.76

1.4

1.5

62.70

65.68

mmol/l

0.44

159

1254

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

218

1740

1.26

2.75

1.4

1.3

65.36

64.14

mmol/l

0.15

172

1374

Memory loss

640

1.43

2.75

1.4

1.3

59.08

60.55

mmol/l

0.13

510

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

2.77

2.75

1.1

1.5

61.77

66.02

mmol/l

0.15

Presbycusis

140

1051

1.33

2.74

1.4

1.3

60.67

mmol/l

0.00

114

830

Central retinal artery occlusion

118

2.07

2.74

1.7

1.3

77.42

63.53

mmol/l

0.68

Sulfasalazine

207

1643

1.26

2.74

1.4

1.3

63.97

64.16

mmol/l

0.02

174

1303

Endometriosis

266

1282

1.24

2.73

1.3

61.73

61.06

mmol/l

0.09

222

978

Malignant neoplasm of hypopharynx

3.94

2.72

1.6

1.3

48.11

61.67

mmol/l

—

Chronic conjunctivitis

153

1.92

2.72

1.1

1.4

58.14

67.37

mmol/l

0.64

127

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

184

1441

1.28

2.72

1.3

1.4

61.37

64.44

mmol/l

0.48

147

1136

Other coagulation defects

349

1.59

2.71

1.5

1.4

68.50

64.49

mmol/l

0.23

283

Other specified/unspecified soft tissue disorders

287

1.65

2.71

1.6

1.3

54.00

62.12

mmol/l

0.83

217

Sequelae of injuries of lower limb

469

1.50

2.70

1.3

55.91

63.12

mmol/l

0.98

377

Open wound of wrist and hand

295

2412

1.21

2.70

1.5

1.4

65.34

64.86

mmol/l

0.06

231

1876

Supervision of normal pregnancy

454

0.63

2.69

1.3

1.4

74.00

66.15

mmol/l

0.44

340

Myositis

119

2.04

2.68

1.0

1.3

61.50

60.80

mmol/l

0.03

Left hemicolectomy

133

1.99

2.68

1.4

1.3

61.83

61.26

mmol/l

0.03

112

Other diseases of arteries and capillaries

511

1.48

2.67

1.4

1.3

62.59

61.18

mmol/l

0.09

413

Secondary polycythaemia

2.15

2.66

1.5

1.3

73.80

60.26

mmol/l

0.77

Other peripheral vertigo

586

1.44

2.66

1.6

1.3

73.04

62.39

mmol/l

1.34

473

Enteropathic arthropathies

2.24

2.65

1.3

1.4

65.18

60.91

mmol/l

0.13

Otalgia

423

1.52

2.64

1.5

60.84

65.54

mmol/l

0.42

344

Premature rupture of membranes

524

0.62

2.64

1.3

1.5

77.14

67.82

mmol/l

0.66

409

311

1.61

2.64

1.7

1.3

57.56

60.27

mmol/l

0.21

242

Injuries involving multiple body regions

169

1.85

2.64

1.5

1.3

43.95

62.55

mmol/l

2.27

142

Tumor necrosis factor alpha inhibitors

628

1.42

2.63

2.1

1.4

70.49

64.62

mmol/l

0.51

503

Voice disturbances

208

1662

1.26

2.62

1.4

64.95

63.66

mmol/l

0.17

172

1328

Burn and corrosion of hip and lower limb, except ankle and foot

2.18

2.62

1.5

1.3

87.47

65.49

mmol/l

0.83

Benign neoplasm of middle ear and respiratory system

432

1.52

2.62

1.5

1.4

53.67

60.91

mmol/l

0.85

345

Benign neoplasm: Anus and anal canal

141

1.94

2.62

1.4

1.3

55.65

62.89

mmol/l

0.53

116

Synovial cyst of popliteal space [Baker]

424

1.52

2.62

1.4

1.3

57.63

61.50

mmol/l

0.34

332

Crohn disease (strict definition, all UC cases excluded)

206

1.76

2.62

1.7

1.4

71.25

67.90

mmol/l

0.16

176

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

101

730

1.39

2.62

1.3

1.4

51.20

62.95

mmol/l

2.53

577

Other specified disorders of muscle

127

1.99

2.62

1.3

48.35

62.30

mmol/l

0.93

102

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

313

1.61

2.61

1.3

53.10

64.33

mmol/l

1.88

241

Orchitis and epididymitis

440

1.51

2.61

1.4

1.3

57.20

68.29

mmol/l

1.49

352

Amiodarone users

630

1.42

2.61

1.5

1.3

70.31

62.79

mmol/l

1.06

512

Macular pucker

133

1005

1.33

2.60

1.4

60.33

63.08

mmol/l

0.33

111

805

Ptosis of eyelid

706

1.40

2.60

1.3

1.4

64.27

61.15

mmol/l

0.35

571

Autoimmune hyperthyroidism

267

1.66

2.60

1.3

70.78

61.65

mmol/l

0.62

211

Myopia

506

1.47

2.59

2.7

1.5

68.03

63.93

mmol/l

0.29

401

Alzheimer’s disease (undefined)

0.00

2.59

0.0

1.2

—

55.39

—

Residual foreign body in soft tissue

192

1.78

2.59

1.8

1.4

66.38

65.90

mmol/l

0.02

154

Malignant neoplasm of accessory sinuses

7.52

2.58

1.0

2.0

52.60

58.29

mmol/l

—

Medical abortion

532

2504

1.16

2.58

1.3

1.4

62.14

61.41

mmol/l

0.14

418

1985

Dental caries 2 and operation codes, only avohilmo

459

3308

0.86

2.58

1.5

64.86

64.05

mmol/l

0.13

376

2604

Postpartum haemorrhage

773

0.66

2.57

1.1

1.5

70.37

68.57

mmol/l

0.10

602

Parapsoriasis

2.25

2.56

1.4

1.3

60.33

64.52

mmol/l

0.16

Benign neoplasm: Small intestine

246

1.69

2.55

1.5

1.3

61.41

61.05

mmol/l

0.02

198

Impetigo

171

1.83

2.55

2.3

1.6

58.77

73.21

mmol/l

0.95

145

Coronary angioplasty

354

2293

1.19

2.53

1.4

1.3

61.58

62.44

mmol/l

0.17

281

1827

Allergic rhinitis

191

1503

1.26

2.53

1.6

67.68

67.44

mmol/l

0.02

142

1198

Subacute thyroiditis

179

1.81

2.53

1.2

1.4

58.78

57.66

mmol/l

0.06

144

Parkinson's disease

136

1036

1.32

2.52

1.3

72.60

62.27

mmol/l

2.29

105

840

Other and unspecified urticaria

141

1079

1.31

2.52

1.5

1.4

65.78

64.75

mmol/l

0.10

119

866

Pre-eclampsia

120

897

1.34

2.52

1.3

1.4

62.46

63.68

mmol/l

0.13

698

Adalimumab

364

1.55

2.50

2.3

1.4

65.31

67.19

mmol/l

0.09

297

Primary coxarthrosis, bilateral

274

2268

1.21

2.50

1.4

1.3

62.73

62.53

mmol/l

0.03

229

1809

Acute nephritic syndrome

2.13

2.50

1.5

1.3

52.33

59.95

mmol/l

0.46

Enthesopathies of lower limb, excluding foot

153

1185

1.30

2.50

1.3

1.4

62.72

63.29

mmol/l

0.06

126

925

Gonarthrosis

578

2898

1.15

2.50

1.3

63.05

61.58

mmol/l

0.38

469

2253

Psoriatic and enteropathic arthropathies

627

1.41

2.49

1.3

67.03

64.83

mmol/l

0.16

490

Demyelinating diseases of the central nervous system

341

1.56

2.48

1.5

1.4

57.64

66.31

mmol/l

0.94

281

Glaucoma secondary to other eye disorders

225

1.71

2.48

1.2

1.3

58.53

64.16

mmol/l

0.38

181

Other and unspecified glaucoma

479

1.47

2.48

1.3

57.89

62.23

mmol/l

0.52

381

Benign neoplasm: Caecum

679

1.39

2.48

1.3

56.39

61.70

mmol/l

0.96

553

Use of donepezil

123

1557

0.76

2.47

1.2

1.3

68.27

60.21

mmol/l

1.33

1240

Exposure to other and unspecified inanimate mechanical forces

310

1.59

2.47

1.7

1.3

74.25

65.46

mmol/l

0.35

257

Other specified/unspecified bacterial intestinal infections

374

1.54

2.46

2.8

1.4

54.43

61.18

mmol/l

0.65

302

Other disorders of bone

135

1032

1.31

2.44

1.3

1.4

61.85

63.65

mmol/l

0.19

104

825

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

161

1260

1.28

2.44

1.4

1.3

58.37

63.84

mmol/l

0.84

112

1017

Left ventricular outflow tract obstruction, narrow definition

249

1.66

2.44

1.3

1.8

76.12

70.52

mmol/l

0.25

211

Thyrotoxicosis factitia

5.22

2.43

2.0

1.3

60.17

60.42

mmol/l

—

Malignant neoplasm of colon

133

1016

1.32

2.43

1.4

1.3

51.46

62.91

mmol/l

3.28

820

Intussusception

103

2.07

2.43

1.6

1.5

55.31

60.69

mmol/l

0.27

Traumatic secondary and recurrent haemorrhage

6.78

2.42

1.8

1.7

64.20

43.50

mmol/l

—

Post-traumatic wound infection, not elsewhere classified

117

1.99

2.42

1.0

1.2

61.24

58.48

mmol/l

0.11

101

Long labour

785

0.68

2.42

1.4

61.08

68.19

mmol/l

0.60

608

Etanercept

273

1.62

2.41

1.8

1.5

69.14

64.45

mmol/l

0.30

229

Fracture at wrist and hand level

239

1958

1.22

2.41

1.6

1.4

62.61

64.63

mmol/l

0.36

190

1537

Benign neoplasm: Descending colon

409

1.50

2.40

1.5

1.3

72.04

60.99

mmol/l

1.19

327

Colitis due to radiation

2.56

2.38

2.1

1.3

65.15

63.36

mmol/l

0.05

Paralytic strabismus

402

1.50

2.37

1.3

74.73

61.96

mmol/l

1.15

319

Non-follicular lymphoma

609

1.41

2.36

1.5

1.3

57.28

62.88

mmol/l

0.70

491

Other and unspecified injuries of lower leg

314

1.57

2.35

1.5

64.67

66.94

mmol/l

0.18

262

Other benign neoplasm of uterus: Other parts/unspecified

339

1.55

2.35

1.3

65.48

61.16

mmol/l

0.32

275

Otitis externa

162

1276

1.27

2.35

1.4

64.69

64.53

mmol/l

0.02

130

1031

Idiopathic thrombocytopenic purpura

147

1.86

2.34

1.5

1.4

74.22

64.51

mmol/l

0.29

121

2.11

2.34

1.3

98.00

63.78

mmol/l

1.15

Gonarthrosis, primary, with knee surgery

538

3858

1.14

2.33

1.3

64.42

61.53

mmol/l

0.99

446

3059

Otitis media, unspecified

469

1.44

2.31

2.1

2.2

77.02

72.82

mmol/l

0.29

394

Sarcoidosis

109

816

1.34

2.31

1.3

65.54

62.56

mmol/l

0.31

657

Superficial injury of wrist and hand

128

980

1.31

2.31

1.4

1.5

67.78

66.06

mmol/l

0.16

102

780

Artrosis, including avohilmo

735

3599

1.12

2.30

1.3

1.4

63.45

62.31

mmol/l

0.29

587

2799

Conduct disorder

2.39

2.30

1.2

2.9

36.22

77.76

mmol/l

—

Sulfonylureas

351

2386

1.18

2.29

1.4

1.3

56.60

62.28

mmol/l

2.18

275

1931

Restless leg syndrome

732

1.36

2.28

1.2

1.4

68.79

62.19

mmol/l

0.82

589

Congenital malformations of eye, ear, face and neck

285

1.59

2.28

1.8

1.7

69.83

70.65

mmol/l

0.05

242

Disorders of puberty, all

2.58

2.28

6.9

2.3

101.00

77.10

mmol/l

0.98

Crystal arthropathies, rheuma endpoint

113

1.98

2.28

1.3

52.07

60.92

mmol/l

0.61

Benign neoplasm: Tongue

156

1.82

2.27

1.7

1.3

56.95

61.86

mmol/l

0.22

132

Dysplasia of cervi uteri

141

845

1.29

2.26

1.5

1.4

55.16

63.41

mmol/l

1.82

122

632

Dermatographic urticaria

302

1.57

2.25

1.2

1.4

61.11

63.83

mmol/l

0.19

252

Toxic effect of ethanol

149

1.83

2.25

3.9

1.3

60.64

70.24

mmol/l

0.34

123

Primary open-angle glaucoma

312

2575

1.18

2.25

1.3

60.13

61.58

mmol/l

0.28

247

2055

Carcinoma in situ of skin of trunk

179

1.76

2.25

1.2

1.4

58.71

61.78

mmol/l

0.20

148

Neovascular glaucoma

232

1.65

2.24

1.2

1.3

58.53

62.86

mmol/l

0.28

189

Ganglion

144

1125

1.28

2.24

1.4

65.59

63.74

mmol/l

0.19

119

875

Benign neoplasm: Duodenum

135

1.88

2.24

1.6

1.4

62.17

63.74

mmol/l

0.06

111

Tuberculosis, IBD comorbidity

457

1.45

2.23

1.6

1.3

54.04

61.40

mmol/l

0.87

365

Other crystal arthropathies

114

1.96

2.23

1.3

1.4

52.07

59.63

mmol/l

0.51

Polyarthritis, unspecified

202

1.70

2.22

1.4

55.16

59.18

mmol/l

0.27

165

Disorders of parathyroid gland, other and/or unspecified

2.58

2.22

1.2

1.3

49.00

63.12

mmol/l

0.85

Systemic lupus erythematosus, unspecified

150

1.82

2.21

1.3

1.4

50.91

63.17

mmol/l

0.84

128

Benign neoplasm: Hypopharynx

3.45

2.21

1.5

1.3

56.50

60.83

mmol/l

—

Seborrhoeic keratosis

194

1574

1.24

2.20

1.4

1.3

60.64

63.36

mmol/l

0.44

165

1254

Burn and corrosion of trunk

143

1.84

2.20

1.3

1.4

58.00

67.61

mmol/l

0.52

121

Follow-up examination after treatment for malignant neoplasms

575

1.40

2.20

1.3

53.90

62.19

mmol/l

1.26

443

Benign neoplasm: Duodenum

136

1.86

2.20

1.6

1.3

62.17

62.01

mmol/l

0.01

117

L04AC Interleukin inhibitors

195

1.70

2.19

2.1

1.4

73.48

66.59

mmol/l

0.22

171

Superficial injury of shoulder and upper arm

584

1.39

2.19

1.5

1.4

66.12

63.63

mmol/l

0.22

477

Pregnancy hypertension

242

1808

1.21

2.19

1.3

1.4

67.26

63.64

mmol/l

0.61

191

1417

Poor fetal growth

288

1.57

2.18

1.8

1.5

66.85

67.03

mmol/l

0.01

235

Thyroiditis

369

1.50

2.18

1.2

1.4

61.80

62.24

mmol/l

0.03

303

Other and unspecified rosacea

451

1.45

2.18

1.4

1.3

59.11

61.54

mmol/l

0.19

363

Other localized connective tissue disorders

2.05

2.17

1.3

77.64

65.27

mmol/l

0.34

Other specified/unspecified hearing loss

476

1.44

2.17

2.3

1.4

65.23

60.62

mmol/l

0.36

368

Mesothelioma

2.20

2.17

1.6

1.3

87.44

61.06

mmol/l

—

All dysplastic lesions of the cervix uteri

117

892

1.31

2.16

1.6

1.4

57.18

66.80

mmol/l

1.84

697

Pediculosis, acariasis and other infestations

250

1.61

2.16

1.7

1.3

69.03

66.00

mmol/l

0.15

209

Other obstructive and reflux uropathy

181

1.73

2.15

1.5

1.3

58.87

71.89

mmol/l

0.86

148

Hydrocele

620

1.38

2.14

1.3

1.4

60.29

66.67

mmol/l

0.76

502

Unspecific neurodegenerative disorder

401

2391

1.16

2.14

1.3

64.99

60.91

mmol/l

1.37

321

1933

Gonococcal infection

137

1.84

2.14

1.7

1.4

52.00

61.09

mmol/l

0.54

115

Endometriosis of rectovaginal septum and vagina

428

1.46

2.14

1.4

55.89

61.28

mmol/l

0.61

332

Dental pulpitis 3

229

1.54

2.13

2.8

2.9

83.00

83.63

mmol/l

0.02

202

Anorexia

2.40

2.13

1.6

1.4

88.00

65.79

mmol/l

—

Contraceptive management

177

1539

0.81

2.11

1.5

1.4

65.40

63.30

mmol/l

0.23

137

1162

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

153

1.79

2.10

1.4

56.61

63.76

mmol/l

0.41

123

Benign neoplasm: Ascending colon

112

856

1.32

2.10

1.3

65.59

62.32

mmol/l

0.38

700

Other disorders of the genitourinary system

117

900

1.31

2.09

1.5

1.3

62.22

61.15

mmol/l

0.12

104

720

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

207

1634

1.22

2.09

1.4

65.41

61.74

mmol/l

0.52

160

1304

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

717

1.34

2.09

1.5

1.4

61.43

63.02

mmol/l

0.14

569

Systemic atrophies primarily affecting the central nervous system

237

1.62

2.09

1.6

1.4

57.74

63.26

mmol/l

0.36

195

Benign neoplasm: Other and unspecified parts of mouth

191

1.69

2.08

1.4

1.3

60.57

61.20

mmol/l

0.02

157

Astigmatism

308

1.53

2.08

1.6

1.8

69.46

68.17

mmol/l

0.07

254

Calculus of kidney and ureter

159

1978

0.80

2.08

1.4

68.71

64.19

mmol/l

0.57

121

1577

Unspecified dementia

109

748

1.32

2.08

1.3

66.21

59.31

mmol/l

1.03

583

Injury of nerves and spinal cord at neck level

2.00

2.06

1.7

1.3

59.92

60.84

mmol/l

0.03

Spinal instabilities

110

1.93

2.06

1.5

1.3

76.19

56.32

mmol/l

1.03

100

Other congenital malformations of skin

199

1.67

2.06

1.4

1.6

97.91

66.61

mmol/l

1.81

170

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

154

1.77

2.05

1.3

1.4

56.80

63.04

mmol/l

0.28

123

Oral leukoplakia and related diseases

350

1.50

2.05

1.4

1.3

58.00

59.74

mmol/l

0.13

278

Behavioural disorders

2.34

2.05

1.2

3.1

38.25

81.74

mmol/l

—

Nonsuppurative otitis media

134

906

1.28

2.05

2.1

1.7

68.91

mmol/l

0.00

103

741

Unspecified chronic bronchitis

184

1.70

2.05

1.2

64.25

58.89

mmol/l

0.31

149

Other benign neoplasms of uterus

408

1.46

2.05

1.3

63.47

60.60

mmol/l

0.22

331

Rare circulating lymphoid malignancy

177

1.71

2.03

1.6

1.9

79.00

66.20

mmol/l

0.46

152

Emergency coronary revascularization (for ACS)

524

3332

1.13

2.02

1.4

1.3

62.75

61.72

mmol/l

0.26

426

2658

Vulvovaginal ulceration/inflammation in other diseases

200

1.66

2.02

2.2

1.5

62.68

65.08

mmol/l

0.13

167

Spontaneous rupture of synovium and tendon

459

1.42

2.01

1.4

1.3

55.38

63.01

mmol/l

0.73

361

Otitis externa, unspecified

535

1.39

1.99

1.4

1.5

69.55

65.57

mmol/l

0.30

435

UC patients in KELA-register (code 208), prior to 1994

240

1.60

1.99

2.2

1.3

64.28

61.83

mmol/l

0.13

197

Correction of physiology of bite - very demanding therapy visit

112

1.89

1.97

1.6

1.4

56.90

67.69

mmol/l

0.60

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

220

1111

1.21

1.97

1.3

61.20

65.90

mmol/l

0.99

178

879

Dislocation, sprain and strain of joint and ligaments of hip

202

1.65

1.97

1.7

1.3

58.44

62.62

mmol/l

0.24

169

Malignant neoplasm of endocrine gland

420

1.44

1.95

1.4

65.07

61.74

mmol/l

0.23

337

Oral lichen ruber planus

127

1.83

1.95

1.4

64.94

59.43

mmol/l

0.22

110

Tuberculosis, wide

479

1.41

1.94

1.6

1.3

53.86

61.49

mmol/l

0.94

382

Other disorders of penis

479

1.41

1.94

1.5

63.46

68.96

mmol/l

0.45

388

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

216

1072

1.21

1.93

1.3

1.4

61.40

66.12

mmol/l

0.98

176

850

Ill-defined and unknown causes of mortality

413

1.44

1.93

1.3

62.31

62.89

mmol/l

0.04

325

Amblyopia ex anopsia

211

1.62

1.92

1.3

1.6

58.50

72.77

mmol/l

1.08

181

Benign neoplasm of breast

711

1.33

1.92

1.3

54.25

64.91

mmol/l

2.61

569

Umbilical hernia

189

1556

1.22

1.91

1.4

1.3

56.74

64.32

mmol/l

1.84

143

1230

Injuries to the wrist and hand

791

5209

1.10

1.90

1.4

63.79

64.11

mmol/l

0.07

632

4107

Malignant neoplasm of nasal cavity and middle ear

3.28

1.90

1.0

1.5

78.14

62.27

mmol/l

—

Benign neoplasm: Skin of eyelid, including canthus

118

922

1.29

1.90

1.3

1.4

62.32

64.07

mmol/l

0.19

739

Diabetes mellitus in pregnancy

662

0.73

1.90

1.4

1.5

67.46

68.99

mmol/l

0.09

518

Panniculitis affecting regions of neck and back

158

1.72

1.89

1.4

1.3

69.38

59.09

mmol/l

0.41

126

Other enthesopathies

216

1804

1.20

1.88

1.3

1.4

62.84

63.18

mmol/l

0.04

176

1409

Dislocation, sprain and strain of joints and ligaments at neck level

636

1.34

1.87

1.5

1.4

62.87

65.09

mmol/l

0.18

507

Obstructed labour due to maternal pelvic abnormality

860

0.72

1.85

1.4

58.47

63.42

mmol/l

0.53

664

Foreign body in alimentary tract

293

1.51

1.85

1.3

1.4

60.62

64.89

mmol/l

0.26

237

Melanocytic naevi

201

1671

1.21

1.85

1.3

1.4

62.52

63.75

mmol/l

0.18

152

1331

Intermittent heterotropia

253

1.55

1.84

1.4

1.9

74.38

70.37

mmol/l

0.22

219

Benign neoplasm of major salivary glands

587

1.35

1.83

1.3

54.90

62.70

mmol/l

1.17

471

Sequelae of injuries of upper limb

502

1.38

1.82

1.4

63.53

63.37

mmol/l

0.01

402

Benign lipomatous neoplasm of other sites/unspecified

580

1.35

1.81

1.4

1.3

57.15

61.17

mmol/l

0.50

463

Other abnormal products of conception

719

0.75

1.80

1.3

1.4

69.65

66.38

mmol/l

0.26

552

Impacted cerumen

624

1.34

1.79

1.5

66.08

64.89

mmol/l

0.08

505

Primary gonarthrosis, bilateral

471

3663

1.13

1.78

1.4

1.3

63.55

61.62

mmol/l

0.52

385

2891

Contact with other hot fluids

131

1.77

1.78

1.3

1.6

57.81

68.33

mmol/l

0.46

114

Benign neoplasm of brain and other parts of central nervous system

370

1.44

1.78

1.8

1.5

73.87

62.03

mmol/l

0.95

296

Melanocytic naevi of trunk

590

1.34

1.78

1.2

1.4

74.48

62.81

mmol/l

1.72

476

Disorder of external ear, unspecified

162

1.68

1.76

1.2

1.3

52.60

62.24

mmol/l

0.73

138

Foreign body in ear

2.00

1.76

1.6

1.4

88.20

73.89

mmol/l

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

2.75

1.75

1.8

1.3

78.13

72.29

mmol/l

—

Bicuspidal aortic valve syndrome

170

1.66

1.74

1.3

1.5

69.91

65.33

mmol/l

0.19

143

Unspecified abortion

201

1.60

1.74

1.4

64.93

66.42

mmol/l

0.06

154

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

110

1.84

1.74

1.9

1.3

62.53

64.28

mmol/l

0.06

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

155

1.69

1.73

1.5

53.76

65.39

mmol/l

0.44

133

Maternal care for known or suspected abnormality of pelvic organs

636

0.74

1.72

1.3

1.5

63.17

67.24

mmol/l

0.30

495

Other enthesopathy of foot (+metatarsalgia)

516

1.36

1.72

1.4

1.3

61.85

64.09

mmol/l

0.20

404

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

202

1.60

1.72

1.5

1.4

57.07

65.34

mmol/l

0.63

161

Benign neoplasm: Other and unspecified parts of small intestine

1.94

1.71

1.5

1.3

61.30

64.44

mmol/l

—

Alzheimer’s disease (undefined), excluding more controls

0.00

1.71

0.0

1.2

—

57.74

—

Metatarsalgia

491

1.37

1.71

1.4

1.3

61.32

63.94

mmol/l

0.24

384

Other orthopaedic follow-up care

266

1.51

1.71

1.4

1.3

62.13

62.15

mmol/l

0.00

205

Impingement syndrome of shoulder

185

1540

1.20

1.71

1.4

64.49

63.23

mmol/l

0.14

154

1201

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

390

1.42

1.71

1.2

1.4

62.78

64.56

mmol/l

0.10

321

Vasomotor rhinitis (mode)

407

1.41

1.70

1.4

1.3

64.67

61.67

mmol/l

0.23

327

Male infertility

148

1.70

1.2

1.3

80.26

66.54

mmol/l

0.56

112

Stenosis and insufficiency of lacrimal passages

595

1.33

1.70

1.5

1.4

56.39

61.52

mmol/l

0.56

479

Heterophoria

382

1.42

1.70

1.8

1.5

82.85

64.40

mmol/l

1.78

310

Use of memantine

242

1795

1.18

1.70

1.3

62.89

60.28

mmol/l

0.51

192

1435

Use of other anti-dementia drugs

242

1795

1.18

1.70

1.3

62.89

60.28

mmol/l

0.51

192

1435

Benign neoplasm: Anus and anal canal

164

1.66

1.69

1.4

1.3

55.65

64.33

mmol/l

0.69

140

Pedal cyclist injured in other and unspecified transport accidents

561

1.34

1.69

1.3

1.4

62.59

64.77

mmol/l

0.18

455

Benign neoplasm: Rectum/anal canal icd-9

2.42

1.69

1.1

1.4

75.50

65.63

mmol/l

—

Viral infections of central nervous system, not elsewhere classified/unspecified

2.41

1.69

1.1

1.3

70.70

61.44

mmol/l

—

Melanocytic naevi, other sites/unspecified

391

1.41

1.68

1.4

54.40

63.75

mmol/l

1.36

324

Superficial injury of ankle and foot

501

1.36

1.68

1.9

1.5

55.46

67.92

mmol/l

2.30

412

Benign neoplasm: Skin of other and unspecified parts of face

692

1.31

1.68

1.3

59.44

62.53

mmol/l

0.37

557

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

375

1.42

1.67

1.3

1.4

71.09

63.39

mmol/l

0.52

296

Benign neoplasm: Skin of ear and external auricular canal

180

1.62

1.67

1.2

1.4

55.00

63.07

mmol/l

0.54

143

Urolithiasis

180

2152

0.83

1.65

1.4

68.17

63.92

mmol/l

0.60

135

1720

Other disorders of cornea

555

1.34

1.65

1.4

60.17

63.09

mmol/l

0.27

447

Other retinal artery occlusion

120

1.77

1.63

1.6

1.4

53.63

66.72

mmol/l

0.85

Colorectal cancer

201

1695

1.19

1.63

1.4

1.3

57.96

62.28

mmol/l

0.76

141

1356

Congenital malformations of genital organs

366

1.42

1.63

2.2

1.8

76.20

70.43

mmol/l

0.29

312

Asthma mixed form (mode), excluding more controls

205

1.57

1.62

1.3

66.60

65.80

mmol/l

0.04

169

Secondary and unspecified malignant neoplasm of lymph nodes

489

1.36

1.60

1.4

62.00

62.98

mmol/l

0.07

390

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

222

1.54

1.60

1.2

1.3

59.37

64.10

mmol/l

0.35

176

Undefined dementia

110

803

1.26

1.60

1.3

66.29

60.28

mmol/l

0.87

632

Colon adenocarcinoma

101

795

1.28

1.59

1.3

51.20

61.93

mmol/l

2.21

638

Tonsillectomy and adenotomy

243

1972

0.86

1.59

1.5

1.6

66.99

67.48

mmol/l

0.06

199

1540

Abnormal serum enzyme levels

222

1868

1.18

1.59

1.4

61.45

64.94

mmol/l

0.68

183

1498

Carcinoma in situ of skin

551

1.33

1.58

1.2

1.3

62.72

61.11

mmol/l

0.13

443

Inflammatory disease of uterus

611

1.31

1.58

1.3

1.4

58.51

63.49

mmol/l

0.44

489

Lateral epicondylitis

647

1.30

1.56

1.3

61.61

62.70

mmol/l

0.08

501

Atrial septal defect

206

1.55

1.56

1.3

2.3

77.12

72.66

mmol/l

0.16

180

Polyp of the female genital tract

252

1258

1.17

1.56

1.3

1.4

61.63

60.81

mmol/l

0.10

198

961

Benign neoplasm: Parotid gland

466

1.36

1.55

1.3

54.84

61.93

mmol/l

0.77

377

Benign neoplasm: salivary glands, exclude unknown (D119)

518

1.34

1.55

1.3

53.35

62.11

mmol/l

1.19

419

Other predominantly sexually transmitted diseases, not elsewhere classified

648

1.30

1.54

1.4

60.67

64.89

mmol/l

0.35

514

Pollen allergy

728

1.28

1.54

1.8

64.38

70.29

mmol/l

0.50

603

Other leukaemias of specified cell type

3.47

1.54

1.8

2.9

82.20

53.73

mmol/l

—

Other benign neoplasm of uterus: Other parts/unspecified

374

1.40

1.54

1.3

65.48

58.70

mmol/l

0.57

300

Infective bursitis

130

1.71

1.54

1.4

1.3

67.88

62.55

mmol/l

0.20

105

Gonarthrosis,primary

810

4687

1.09

1.54

1.3

1.4

64.36

61.37

mmol/l

1.26

653

3701

Pedal cyclist injured in transport accident

150

1240

1.21

1.52

1.4

67.17

64.92

mmol/l

0.22

125

986

Dacryoadenitis

0.00

1.52

0.0

1.3

—

63.33

—

Malignant neoplasm of gum

2.94

1.52

1.2

1.4

79.67

66.81

mmol/l

—

Pyoderma

1.88

1.51

5.6

1.3

67.00

63.92

mmol/l

0.06

Hallux rigidus

116

935

1.25

1.51

1.3

67.67

62.70

mmol/l

0.66

736

Graves disease, strict definition

477

1.35

1.51

1.3

1.4

72.23

63.93

mmol/l

0.65

383

Other and unspecified tonsillitis

172

1221

1.20

1.50

2.2

1.5

65.60

66.57

mmol/l

0.10

138

935

Temporal arteritis

234

1.51

1.50

1.6

1.3

57.10

59.66

mmol/l

0.22

191

Burn and corrosion of wrist and hand

154

1.63

1.50

1.7

1.4

64.00

67.30

mmol/l

0.11

132

Single delivery by caesarean section

422

0.72

1.50

1.2

1.5

64.59

66.05

mmol/l

0.08

319

Valgus deformity, not elsewhere classified

2.48

1.49

6.9

1.2

72.78

61.17

mmol/l

—

Divergent concomitant strabismus

376

1.39

1.48

1.3

1.4

63.53

62.74

mmol/l

0.04

310

malignant neoplasm of male genital organs

307

1707

1.14

1.47

1.3

63.12

64.49

mmol/l

0.25

256

1362

Maternal care for other known or suspected fetal problems

451

0.72

1.47

1.6

67.00

69.25

mmol/l

0.12

348

Giant cell arteritis

268

1.47

1.6

1.3

53.70

59.83

mmol/l

0.71

218

Tinnitus

176

1483

1.19

1.47

1.3

63.38

63.00

mmol/l

0.04

147

1175

Other benign neoplasms of uterus

437

1.36

1.47

1.3

63.47

58.58

mmol/l

0.42

349

Carcinoma in situ of skin, other sites/unspecified

1.91

1.46

1.2

1.3

52.89

60.61

mmol/l

—

Vascular dementia (undefined)

233

1.50

1.46

1.4

1.3

48.24

59.66

mmol/l

1.25

184

Combinations of oral blood glucose lowering drugs

220

1890

1.17

1.46

1.3

60.78

63.65

mmol/l

0.54

169

1522

Disorders of puberty

2.39

1.46

8.4

1.8

98.67

75.36

mmol/l

—

Other secondary gonarthrosis

302

1.43

1.45

1.4

58.41

60.84

mmol/l

0.23

242

Meniscus derangement

467

2876

1.11

1.44

1.4

1.3

65.71

61.78

mmol/l

1.26

369

2234

Sudden idiopathic hearing loss

594

1.30

1.44

1.2

1.4

65.89

62.69

mmol/l

0.30

475

Hypermetropia

378

1.38

1.44

2.2

1.8

67.95

65.75

mmol/l

0.14

310

Bruxism

1.99

1.44

1.7

1.4

69.15

71.73

mmol/l

0.05

Biomechanical lesions, not elsewhere classified

261

1.47

1.44

1.2

1.3

64.85

62.36

mmol/l

0.12

215

Other and unspecified follicular disorders

164

1.60

1.43

1.4

1.3

64.60

68.17

mmol/l

0.14

139

Effects of foreign body entering through natural orifice

162

1359

1.19

1.43

1.4

63.17

65.53

mmol/l

0.27

126

1083

Other ill-defined and unspecified causes of mortality

371

1.38

1.42

1.3

60.60

62.39

mmol/l

0.12

292

Family history of malignant neoplasm

439

1.35

1.42

1.3

1.4

72.13

64.85

mmol/l

0.44

347

Malignant neoplasm of mesothelium and soft tissue

254

1.47

1.41

1.4

1.3

73.84

60.96

mmol/l

0.83

211

Malignant neoplasm of prostate

303

1680

1.14

1.41

1.3

63.18

64.53

mmol/l

0.25

254

1341

Use of levodopa decarboxylase inhibitor

110

891

1.24

1.40

1.2

1.3

74.33

61.84

mmol/l

2.37

720

Universal erythroderma, KELA reimbursement

1.96

1.39

1.6

1.3

67.29

63.59

mmol/l

—

Glaucoma, exfoliation

105

848

1.24

1.37

1.2

1.3

58.87

60.20

mmol/l

0.14

668

Supervision of high-risk pregnancy

454

0.74

1.37

1.5

1.4

71.74

64.62

mmol/l

0.47

337

Other arterial embolism and thrombosis

143

1.62

1.36

1.3

1.2

58.39

61.24

mmol/l

0.09

122

Dislocation, sprain and strain of joints and ligaments of knee

315

3296

0.89

1.35

1.5

1.4

60.47

65.32

mmol/l

1.41

244

2580

Follow-up care involving plastic surgery

175

1.55

1.35

1.3

64.44

64.59

mmol/l

0.01

135

Complications associated with artificial fertilization

0.00

1.34

0.0

1.7

—

79.87

—

Dental pulpitis 3, only avohilmo

210

1.43

1.34

1.4

3.2

79.03

83.87

mmol/l

0.20

185

Obstructed labour due to malposition and malpresentation of fetus

722

0.76

1.34

1.4

1.5

61.89

68.86

mmol/l

0.51

564

Adult respiratory distress syndrome

2.06

1.34

2.5

1.3

70.00

60.53

mmol/l

0.19

Glucosamine medication

484

3506

1.10

1.33

1.3

63.62

61.06

mmol/l

0.78

382

2788

Tongue abnormality

393

1.36

1.33

1.4

1.3

55.67

58.38

mmol/l

0.24

317

Psoriatic arthropathies

532

1.30

1.32

1.3

67.38

65.42

mmol/l

0.13

419

Other disorders of conjunctiva

110

898

1.23

1.31

1.3

68.22

64.16

mmol/l

0.48

719

Multiple delivery

416

0.67

1.31

1.5

68.41

62.09

mmol/l

0.37

314

Ulcerative rectosigmoiditis

368

1.36

1.31

1.5

1.4

57.73

64.92

mmol/l

0.62

301

L02BX Other hormone antagonists and related agents

284

1.42

1.30

1.3

1.4

61.58

65.89

mmol/l

0.30

236

Periodontal disease, other/unspecified

2.84

1.29

2.0

1.2

43.20

54.67

mmol/l

—

Giant cell arteritis with polymyalgia rheumatica

243

1.45

1.29

1.6

1.3

57.10

60.51

mmol/l

0.32

198

Malignant neoplasm of ovary

302

1.40

1.28

1.2

1.4

58.58

58.09

mmol/l

0.03

238

Perineal laceration during delivery

401

0.69

1.28

1.3

1.6

79.46

68.87

mmol/l

0.41

311

Melanocytic naevi of upper limb, including shoulder

1.80

1.27

1.6

1.3

66.00

68.13

mmol/l

—

Multiple myeloma

146

1.59

1.27

1.2

1.3

52.94

62.36

mmol/l

0.67

117

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

146

1.59

1.27

1.2

1.3

52.94

62.36

mmol/l

0.67

117

Suppurative and unspecified otitis media

202

1547

1.16

1.26

1.6

71.52

67.53

mmol/l

0.50

149

1244

Bronchitis, not specified as acute or chronic

466

1.31

1.26

1.5

1.3

59.68

63.73

mmol/l

0.38

373

Parkinson's disease, strict definition

115

949

1.22

1.25

1.3

74.12

62.27

mmol/l

2.71

767

Benign neoplasm: Other and unspecified parts of small intestine

100

1.72

1.24

1.5

1.3

61.30

61.53

mmol/l

—

Normal-pressure hydrocephalus

355

1.36

1.24

1.6

1.3

71.57

59.66

mmol/l

1.33

285

Other specified/unspecified disorders of bone/cartilage

123

1.64

1.24

1.3

47.17

61.44

mmol/l

1.60

105

Third [oculomotor] nerve palsy

100

1.72

1.24

1.1

1.3

87.92

65.38

mmol/l

0.85

Use of anticholinesterases

245

2253

0.88

1.23

1.3

68.63

60.04

mmol/l

2.87

194

1811

N06DA Anticholinesterases

245

2253

0.88

1.23

1.3

68.63

60.04

mmol/l

2.87

194

1811

Undescended testicle

1.93

1.23

5.3

3.2

86.58

85.47

mmol/l

0.02

Glaucoma-related operations

399

1.34

1.23

1.3

54.29

59.79

mmol/l

0.49

323

Spontaneous abortion

226

1757

0.87

1.21

1.4

68.27

63.38

mmol/l

0.94

184

1380

Spirochaetal infections, other/unspecified

487

1.30

1.21

1.3

57.93

61.13

mmol/l

0.24

392

Ectropion of eyelid

238

1.44

1.21

1.1

1.3

56.82

59.98

mmol/l

0.21

190

Other disorders of pigmentation

247

1.43

1.19

1.5

1.4

56.89

62.20

mmol/l

0.32

200

Pedal cyclist injured in noncollision transport accidents

568

1.27

1.18

1.4

69.12

65.90

mmol/l

0.20

459

Sequelae of other and unspecified infectious and parasitic diseases

239

1.43

1.18

1.2

1.4

66.76

65.14

mmol/l

0.07

197

Congenital malformations and deformations of the musculoskeletal system

408

1.32

1.18

2.9

2.0

76.42

72.43

mmol/l

0.21

350

ILD medications: pirfenidone

2.03

1.17

1.4

1.3

65.60

59.16

mmol/l

—

Other benign neoplasms of connective and other soft tissue

498

1.29

1.17

1.3

1.4

65.86

65.06

mmol/l

0.05

404

Bacterial, viral and other infectious agents

402

1.32

1.17

1.4

59.81

66.78

mmol/l

0.56

326

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

316

1.37

1.17

1.2

1.3

64.45

64.94

mmol/l

0.02

256

Secondary malignant neoplasm of respiratory and digestive organs

1.83

1.16

1.1

1.2

61.50

57.95

mmol/l

—

Atrophic disorders of skin

107

885

1.21

1.16

1.5

1.3

69.09

63.14

mmol/l

0.85

709

Hypertrophic disorders of skin

240

1.42

1.16

1.4

52.12

66.76

mmol/l

1.47

197

Convergent concomitant strabismus

240

1.42

1.16

1.2

1.5

73.63

66.26

mmol/l

0.27

199

Vertical strabismus

174

1.50

1.16

1.5

1.4

96.95

63.71

mmol/l

1.86

143

Malignant neoplasm of breast, HER-positive

238

2655

0.88

1.15

1.4

55.95

61.13

mmol/l

1.41

185

2099

Crushed, pushed or stepped on by crowd or human stampede

266

1.40

1.14

1.9

1.4

61.66

73.23

mmol/l

0.91

213

Diseases of middle ear and mastoid

376

2787

1.11

1.14

1.5

68.03

65.40

mmol/l

0.48

282

2215

Burns and corrosions confined to eye and internal organs

1.69

1.14

1.1

1.3

55.64

65.33

mmol/l

0.41

Trigger finger

778

1.22

1.14

1.3

60.18

64.45

mmol/l

0.49

611

Other otitis externa (chronic)

335

1.35

1.13

1.2

1.4

60.30

63.12

mmol/l

0.21

271

Ankylosing spondylitis

387

1.32

1.13

1.5

1.3

61.36

63.85

mmol/l

0.19

306

Dental caries 2

533

3854

1.09

1.12

1.6

1.5

66.28

64.70

mmol/l

0.31

435

3035

Postpartum hemorraghe, all women as controls

752

0.78

1.12

1.1

1.5

70.37

67.93

mmol/l

0.14

586

Malignant melanoma, excluding all cancers (controls excluding all cancers)

124

1044

1.19

1.12

1.3

62.72

64.59

mmol/l

0.18

102

834

Congenital iodine-deficiency syndrome/hypothyroidism

192

1.47

1.12

1.5

1.4

60.45

60.84

mmol/l

0.02

152

Status post-ami

434

0.73

1.12

1.4

1.3

71.64

63.04

mmol/l

0.60

354

Open wound of hip and thigh

135

1.56

1.11

1.3

1.4

55.45

64.73

mmol/l

0.24

118

Complications predominantly related to the puerperium

1129

0.82

1.10

1.4

63.24

64.50

mmol/l

0.09

875

Orthopaedic devices associated with adverse incidents

104

1.65

1.10

1.1

1.3

78.90

60.32

mmol/l

—

Other and unspecified injuries of wrist and hand

168

1.50

1.10

1.6

60.11

64.56

mmol/l

0.25

139

Other and unspecified injuries of ankle and foot

160

1.51

1.09

1.5

1.3

57.79

68.37

mmol/l

0.59

139

Primary open-angle glaucoma, strict

239

2115

1.13

1.09

1.4

1.3

60.56

61.39

mmol/l

0.13

190

1687

Lyme disease

141

1646

0.85

1.08

1.3

1.4

61.40

63.67

mmol/l

0.29

105

1327

Artificial joint operation, meniscal resection

799

4973

1.07

1.08

1.4

63.63

61.70

mmol/l

0.70

641

3903

Puerperal sepsis

706

0.78

1.08

1.5

1.4

64.91

65.14

mmol/l

0.01

551

Varicella [chickenpox]

185

1.47

1.08

1.5

1.4

77.42

74.86

mmol/l

0.10

155

Antenatal screening

470

0.79

1.08

1.4

69.55

65.74

mmol/l

0.26

354

Carbimazole or st.post thyroidectomy, condition for graves disease

142

1214

1.17

1.08

1.3

1.4

68.96

63.93

mmol/l

0.65

106

972

DVT of lower extremities

148

1270

1.17

1.08

1.4

1.3

63.91

62.81

mmol/l

0.12

107

1010

Ulcerative colitis (strict definition, all Crohn cases excluded)

702

1.23

1.08

1.5

1.4

66.87

65.56

mmol/l

0.09

555

Atopic conjunctivitis

202

1.44

1.07

1.6

1.5

70.50

72.85

mmol/l

0.08

167

Impacted teeth

499

0.74

1.07

1.7

1.5

73.09

72.27

mmol/l

0.04

406

Other acquired deformities of musculoskeletal system and connective tissue

253

1.39

1.07

1.2

1.3

56.61

62.46

mmol/l

0.40

202

malignant neoplasm of female genital organs

140

1198

1.17

1.07

1.3

58.26

60.72

mmol/l

0.35

108

944

FESS (DNB20)

649

1.24

1.06

1.3

1.4

68.92

64.32

mmol/l

0.45

522

Fourth [trochlear] nerve palsy

121

1.58

1.06

1.3

83.92

61.79

mmol/l

1.01

107

Foreign body or object entering through skin

279

1.37

1.06

1.5

1.4

75.20

65.85

mmol/l

0.28

233

Other spirochaetal diseases

143

1663

0.86

1.06

1.4

61.07

63.96

mmol/l

0.40

107

1339

Cholesteatoma of middle ear

325

0.67

1.05

1.2

1.3

66.06

61.74

mmol/l

0.18

261

Dental caries 2 and operation codes

518

3797

1.08

1.05

1.6

1.5

66.45

64.83

mmol/l

0.32

424

2996

Benign neoplasm: Skin, unspecified

195

1.44

1.05

1.5

1.4

60.90

61.55

mmol/l

0.02

159

Toxic effect of alcohol

1.68

1.04

5.8

1.3

65.67

65.19

mmol/l

—

Embedded and impacted teeth

739

0.80

1.04

1.6

68.51

70.67

mmol/l

0.14

602

Other bursitis of hip

106

1.62

1.03

1.3

54.58

59.33

mmol/l

0.19

Other bursal cyst

1.75

1.03

1.7

1.3

96.54

61.77

mmol/l

0.96

Donors of organs and tissues

2.07

1.03

1.1

1.3

57.86

72.28

mmol/l

—

Examination and encounter for administrative purposes

179

1.46

1.03

1.4

1.3

60.80

62.09

mmol/l

0.05

137

Erectile dysfunction

447

1.28

1.02

1.5

1.4

65.78

66.84

mmol/l

0.07

364

Colorectal adenocarcinoma

161

1399

1.15

1.01

1.4

1.3

58.37

62.36

mmol/l

0.55

112

1123

Malignant neoplasm of eye and adnexa

1.90

1.01

1.4

69.67

57.15

mmol/l

—

Tarsal tunnel syndrome

1.90

1.01

1.3

57.00

63.07

mmol/l

—

Ménière disease

636

1.23

1.01

1.2

1.3

65.03

61.20

mmol/l

0.38

514

Traction detachment of retina

2.02

1.00

1.4

55.71

63.60

mmol/l

—

Phlebitis and thrombophlebitis (not including DVT)

164

1429

1.15

1.00

1.4

62.50

63.08

mmol/l

0.06

133

1134

Propionic acid derivatives

263

1180

1.12

1.00

1.4

1.6

67.38

64.05

mmol/l

0.53

213

937

Radial styloid tenosynovitis [de Quervain]

231

1.39

0.99

1.3

64.35

64.63

mmol/l

0.01

175

Asthma mixed form (mode)

231

1.39

0.99

1.3

66.60

65.20

mmol/l

0.08

190

Ectopic pregnancy

819

1.20

0.99

1.3

1.4

68.13

63.56

mmol/l

0.43

637

Lesion of plantar nerve

370

1.30

0.99

1.3

62.55

60.24

mmol/l

0.16

300

Suggestive for eosinophilic asthma

512

1.25

0.98

1.3

69.08

62.80

mmol/l

0.56

412

Chronic iridocyclitis

275

1.35

0.97

1.2

1.5

58.17

63.18

mmol/l

0.50

224

TMD related operations

821

1.20

0.97

1.5

1.4

62.86

64.25

mmol/l

0.12

649

Bursitis of shoulder

116

1.56

0.97

1.2

1.3

84.77

56.80

mmol/l

0.90

Benign lipomatous neoplasm

201

1780

1.13

0.97

1.3

1.4

60.91

64.66

mmol/l

0.70

167

1409

Postpartum hemorraghe, parous women as controls

647

0.80

0.96

1.1

1.4

70.37

68.14

mmol/l

0.13

508

Non-allergic asthma

547

0.76

0.96

1.6

1.5

62.47

66.59

mmol/l

0.21

442

Injury of muscle and tendon at wrist and hand level

731

1.21

0.96

1.3

64.10

63.63

mmol/l

0.03

577

Birth asphyxia

1.92

0.95

2.3

2.7

69.86

92.17

mmol/l

—

Other nonscarring hair loss

1.91

0.94

1.1

1.4

44.14

65.45

mmol/l

—

Melanocytic naevi of upper limb, including shoulder

1.62

0.94

1.6

1.3

66.00

66.92

mmol/l

—

Crowding of teeth, including avohilmo

256

1.32

0.94

3.6

2.5

82.71

80.42

mmol/l

0.09

228

Benign neoplasm of breast

789

1.20

0.93

1.3

54.25

61.11

mmol/l

1.34

625

Acute nasopharyngitis (common cold)

567

1.23

0.92

1.4

58.47

64.56

mmol/l

0.65

441

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

201

1.40

0.92

1.3

1.4

61.71

62.41

mmol/l

0.03

164

Use of rivastigmine

1111

0.84

0.91

1.2

1.3

69.51

60.21

mmol/l

1.51

871

Procreative management

192

1436

1.13

0.90

1.8

1.6

72.79

64.86

mmol/l

1.41

160

1107

Episcleritis

236

1.36

0.90

1.2

1.3

61.58

60.91

mmol/l

0.03

203

Disorders of vitreous body

401

3619

1.09

0.90

1.3

61.36

62.38

mmol/l

0.20

320

2875

Malignant neoplasm of thyroid gland

385

1.28

0.89

1.2

1.3

65.67

60.15

mmol/l

0.35

310

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

267

2113

1.11

0.89

1.3

1.4

67.07

63.32

mmol/l

0.70

211

1657

Postmenopausal atrophic vaginitis

212

1137

1.12

0.89

1.3

61.38

59.99

mmol/l

0.22

169

865

Non-Hodgkin lymphoma, all

237

1.36

0.88

1.4

1.3

69.11

63.31

mmol/l

0.31

194

Acute laryngitis and tracheitis

450

1.25

0.87

2.8

1.7

70.35

69.09

mmol/l

0.07

366

Benign neoplasm: Skin of lower limb, including hip

128

1.49

0.86

1.5

1.3

57.83

63.18

mmol/l

0.19

102

Fall on and from ladder

414

1.26

0.86

1.3

1.4

66.02

65.33

mmol/l

0.04

335

Hypertrophic scar

221

1.36

0.85

1.4

53.29

68.11

mmol/l

1.39

180

Prolapse and hernia of ovary and fallopian tube

314

1.30

0.85

1.1

1.3

59.06

57.24

mmol/l

0.12

241

Appendectomy

451

4033

1.08

0.85

1.5

1.4

64.40

64.09

mmol/l

0.05

360

3144

Other contact dermatitis

388

1.27

0.85

1.4

61.51

64.38

mmol/l

0.17

316

Disorders of vitreous body and globe

412

3720

1.08

0.85

1.3

61.49

62.30

mmol/l

0.16

327

2958

Follicular lymphoma

213

1.37

0.84

1.4

66.46

65.89

mmol/l

0.02

169

Injury of muscle and tendon at lower leg level

789

1.18

0.83

1.8

1.4

57.28

64.50

mmol/l

1.13

633

Ethmoidectomy

688

1.19

0.83

1.2

1.4

69.85

64.22

mmol/l

0.59

557

Abdominal aortic aneurysm (AAA)

556

1.22

0.83

1.3

57.73

65.03

mmol/l

0.95

452

Benign neoplasm: Skin of ear and external auricular canal

214

1.36

0.83

1.2

1.4

55.00

61.12

mmol/l

0.39

178

Benign neoplasm: Skin of eyelid, including canthus

118

1022

1.16

0.82

1.3

62.32

62.04

mmol/l

0.03

823

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

735

1.19

0.82

1.4

1.3

62.75

63.48

mmol/l

0.05

591

Arthropathic psoriasis

616

1.20

0.82

1.3

1.4

64.71

64.07

mmol/l

0.04

499

Sequelae of infectious and parasitic diseases

408

1.25

0.82

1.4

1.3

64.24

62.87

mmol/l

0.08

326

Other infective otitis externa

293

1.30

0.81

1.6

1.3

59.33

63.19

mmol/l

0.22

245

Other and unspecified mononeuropathies of lower limb

155

1.43

0.81

1.7

1.3

41.59

58.48

mmol/l

2.33

128

Corneal ulcer

117

1014

1.16

0.81

1.5

1.4

68.13

64.88

mmol/l

0.32

811

Viral haemorrhagic fevers, not elsewhere classified/unspecified

409

1.25

0.81

1.4

1.3

48.46

62.03

mmol/l

2.47

332

Foreign body entering into or through eye or natural orifice

418

1.25

0.81

1.3

1.4

59.95

66.62

mmol/l

0.50

338

Arthropod-borne viral fevers and viral haemorrhagic fevers

518

1.22

0.80

1.4

1.3

52.24

62.43

mmol/l

1.53

416

Contusion of other and unspecified parts of foot

181

1.39

0.80

2.0

1.6

50.61

72.78

mmol/l

2.63

156

Medicines for HER+ breast cancer

256

2736

0.91

0.79

1.4

57.60

61.28

mmol/l

0.86

198

2167

Benign neoplasm of other and unspecified sites

156

1.42

0.79

1.2

1.3

61.00

61.98

mmol/l

0.04

128

Benign neoplasm: Connective and other soft tissue, unspecified

1.68

0.79

1.5

1.4

91.38

72.53

mmol/l

—

Personal history of malignant neoplasm

173

1.39

0.79

1.7

1.4

64.47

62.14

mmol/l

0.13

139

Paranoid personality disorder

1.68

0.79

1.1

1.3

68.80

63.03

mmol/l

—

Reactive arthropathies, FINNGEN

339

1.27

0.78

1.5

1.4

56.14

65.16

mmol/l

1.03

268

Peritonsillar abscess

113

980

1.15

0.78

2.2

1.4

61.89

63.76

mmol/l

0.16

767

Female infertility, cervigal, vaginal, other or unspecified origin

143

842

1.14

0.77

1.4

68.14

63.42

mmol/l

0.61

124

635

Primary angle-closure glaucoma

287

1.30

0.77

1.2

1.3

61.03

60.69

mmol/l

0.02

233

Malignant neoplasm of stomach

305

1.28

0.76

1.3

54.35

62.56

mmol/l

0.91

248

False labour

627

0.85

0.75

1.2

1.5

73.61

68.61

mmol/l

0.41

486

Malignant neoplasm of pancreas

378

1.25

0.74

1.2

1.3

69.42

61.63

mmol/l

0.47

303

Other and unspecified types of non-Hodgkin lymphoma, hilmo

245

1.31

0.74

1.5

1.3

57.07

60.08

mmol/l

0.18

198

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

578

1.20

0.74

1.5

1.3

70.98

63.53

mmol/l

0.58

462

Perforation of tympanic membrane

569

1.20

0.74

1.5

1.4

62.84

64.08

mmol/l

0.09

465

Female infertility

158

867

1.13

0.73

1.5

1.4

67.73

63.71

mmol/l

0.56

139

652

Non-small cell lung cancer, squamous

263

1.30

0.73

1.2

1.3

59.37

63.58

mmol/l

0.30

212

Non-small cell lung cancer, squamous, helper endpoint

263

1.30

0.73

1.2

1.3

59.37

63.58

mmol/l

0.30

212

Tuberculosis

406

1.24

0.73

1.6

1.3

55.25

61.52

mmol/l

0.70

322

Chondropathies

819

1.16

0.73

1.3

1.4

67.46

63.56

mmol/l

0.37

660

Benign neoplasm: Rectum/anal canal icd-9

1.69

0.73

1.1

1.3

75.50

62.38

mmol/l

—

Cyst of kidney

416

1.23

0.72

1.8

1.3

55.93

61.29

mmol/l

0.53

326

Melanoma in situ

220

1.33

0.72

1.1

1.4

66.88

64.48

mmol/l

0.07

174

Other disorders of patella

100

867

1.16

0.72

1.5

1.4

65.69

64.56

mmol/l

0.09

681

Bullous keratopathy

1.60

0.72

1.4

1.3

60.89

64.67

mmol/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

467

0.79

0.71

1.5

1.4

70.03

63.51

mmol/l

0.39

367

Lichen ruber planus, wide definition including periferal and oral lichen planus

155

1385

1.12

0.71

1.4

58.99

62.89

mmol/l

0.65

121

1104

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

554

1.19

0.70

1.5

1.3

71.47

63.61

mmol/l

0.59

443

Deep endometriosis

545

1.20

0.70

1.4

55.04

62.67

mmol/l

1.04

441

Other psoriatic arthropathies

536

1.20

0.70

1.3

67.13

63.49

mmol/l

0.25

431

Other juvenile arthritis

152

1.39

0.69

1.6

1.9

60.00

75.15

mmol/l

0.82

130

Oral lichen ruber planus wide, hypothyreosis or thyroxin

338

1.25

0.68

1.4

1.3

50.70

59.52

mmol/l

1.04

274

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.64

0.67

1.1

1.2

79.14

61.53

mmol/l

—

Unspecified lump in breast

115

1014

1.14

0.67

1.2

1.4

55.21

63.02

mmol/l

1.58

802

L02BG Aromatase inhibitors

210

2299

0.91

0.66

1.4

57.69

61.43

mmol/l

0.80

161

1822

Other menopausal disorders

163

1045

0.90

0.66

1.5

1.4

57.66

61.43

mmol/l

0.59

130

791

Nasal polyp

128

1137

1.13

0.66

1.3

68.44

63.38

mmol/l

0.66

101

896

Haemorrhage in early pregnancy

117

1290

0.88

0.66

1.3

1.4

70.73

63.44

mmol/l

0.94

1003

Inflammatory disease of cervix uteri

413

1.21

0.64

1.3

63.19

61.81

mmol/l

0.07

328

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

371

0.78

0.64

1.1

1.4

62.43

61.32

mmol/l

0.05

296

Endometriosis of pelvic peritoneum

662

1.16

0.64

1.3

1.4

68.57

63.63

mmol/l

0.41

493

Pustulosis palmaris et plantaris

216

1.30

0.63

1.3

1.4

71.06

59.52

mmol/l

0.42

182

Contact with machinery

579

0.83

0.63

1.2

1.3

74.32

64.68

mmol/l

0.73

473

Deep bite

467

1.18

0.62

3.0

2.0

62.63

72.80

mmol/l

0.86

398

Vestibular neuronitis

535

1.18

0.61

1.4

64.24

61.40

mmol/l

0.21

432

Malignant neoplasm of breast

428

2907

1.06

0.60

1.3

1.4

60.59

60.78

mmol/l

0.03

330

2304

Cholera

227

1.28

0.60

1.1

1.3

67.83

59.58

mmol/l

0.40

178

Other/unspecified disorders of vestibular function

236

1.28

0.60

1.4

1.3

62.83

61.16

mmol/l

0.08

188

Foreign body in respiratory tract

272

1.25

0.59

1.2

1.5

63.42

65.34

mmol/l

0.07

219

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

281

1.25

0.59

1.2

1.4

74.96

65.80

mmol/l

0.43

228

Benign neoplasm: Skin, unspecified

219

1.28

0.58

1.5

1.4

60.90

62.13

mmol/l

0.05

180

LSIL lesion of the vagina

1.52

0.58

1.3

44.75

67.67

mmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

409

1.20

0.58

1.3

67.33

63.87

mmol/l

0.25

336

Psoriatic arthropathies, ICD10

557

1.17

0.58

1.3

67.89

63.92

mmol/l

0.28

447

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

716

1.15

0.58

1.2

1.3

58.88

61.47

mmol/l

0.26

578

Alzheimer disease, including avohilmo

315

2124

1.07

0.57

1.3

63.90

60.59

mmol/l

0.89

258

1704

Vascular syndromes of brain in cerebrovascular disorders

292

1.24

0.57

1.4

1.3

64.33

61.70

mmol/l

0.13

241

Malignant neoplasm of breast, HER-negative

179

1636

1.09

0.57

1.3

1.4

67.31

61.64

mmol/l

0.85

137

1293

Chronic diseases of tonsils and adenoids

518

3455

0.95

0.57

1.4

1.5

63.47

64.51

mmol/l

0.20

415

2705

Myocardial infarction, unclassifiable

190

1554

1.09

0.56

1.5

1.3

63.13

61.31

mmol/l

0.23

151

1242

Mixed conductive and sensorineural hearing loss

766

1.14

0.55

1.4

1.3

58.41

62.04

mmol/l

0.44

612

Recurrent dislocation of patella

133

1.36

0.55

1.0

1.5

57.46

70.34

mmol/l

0.67

116

Malignant neoplasm of breast, HER2-negative

417

2894

1.06

0.55

1.3

1.4

60.78

60.65

mmol/l

0.02

322

2294

Lichen planus, including avohilmo

135

1221

1.11

0.55

1.4

60.43

63.83

mmol/l

0.48

107

972

Spondylopathies (FG)

682

1.15

0.54

1.6

1.3

61.27

64.67

mmol/l

0.30

531

Acute appendicitis, no complications

352

3303

1.06

0.54

1.5

1.4

62.34

63.69

mmol/l

0.24

272

2563

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

853

1.13

0.53

1.3

61.88

63.52

mmol/l

0.15

683

Anti-inflammatory and antirheumatic products, non-steroids

253

1180

1.08

0.53

1.3

1.6

67.33

64.05

mmol/l

0.52

207

937

Other other unspecified disorders of the circulatory system

205

1.27

0.52

1.2

1.5

64.19

62.45

mmol/l

0.06

174

Eustachian salpingitis and obstruction

277

1.23

0.52

1.1

1.5

66.14

68.72

mmol/l

0.08

232

Pregnancy, childbirth and the puerperium

252

1417

0.93

0.52

1.3

1.4

62.32

59.94

mmol/l

0.42

197

1135

Carcinoma in situ of skin of scalp and neck

126

1.36

0.52

1.2

1.4

56.59

64.45

mmol/l

0.41

101

Haemangioma and lymphangioma, any site

443

1.18

0.51

1.5

62.87

64.44

mmol/l

0.08

362

Scleritis and episcleritis

287

1.22

0.51

1.2

1.3

61.72

61.82

mmol/l

0.00

240

Alzheimer’s disease (Late onset)

195

1543

1.08

0.51

1.3

63.55

60.65

mmol/l

0.50

154

1231

Nontoxic multinodular goitre

160

1466

1.09

0.51

1.3

1.4

59.96

61.26

mmol/l

0.18

124

1163

Congenital malformations of ovaries, fallopian tubes and broad ligaments

188

1.28

0.51

1.2

1.4

74.32

68.31

mmol/l

0.20

160

Disorders of orbit

224

1.25

0.51

1.2

1.3

65.43

60.16

mmol/l

0.30

178

Other specified disorders of external ear

191

0.73

0.51

1.7

1.3

56.63

64.76

mmol/l

—

165

Benign neoplasm: Skin of lower limb, including hip

144

1.33

0.51

1.5

1.3

57.83

60.64

mmol/l

0.09

121

Benign neoplasm of eye and adnexa

537

1.16

0.50

1.3

60.35

62.71

mmol/l

0.18

429

Triptan medication for migraine, min. 3 purchases

305

2260

1.07

0.50

1.4

71.02

63.43

mmol/l

1.87

245

1774

Papillary adenocarcinoma of thyroid gland

288

1.22

0.50

1.3

68.81

59.77

mmol/l

0.46

228

Other acute skin changes due to ultraviolet radiation

189

1.27

0.49

1.6

1.3

57.42

64.89

mmol/l

0.37

152

Other benign neoplasms of connective and other soft tissue

557

1.15

0.49

1.3

1.4

65.86

63.19

mmol/l

0.19

446

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

136

1.33

0.49

1.3

1.4

60.23

63.16

mmol/l

0.13

106

1.57

0.49

1.3

1.2

62.00

61.58

mmol/l

—

Carcinoma in situ of breast, intraductal

464

1.17

0.49

1.1

1.3

63.16

61.98

mmol/l

0.07

375

Disorders in reading

1.56

0.49

1.9

3.4

80.43

80.92

mmol/l

—

Respiratory tuberculosis

335

1.20

0.48

1.6

1.3

54.24

61.51

mmol/l

0.71

265

Respiratory tuberculosis, confirmed and not-confirmed

335

1.20

0.48

1.6

1.3

54.24

61.51

mmol/l

0.71

265

Endometriosis of ovary

100

895

1.12

0.48

1.3

1.4

63.28

62.39

mmol/l

0.08

673

Endometriosis ASRM stages 3,4

149

1366

1.09

0.48

1.4

60.54

62.49

mmol/l

0.24

124

1085

L02BB Anti-androgens

484

1.16

0.48

1.2

1.3

54.28

66.10

mmol/l

2.32

385

Alzheimer disease

268

1894

1.07

0.47

1.3

62.10

60.67

mmol/l

0.27

215

1518

Pulmonary oedema

102

1.38

0.47

1.1

1.2

54.21

62.54

mmol/l

0.41

conjunctival haemorrhage

466

1.16

0.47

1.3

68.50

64.76

mmol/l

0.26

373

Serous carcinoma of ovary

227

1.24

0.47

1.3

1.4

61.71

58.24

mmol/l

0.17

175

Artificial joint re-operation

476

1.16

0.47

1.5

1.4

58.72

60.36

mmol/l

0.11

384

Juvenile arthritis (FINNGEN)

173

1.27

0.46

1.6

1.8

60.00

71.33

mmol/l

0.56

142

Allergic urticaria

411

1.17

0.46

1.5

1.4

72.85

64.67

mmol/l

0.60

335

Reactive arthropathies

467

1.16

0.46

1.5

1.4

56.19

66.14

mmol/l

1.39

364

Testicular hypofunction

120

1.34

0.46

1.4

1.2

75.18

65.72

mmol/l

0.29

Childhood allergy (age < 16)

338

1.17

0.46

1.9

3.1

75.71

82.43

mmol/l

0.38

288

Migraine, single triptan purchase ok & required. ICD-code if available is included

473

3355

0.95

0.46

1.5

1.4

69.18

63.53

mmol/l

1.76

380

2620

Triptan medication for migraine, single purchase ok

473

3355

0.95

0.46

1.5

1.4

69.18

63.53

mmol/l

1.76

380

2620

Dermatitis due to ingested food

150

1.29

0.45

5.6

3.6

79.33

83.66

mmol/l

0.12

134

Normotensive glaucoma

600

1.14

0.45

1.4

1.3

59.90

61.11

mmol/l

0.10

479

Contact with nonpowered hand tool

192

1.25

0.45

1.5

1.3

68.32

65.41

mmol/l

0.10

160

Pregnancy examination and test

308

0.85

0.44

1.3

1.4

79.27

64.33

mmol/l

0.93

231

Melanocytic naevi of other and unspecified parts of face

275

1.20

0.43

1.6

1.4

62.12

66.74

mmol/l

0.27

224

Anogenital herpesviral [herpes simplex] infection

193

1.25

0.43

1.4

1.5

51.84

69.79

mmol/l

1.95

162

Premenstrual syndrome

1.62

0.43

2.2

1.2

65.60

69.74

mmol/l

—

Foreign body on external eye

724

0.88

0.43

1.4

1.3

62.43

64.77

mmol/l

0.16

578

Calcaneal spur

1.44

0.42

1.0

1.3

71.50

63.09

mmol/l

—

Lichen sclerosus et atrophicus

641

1.13

0.42

1.6

1.3

73.33

61.42

mmol/l

1.69

515

Malignant neoplasm of other and unspecified parts of biliary tract

1.44

0.42

1.3

61.60

64.23

mmol/l

—

Retained placenta and membranes, without haemorrhage

613

1.13

0.42

1.3

1.4

60.14

65.23

mmol/l

0.51

477

Cyst of Bartholin Gland

158

1.27

0.42

1.7

1.3

59.73

64.04

mmol/l

0.23

131

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

501

1.11

0.41

1.6

1.5

71.79

69.25

mmol/l

0.18

386

Use of pergolide

0.00

0.41

0.0

1.0

—

57.07

—

Other obstetric conditions, not elsewhere classified

520

1.11

0.41

1.6

1.5

70.53

68.64

mmol/l

0.13

402

Acne varioliformis

0.00

0.41

0.0

1.3

—

64.13

—

Explosion of other materials

0.00

0.41

0.0

1.4

—

66.00

—

Congenital malformations of uterus and cervix

1.34

0.40

1.1

1.4

98.50

74.91

mmol/l

—

Pustular psoriasis

241

1.21

0.40

1.3

1.4

73.68

59.79

mmol/l

0.55

195

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

1.35

0.39

1.2

1.4

58.86

63.69

mmol/l

—

Thyrotoxicosis with toxic multinodular goitre

390

1.16

0.39

1.5

1.3

58.47

59.37

mmol/l

0.05

315

Adhesive capsulitis of shoulder

110

1007

1.09

0.39

1.4

1.3

62.51

63.91

mmol/l

0.16

793

Malignant neoplasm of bladder

409

1.15

0.39

1.4

1.3

55.70

64.26

mmol/l

0.80

320

Benign neoplasm of bone and articular cartilage

363

1.16

0.38

1.4

1.5

58.71

68.50

mmol/l

0.77

294

Myocardial infarction, with ST-elevation

111

1207

0.92

0.38

1.3

63.69

62.42

mmol/l

0.15

960

Carcinoma in situ of skin of scalp and neck

134

1.27

0.37

1.2

1.3

56.59

61.42

mmol/l

0.23

110

Mouth breathing

270

2560

1.05

0.37

1.6

1.5

66.39

64.65

mmol/l

0.27

223

2021

Caught, crushed, jammed or pinched in or between objects

198

1.21

0.36

1.3

1.4

53.39

69.38

mmol/l

1.04

163

Dementia in Alzheimer disease

150

1195

1.07

0.36

1.3

63.63

60.39

mmol/l

0.50

115

947

Other/unspecified enthesopathies, not elsewhere classified

488

1.13

0.36

1.4

1.3

63.43

63.55

mmol/l

0.01

378

Other and unspecified disorders of vitreous body

294

3069

0.95

0.35

1.3

1.4

62.19

62.41

mmol/l

0.03

231

2439

Benign neoplasm of ovary

123

1140

1.08

0.35

1.5

1.4

57.37

62.80

mmol/l

1.04

106

906

Cysts of oral region, not elsewhere classified

199

1.21

0.35

1.5

1.3

59.89

58.81

mmol/l

0.04

161

Gestational [pregnancy-induced] hypertension

111

1022

1.08

0.35

1.3

1.4

71.59

64.83

mmol/l

0.77

795

Benign neoplasm of thyroid gland

189

0.79

0.34

1.2

1.3

85.88

60.15

mmol/l

—

156

Disorders of breast

350

3106

1.04

0.34

1.4

57.60

62.24

mmol/l

1.47

277

2457

Nontoxic goitre/thyroid nodule

242

2298

1.05

0.34

1.3

1.4

62.03

62.06

mmol/l

0.00

190

1836

LSIL lesion of the vulva

136

1.25

0.33

1.3

49.00

65.50

mmol/l

1.52

109

Haemangioma, any site

415

1.13

0.33

1.5

59.53

64.58

mmol/l

0.33

340

Nontoxic single thyroid nodule

426

1.13

0.32

1.1

1.3

65.90

62.11

mmol/l

0.25

342

Malignant neoplasm of oesophagus

137

1.25

0.32

1.4

1.3

73.67

62.68

mmol/l

0.61

117

Testicular dysfunction

137

1.24

0.32

1.4

1.3

77.00

65.62

mmol/l

0.40

111

Benign neoplasm: Appendix

1.35

0.31

1.6

1.4

43.43

71.36

mmol/l

—

Other obstructed labour

337

0.86

0.31

1.7

1.4

49.00

68.36

mmol/l

1.96

266

Uterine polyps

532

1.11

0.31

1.2

1.4

66.21

61.92

mmol/l

0.29

398

Abnormal spermatozoa

666

1.10

0.31

1.6

1.3

65.70

65.52

mmol/l

0.01

539

Benign neoplasm: Parathyroid gland

1.33

0.31

1.4

85.00

70.31

mmol/l

—

Melanoma in situ

249

1.17

0.30

1.1

1.3

66.88

62.81

mmol/l

0.13

200

Benign neoplasm of other and unspecified sites

184

1.20

0.30

1.2

1.3

61.00

64.29

mmol/l

0.15

154

Leiomyoma of uterus

317

1711

1.04

0.30

1.3

1.4

59.13

62.94

mmol/l

0.94

256

1354

Tooth eruption problems

444

1.12

0.29

2.1

70.39

73.73

mmol/l

0.19

371

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

307

1.14

0.28

1.2

1.4

74.96

65.83

mmol/l

0.43

252

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

354

2781

1.04

0.28

1.5

1.4

60.95

64.34

mmol/l

0.83

299

2190

Plantar fascial fibromatosis

497

1.11

0.28

1.5

1.3

66.89

63.62

mmol/l

0.23

387

Hordeolum and other deep inflammation of eyelid

251

1.16

0.28

1.7

1.4

48.05

64.61

mmol/l

1.57

200

Pilonidal cyst

317

1.14

0.28

1.5

1.4

65.52

70.08

mmol/l

0.21

250

Benign neoplasm: Skin of lip

1.30

0.28

1.3

1.5

67.25

66.54

mmol/l

—

Use of selegiline

290

0.86

0.27

1.3

70.41

60.50

mmol/l

0.47

234

Impotence

252

1.15

0.27

1.2

1.3

63.14

65.66

mmol/l

0.13

207

Benign neoplasm: Skin of lip

1.23

0.27

1.3

1.4

67.25

63.83

mmol/l

—

Maternal care for known or suspected disproportion

113

1.24

0.26

1.2

1.6

53.43

68.31

mmol/l

—

Use of galantamine

531

0.90

0.26

1.4

1.3

67.46

60.01

mmol/l

0.70

421

Injury of muscle and tendon at hip and thigh level

489

0.90

0.26

1.4

1.3

63.74

62.97

mmol/l

0.04

394

Hypertrophy of breast in women and men

106

992

1.07

0.26

1.5

1.4

58.26

64.56

mmol/l

1.03

785

Granuloma annulare

0.69

0.26

1.6

1.2

52.20

65.48

mmol/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

197

1.17

0.26

1.3

1.4

67.75

59.49

mmol/l

0.43

160

Other/unspecified reactive arthropathies

339

1.12

0.25

1.5

1.4

57.81

64.84

mmol/l

0.65

281

Excessive vomiting in pregnancy

292

1.13

0.25

1.3

1.5

56.36

63.89

mmol/l

0.75

237

Lichen planus

822

1.07

0.24

1.3

63.09

61.80

mmol/l

0.11

662

LSIL lesion of the cervix uteri, vagina or vulva

552

1.09

0.23

1.6

1.4

55.76

64.85

mmol/l

1.29

430

Preterm labour and delivery

124

1309

0.95

0.23

1.5

1.4

64.30

63.90

mmol/l

0.03

104

1013

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

239

1866

1.04

0.22

1.4

56.24

62.06

mmol/l

1.63

186

1488

Internal derangement of knee

249

2393

1.04

0.22

1.4

58.49

62.62

mmol/l

0.88

202

1868

Other benign neoplasm of uterus: Corpus uteri

1.25

0.22

1.0

1.3

54.80

61.58

mmol/l

—

Congenital deformities of feet

0.75

0.22

1.1

1.5

52.86

78.20

mmol/l

—

Struck by thrown, projected or falling objec

200

1.15

0.22

1.5

79.78

65.69

mmol/l

0.56

169

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

699

1.07

0.22

1.1

1.4

57.33

64.26

mmol/l

0.88

559

Acute appendicitis, with complications

111

1174

0.94

0.22

1.4

73.09

63.52

mmol/l

1.38

934

Other lesions of median nerve

172

1.17

0.22

1.4

1.3

56.21

58.86

mmol/l

0.13

135

Muscular dystrophy

1.22

0.22

1.4

1.6

90.00

75.06

mmol/l

—

Inflammatory myopathy

0.00

0.21

0.0

1.6

—

66.80

—

Benign neoplasm: Penis

0.00

0.21

0.0

1.6

—

62.30

—

Sunburn

0.00

0.21

0.0

1.5

—

71.10

—

Upper arm

0.00

0.21

0.0

1.4

—

61.64

—

Benign neoplasm: Extrahepatic bile ducts

0.00

0.21

0.0

1.5

—

60.00

—

Inhalation of gastric contents

0.00

0.21

0.0

1.5

—

71.10

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.21

0.0

1.3

—

55.60

—

Maxillary hypoplasia

0.00

0.21

0.0

1.9

—

79.80

—

Erythrasma

0.00

0.21

0.0

1.5

—

78.33

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.21

0.0

1.2

—

50.67

—

Pseudopolyposis of colon

0.00

0.21

0.0

1.6

—

51.33

—

Follicular lymphoma, hilmo

258

1.13

0.21

1.4

1.3

66.46

60.45

mmol/l

0.30

204

Retinal breaks without detachment

101

954

1.06

0.21

1.3

1.4

56.82

63.64

mmol/l

1.38

751

Craniosynostosis EXCLUDE syndromes

0.00

0.21

0.0

1.5

—

85.00

—

Other disorders of breast

721

1.07

0.20

1.5

1.4

62.64

63.97

mmol/l

0.09

574

Other and/or unspecified nontoxic goitre

518

1.08

0.20

1.4

1.3

62.49

60.60

mmol/l

0.13

415

Relapsing polychondritis

0.00

0.20

0.0

1.4

—

50.64

—

Ankylosing spondylitis, ICD10

441

1.09

0.20

1.5

1.4

61.44

64.64

mmol/l

0.24

361

Congenital malformations of ear causing impairment of hearing

0.00

0.20

0.0

2.4

—

57.21

—

Use of glatiramer acetate

1.25

0.20

1.0

1.4

53.33

67.86

mmol/l

—

LSIL lesion of the cervix uteri

374

1.10

0.20

1.7

1.4

59.39

66.54

mmol/l

0.63

304

Dislocation, sprain and strain of joints and ligaments of elbow

288

1.11

0.20

2.1

1.5

60.73

66.90

mmol/l

0.35

244

Rheumatic fever incl heart disease

174

1.15

0.19

1.3

56.64

61.86

mmol/l

0.21

139

Spermatocele

375

1.09

0.19

1.4

1.3

75.39

66.20

mmol/l

0.55

305

Adenocarcinoma and papillary adenocarcinoma of stomach

156

1.16

0.18

1.3

60.23

63.96

mmol/l

0.17

126

Infectious mononucleosis

238

0.88

0.18

1.3

1.5

105.00

72.55

mmol/l

1.41

202

Nonspecific lymphadenitis

280

1.11

0.18

1.4

1.3

56.12

64.09

mmol/l

0.50

232

Medical treatment for female infertility

549

1.07

0.18

1.4

1.5

83.77

68.34

mmol/l

1.14

429

Alzheimer’s disease, wide definition

203

1639

1.04

0.18

1.3

64.18

60.63

mmol/l

0.67

161

1305

Lumbosacral root disorders, not elsewhere classified

1.19

0.18

1.1

1.2

66.14

60.52

mmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

321

0.90

0.18

1.1

1.4

62.43

64.12

mmol/l

0.07

261

Benign neoplasm: Parathyroid gland

1.17

0.18

1.4

1.3

85.00

64.36

mmol/l

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

214

1.12

0.17

1.3

62.00

60.17

mmol/l

0.09

173

Calcific tendinitis of shoulder

281

1.10

0.17

1.3

60.21

64.37

mmol/l

0.16

221

Benign neoplasm: Appendix

1.13

0.17

1.6

1.3

43.43

62.40

mmol/l

—

Malignant melanoma of skin

702

0.94

0.17

1.4

1.3

59.64

62.15

mmol/l

0.19

564

Benign leiomyoma with endometriosis

114

1089

1.05

0.17

1.3

1.4

58.66

62.78

mmol/l

0.66

873

Melanocytic naevi of other and unspecified parts of face

301

1.10

0.17

1.6

1.3

62.12

64.58

mmol/l

0.13

246

Preparation and fitting of bite rail to mouth

650

1.06

0.17

1.5

1.4

66.33

66.22

mmol/l

0.01

516

Benign mammary dysplasia

110

1052

1.05

0.16

1.4

60.13

62.02

mmol/l

0.19

833

Torsion of ovary, ovarian pedicle and fallopian tube

1.14

0.16

1.4

1.5

56.00

63.49

mmol/l

—

Otosclerosis

494

0.93

0.16

1.6

1.3

75.22

61.12

mmol/l

0.94

397

Suppurative otitis media, unspecified

111

1.17

0.15

1.2

1.4

74.75

69.41

mmol/l

—

Contact with other sharp object(s)

245

1.10

0.15

1.5

1.4

64.62

71.51

mmol/l

0.32

200

Malignant neoplasm of corpus uteri

635

1.06

0.14

1.1

1.3

57.79

59.15

mmol/l

0.13

499

Acute appendicitis

463

4288

1.02

0.14

1.4

64.97

63.93

mmol/l

0.20

360

3346

Dental caries 1 and operation codes, only avohilmo

217

1122

0.97

0.14

1.5

1.6

68.31

65.83

mmol/l

0.30

182

896

Benign neoplasm: Choroid

357

0.92

0.14

1.2

1.3

59.59

60.61

mmol/l

0.06

288

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

787

0.95

0.14

1.1

1.3

57.33

62.51

mmol/l

0.59

626

Dissection of aorta

170

1.12

0.13

1.1

1.2

84.79

65.06

mmol/l

1.06

141

Erythema nodosum

151

1.13

0.13

1.4

43.09

63.25

mmol/l

2.53

126

Infections of genitourinary tract in pregnancy

437

0.94

0.12

1.5

1.4

60.07

63.75

mmol/l

0.20

345

Malignant melanoma

943

1.04

0.12

1.3

62.30

63.25

mmol/l

0.07

771

Pregnancy with abortive outcome

494

2542

1.02

0.12

1.3

1.4

62.30

61.38

mmol/l

0.18

402

2013

Benign lipomatous neoplasm

201

1961

1.03

0.12

1.3

1.4

60.91

62.90

mmol/l

0.31

167

1549

L02BA Anti-estrogens

105

1087

0.97

0.11

1.4

54.67

61.98

mmol/l

1.17

869

MS-disease / Multiple Sclerosis

269

1.08

0.11

1.3

1.4

60.67

66.28

mmol/l

0.33

226

Anomalies of dental arch relationship, including avohilmo

805

1.04

0.11

2.3

1.7

67.00

69.99

mmol/l

0.22

651

Use of levodopa decarbox-comt-inhibitor

192

1.10

0.11

1.1

1.3

75.13

63.71

mmol/l

0.66

157

Achilles tendinitis

534

1.05

0.10

1.2

1.3

58.76

60.68

mmol/l

0.17

414

Calculus of lower urinary tract

290

0.93

0.10

1.6

1.3

59.87

65.26

mmol/l

0.32

236

Habitual aborter

1.14

0.10

1.0

1.6

141.60

80.29

mmol/l

—

Other keratitis

555

1.05

0.10

1.5

1.4

56.64

62.74

mmol/l

0.50

446

Benign neoplasm: Bladder

1.11

0.10

1.8

1.4

74.00

67.67

mmol/l

—

Benign neoplasm of thyroid gland

166

0.90

0.09

1.2

1.4

85.88

58.96

mmol/l

—

140

Postprocedural disorders of ear and mastoid process, not elsewhere classified

1.06

0.09

1.2

1.4

69.80

65.10

mmol/l

—

Injury of muscle and tendon at shoulder and upper arm level

232

2362

0.98

0.09

1.3

61.31

63.98

mmol/l

0.41

188

1877

Dental caries 2, only avohilmo

488

3802

1.01

0.09

1.6

1.5

64.80

65.13

mmol/l

0.05

399

3004

Lesion of sciatic nerve

298

0.94

0.08

1.2

1.3

61.14

60.23

mmol/l

0.04

238

Myelodysplastic syndrome

1.04

0.08

1.7

1.3

51.83

60.13

mmol/l

—

Early lumbar disc prolapse, operated

312

1.06

0.08

1.7

1.4

68.78

67.78

mmol/l

0.05

241

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

627

1.04

0.08

1.5

1.3

71.66

61.70

mmol/l

0.83

501

Conductive hearing loss, unspecified

440

0.95

0.08

3.0

1.4

75.06

63.16

mmol/l

0.72

348

Benign leiomyoma with endometriosis

114

1169

0.97

0.08

1.3

1.4

58.66

61.67

mmol/l

0.43

929

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.03

0.08

1.3

75.14

70.24

mmol/l

—

Chalazion

591

0.96

0.07

1.5

1.4

55.84

64.64

mmol/l

0.93

470

Benign neoplasm of ovary

123

1258

0.98

0.07

1.5

1.4

57.37

61.98

mmol/l

0.82

106

997

Benign neoplasm: Connective and other soft tissue of head, face and neck

0.87

0.07

1.3

75.14

70.43

mmol/l

—

Benign neoplasm: Choroid

314

1.05

0.07

1.2

1.4

59.59

64.16

mmol/l

0.34

255

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

226

1.06

0.06

1.1

1.4

65.59

64.00

mmol/l

0.06

176

Bicipital tendinitis

234

0.94

0.06

1.8

1.3

89.06

61.84

mmol/l

1.43

184

Laparoscopic right hemicolectomy

374

1.04

0.06

1.1

1.4

53.35

59.32

mmol/l

0.76

307

Pterygium

162

0.92

0.06

1.3

1.4

54.20

64.19

mmol/l

—

135

Benign neoplasm of eye and adnexa

604

1.03

0.05

1.3

60.35

62.19

mmol/l

0.13

483

Labour and delivery complicated by umbilical cord complications

171

0.94

0.05

1.3

1.5

56.91

68.10

mmol/l

0.30

137

Transient global amnesia

646

0.97

0.05

1.3

68.41

60.80

mmol/l

0.57

514

Other osteochondropathies

333

0.96

0.05

1.2

1.4

66.41

67.33

mmol/l

0.04

279

Diseases of appendix

505

4569

1.01

0.04

1.4

64.98

63.57

mmol/l

0.31

397

3571

Adenomyosis (Endometriosis of uterus)

844

1.02

0.04

1.2

1.4

63.03

61.19

mmol/l

0.17

640

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

477

1.03

0.04

1.3

1.4

67.33

62.32

mmol/l

0.39

382

Leiomyoma of uterus

479

2741

0.99

0.04

1.4

60.46

61.33

mmol/l

0.18

384

2162

Benign neoplasm of bone and articular cartilage

408

1.03

0.04

1.4

58.71

65.77

mmol/l

0.49

329

Presbyopia

299

1.04

0.03

1.6

1.2

59.35

61.87

mmol/l

0.13

247

Appendicitis, broad definition

498

4527

1.01

0.03

1.4

64.82

63.77

mmol/l

0.21

392

3535

Use of ropinirole

229

0.96

0.03

1.5

1.3

81.82

62.39

mmol/l

1.14

188

Adenocarcinoma and papilloma adenocarcinoma of rectum

599

1.02

0.02

1.5

1.3

70.50

61.77

mmol/l

0.66

478

Dental caries 3 and operation codes, only avohilmo

251

1269

0.99

0.02

1.4

1.6

67.83

65.80

mmol/l

0.27

212

1022

Oral lichen ruber planus, including avohilmo

341

1.03

0.02

1.5

1.4

60.74

59.59

mmol/l

0.06

275

Hypertrophy of breast

840

0.99

0.02

1.5

1.4

59.14

64.75

mmol/l

0.69

660

Haemangioma and lymphangioma, any site

511

1.02

0.02

1.5

62.87

63.98

mmol/l

0.06

411

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

139

1379

1.01

0.02

1.3

1.4

59.32

63.15

mmol/l

0.58

111

1120

Exposure to other and unspecified animate mechanical forces

107

0.93

0.02

2.3

1.6

64.10

72.72

mmol/l

—

Maternal care for other conditions predominantly related to pregnancy

650

0.99

0.01

1.3

1.5

68.65

68.58

mmol/l

0.00

497

Haemangioma, any site

478

0.98

0.01

1.5

59.53

62.77

mmol/l

0.19

386

Malignant neoplasm of rectum

598

0.99

0.01

1.6

1.3

67.35

62.36

mmol/l

0.34

474

Other blood glucose lowering drugs, excl. Insulins

119

1183

1.01

0.00

1.4

1.3

65.70

61.92

mmol/l

0.46

954

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

256

0.98

0.00

1.6

1.3

48.06

67.10

mmol/l

1.46

203

Abnormal findings in secretions and smears from cervix uteri vagina vulva

256

2008

1.00

0.00

1.5

1.4

59.61

64.42

mmol/l

1.05

216

1568

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

235

0.98

0.00

1.3

67.75

61.13

mmol/l

0.33

197

Tooth agenesis EXCLUDE clefts and syndromes

116

1.03

0.00

2.0

2.6

68.25

76.17

mmol/l

0.17

105

Early lumbar disc prolapse operation

355

0.99

0.00

1.6

1.4

70.93

66.75

mmol/l

0.24

284

Bitten or struck by other mammals

465

0.99

0.00

1.3

1.4

54.90

64.49

mmol/l

0.55

384

Recurrent dislocation and subluxation of joint

279

1.00

0.00

1.8

1.3

72.15

66.26

mmol/l

0.20

220

Pathological resorption of teeth

128

1.02

0.00

1.5

1.4

40.88

59.19

mmol/l

—

100

Carcinoma in situ of breast, intraductal

544

0.99

0.00

1.1

1.3

63.16

59.94

mmol/l

0.21

426

Alzheimer’s disease (Atypical or mixed)

689

1.00

0.00

1.3

55.60

59.89

mmol/l

0.52

542

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

343

0.99

0.00

1.6

1.4

71.00

64.87

mmol/l

0.24

271

Mandibular retrognathia

255

1.02

0.00

1.8

2.2

66.10

70.73

mmol/l

0.21

222

Chronic suppurative otitis media, including avohilmo

455

0.99

0.00

1.6

1.5

61.20

65.68

mmol/l

0.28

368

Chronic suppurative otitis media

392

0.99

0.00

1.4

61.63

65.29

mmol/l

0.19

319

Cyst of iris, ciliary body and anterior chamber

0.00

0.0

2.0

—

49.50

—

Hereditary angioödema type 1

0.00

0.0

1.0

—

55.60

—

Other and unspecified disorders of sclera

0.00

0.0

1.8

—

69.83

—

Accident to watercraft causing other injury

0.00

0.0

1.8

—

41.40

—

Other histiocytosis syndromes

0.00

0.0

1.0

—

93.29

—

Retained (old) intraocular foreign body

0.00

0.0

1.7

—

67.50

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.0

1.0

—

53.11

—

Syndactyly

0.00

0.0

1.7

—

44.83

—

Malignant neoplasm of meninges

0.00

0.0

1.4

—

71.60

—

Noninfective disorders of pinna

0.00

0.0

1.3

—

75.50

—

Sleepwalking [somnambulism]

0.00

0.0

2.3

—

57.88

—

Airway disease due to specific organic dust

0.00

0.0

1.4

—

66.67

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.0

1.8

—

53.00

—

Defect, injury or illness of skull

0.00

0.0

1.7

—

74.67

—

Benign neoplasm: Ciliary body

0.00

0.0

1.6

—

63.44

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.0

1.2

—

61.67

—

Fracture of upper limb, level unspecified

0.00

0.0

1.2

—

79.83

—

Crushing injury of shoulder and upper arm

0.00

0.0

1.8

—

64.40

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

0.0

2.0

—

50.40

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

0.00

0.0

1.6

—

72.38

—

Malignant neoplasms of independent (primary) multiple sites

0.00

0.0

1.4

—

69.20

—

Injury of blood vessels at shoulder and upper arm level

0.00

0.0

1.8

—

53.75

—

Carcinoma in situ of stomach

0.00

0.0

1.2

—

53.20

—

Benign neoplasm of mesothelial tissue

0.00

0.0

1.8

—

50.00

—

Traumatic amputation of hip and thigh

0.00

0.0

2.0

—

55.78

—

Carcinoma in situ, other/unspecified

0.00

0.0

1.2

—

55.60

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.3

—

57.25

—

Carcinoma in situ of anus and anal canal

0.00

0.0

1.2

—

59.40

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

0.0

1.3

—

44.83

—

Exposure to high-pressure jet

0.00

0.0

1.7

—

72.33

—

Digeorge syndrome

0.00

0.0

2.2

—

89.60

—

Atrophy of thyroid (acquired)

0.00

0.0

1.7

—

60.14

—

Other combined immunodeficiencies

0.00

0.0

1.2

—

41.33

—

Persistent hyperplasia of thymus

0.00

0.0

1.0

—

66.83

—

Accident to watercraft causing drowning and submersion

0.00

0.0

2.2

—

42.60

—

Occupant of railway train or railway vehicle injured in transport accident

0.00

0.0

1.6

—

66.14

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

0.0

1.8

—

57.25

—

Brain mixed glioma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.8

—

49.20

—

Toxic encephalopathy

0.00

0.0

1.3

—

65.67

—

Malignant neoplasm of placenta, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

91.00

—

Indeterminate sex and pseudohermaphroditism

0.00

0.0

1.4

—

86.86

—

Exposure to high and low air pressure and changes in air pressure

0.00

0.0

1.7

—

67.50

—

Malignant neoplasm of other and unspecified male genital organs

0.00

0.0

1.5

—

55.25

—

Merkel cell carcinoma of skin, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

53.17

—

Unspecified drowning and submersion

0.00

0.0

1.0

—

60.60

—

Endometriosis ASRM stages 1,2

810

1.00

0.00

1.3

1.4

69.00

62.94

mmol/l

0.55

640

Myopathy due to other toxic agents

0.00

0.0

1.2

—

71.60

—

Other and unspecified disorders of lacrimal system

0.00

0.0

1.2

—

51.80

—

Nanophthalmos, microphthalmos and macrophthalmos

0.00

0.0

2.2

—

67.60

—

Merkel cell carcinoma of skin

0.00

0.0

1.4

—

55.86

—

Polyarteritis nodosa and related conditions

0.95

0.00

1.5

1.4

51.50

66.87

mmol/l

—

Hypotony of eye

0.00

0.0

1.6

—

48.13

—

Benign neoplasm of mesothelial tissue

0.00

0.0

1.7

—

56.50

—

Benign neoplasm: Connective and other soft tissue of pelvis

0.00

0.0

3.1

—

79.67

—

Hydroxyapatite deposition disease

0.00

0.0

2.0

—

31.60

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.0

1.3

—

61.38

—

Night blindness

0.00

0.0

1.0

—

68.40

—

Mucinosis of skin

0.00

0.0

1.7

—

75.50

—

Traumatic subcutaneous emphysema

0.00

0.0

1.0

—

83.40

—

Moyamoya

0.00

0.0

1.7

—

79.17

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.2

—

55.00

—

Benign neoplasm: Penis

0.00

0.0

1.6

—

90.57

—

Mosquito-borne viral encephalitis

0.00

0.0

1.2

—

53.40

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

0.0

1.3

—

51.13

—

Gastric ulcer - Acute with haemorrhage, drug-induced

0.00

0.0

1.1

—

61.37

—

Carcinoma in situ of anus and anal canal

0.00

0.0

1.0

—

60.20

—

Kaschin-Beck disease

0.00

0.0

1.1

—

50.56

—

Disorders of muscle in diseases classified elsewhere

0.00

0.0

2.7

—

49.17

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

0.0

1.3

—

81.00

—

Brain mixed glioma

0.00

0.0

1.5

—

55.88

—

Knuckle pads

0.00

0.0

1.2

—

55.67

—

Juvenile dermatomyositis

0.00

0.0

1.0

—

78.60

—

Macular pucker, drug-induced

0.00

0.0

1.5

—

48.17

—

Other disorders of bone development and growth

0.00

0.0

1.4

—

65.20

—

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

0.00

0.0

1.3

—

52.17

—

Calculus of urinary tract in diseases classified elsewhere

0.00

0.0

1.8

—

61.20

—

Functional disorders of polymorphonuclear neutrophils

0.00

0.0

1.2

—

51.00

—

Acquired ichthyosis

0.00

0.0

2.0

—

56.00

—

Unspecified hairloss

0.00

-0.00

0.0

1.6

—

66.22

—

Abnormalities of ear ossicles

0.00

-0.00

0.0

1.6

—

62.44

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sodium [Moles/volume] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS